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Abstract
Alzheimer’s disease, the most common form of dementia, is an extremely serious health prob-
lem, and one that will become even more so in the coming decades as the global population
ages. This has led to a massive effort to develop both new treatments for the condition and
new methods of diagnosis; in fact the two are intimately linked as future treatments will depend
on earlier diagnosis, which in turn requires the development of biomarkers that can be used to
identify and track the disease. This is made possible by studies such as the Alzheimer’s dis-
ease neuroimaging initiative which provides previously unimaginable quantities of imaging and
other data freely to researchers.
It is the task of early diagnosis that this thesis focuses on. We do so by borrowing modern
machine learning techniques, and applying them to image data. In particular, we use Gaussian
processes (GPs), a previously neglected tool, and show they can be used in place of the more
widely used support vector machine (SVM). As combinations of complementary biomarkers
have been shown to be more useful than the biomarkers are individually, we go on to show GPs
can also be applied to integrate different types of image and non-image data, and thanks to their
properties this improves results further than it does with SVMs.
In the ﬁnal two chapters, we also look at different ways to formulate both the prediction of
conversion to Alzheimer’s disease as a machine learning problem and the way image data can
be used to generate features for input as a machine learning algorithm. Both of these show how
unconventional approaches may improve results.
The result is an advance in the state-of-the-art for a very clinically important problem,
which may prove useful in practice and show a direction of future research to further increase
the usefulness of such methods.Acknowledgements 5
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Chapter 1
Introduction
1.1 Alzheimer’s disease biology and biomarkers
Alzheimer’s disease (AD) is a condition causing dementia, primarily in the elderly popu-
lation. The condition is named for Alois Alzheimer, a German psychiatrist who was the
ﬁrst to identify and describe the condition, and link its symptoms and pathology in 1906
[Berchtold and Cotman, 1998]. While a number of other conditions are known to cause de-
mentia, AD remains by far the most common, although it may often occur alongside other
dementia-causing conditions such as vascular dementia, the second most common such disease
[Zekry et al., 2002]. A small minority of AD cases are inherited familial AD, but the vast major-
ity of cases occur sporadically and among these, age is by far the most important risk factor. The
prevalance among people over 84 years old is estimated to be up to 42% [Hebert et al., 2003].
As a consequence of ageing populations worldwide, due to improved healthcare and living
conditions, the number of people living with AD is expected to rise to a global total of more
than 100 million in 2050 [Brookmeyer et al., 2007], which would represent a quadrupling since
2006. This will translate into a huge economic impact; as AD cannot be cured and gradually
progresses, producing increasingly severe symptoms, it results in huge costs from patient care
alongside lost productivity of patients and carers. The consequent costs were estimated at $100
billion annually in the US in 1998 [Meek et al., 1998]. The early stages of AD are marked by
short term memory loss, with the symptoms progressing to loss of longer term memories and
other cognitive domains. AD ultimately leads to death, with no cure currently in existence.
1.2 Diagnosis of Alzheimer’s disease
Typically, in the clinic a diagnosis of probable AD is made based on a set of consensus cri-
teria which are regularly reviewed [McKhann et al., 2011]. Such a diagnosis may be based
on examining the patient and their medical history, and interviewing them and those they are
in regular contact with, as well as cognitive testing such as mini-mental state examination1.3. Neuropathology of Alzheimer’s disease 16
(MMSE) [Folstein et al., 1975] or the Alzheimer’s disease assessment scale cognitive subscale
(ADAS-cog) [Rosen et al., 1984], and imaging. This is known as probable AD because the
gold standard for AD diagnosis is based on histology and so can only be made at autopsy
[Kist and Hastie, 1995]. The correspondence between a diagnosis in the clinic and subsequent
conﬁrmation by autopsy has been studied and found to be high [Ranginwala et al., 2008] al-
though this may vary substantially between different AD centres [Beach et al., 2012]. In more
recent years, the emphasis has shifted heavily to diagnosing the condition in its very early stages
[Chong and Sahadevan, 2005], as the disease process is thought to begin long before symptoms
become obvious, and future disease modifying treatments will be of most use to patients at
this stage. This has led to the introduction of the concept of mild cognitive impairment (MCI)
[Petersen et al., 1999], deﬁned as a memory impairment greater than would be expected from
normal ageing, but less than that of AD, and which does not affect a patient’s ability to carry
out routine tasks from day to day. Diagnostic criteria for MCI match this deﬁnition. MCI can
be seen as a risk state for AD because the annual rate of conversion from MCI to AD is 10-
15%, as opposed to only 1-2% for the general population. However MCI cannot be seen as
equivalent to actual prodromal AD, as MCI is in fact quite heterogenous and can be the mani-
festation of a variety of different conditions [Dubois and Albert, 2004]. However a subtype of
MCI is recognised as being the early stages of AD, known as MCI due to Alzheimer’s disease
[Albert et al., 2011].
1.3 Neuropathology of Alzheimer’s disease
The effect of AD pathology on the gross scale is characterised by atrophy caused by loss of
neurons, most marked in several structures in the brain’s temporal lobes and in enlargement of
the ventricles. However, such changes are also present in normal ageing [Raz et al., 2005] but
proceed at a much slower pace. A more speciﬁc effect of AD is seen in amyloid plaques and
neuroﬁbrillary tangles.
Plaques are dense aggregates of insoluble protein that form around neurons. In AD, their
main constituent is beta amyloid (A); however plaques have also been observed in the brains
of undemented elderly people and it is the speciﬁc distribution of plaques, not their mere pres-
ence, that is indicative of AD [Bouras et al., 1994]. A exists in two common forms, A40
and A42. Both are formed from sequential cleavage of the amyloid precursor protein by the
enzymes - and - secretase. The more common A40 form is soluble and is found in cere-
brospinal ﬂuid (CSF) [Ghiso and Frangione, 2002] whereas the insoluble A42 form is pro-
duced when cleavage by  secretase occurs at the A42 rather than A40 residue [Selkoe, 2004]1.4. Treatment of Alzheimer’s disease 17
Figure 1.1: Formation of plaques from APP. Courtesy of National Institute on Aging/National
Institutes of Health, http://www.nia.nih.gov/alzheimers/scientiﬁc-images.
and is strongly implicated in AD [Yin et al., 2007]. The resulting plaques are toxic to neurons
[Yankner et al., 1990].
Neuroﬁbrillary tangles (NFTs) are bundles of insoluble protein that accumulate inside neu-
rons. Similarly to plaques, different types of NFT are associated with different conditions, and
they are also sometimes found in otherwise healthy brains, so it is the pattern and type of NFT
rather than their presence that is indicative of AD [Bouras et al., 1994]. The primary protein in
NFTs is tau protein. AD disrupts the dephosphorylation of tau protein, leading to hyperphos-
phorylation. This means that the tau can no longer perform its role in assisting the stabilisation
of microtubules within the neuron, causing them to begin to disintegrate. The unbound tau
instead clumps together to form tangles [Lee et al., 2005].
1.4 Treatment of Alzheimer’s disease
Currently available treatments for AD remain entirely targeted at treating the symptoms rather
than interrupting the disease process. Of the ﬁve drugs, four are targeted at the reduction in
activity of cholinergic neurons which marks AD [Geula and Mesulam, 1995]. They do this by
acting as acetylcholinesterase inhibitors which slow down the rate at which acetylcholine is
broken down, which partially compensates for the loss of cholinergic neurons [Stahl, 2000].1.5. Alzheimer’s Disease biomarkers 18
Figure 1.2: Formation of neuroﬁbrillary tangles and their interaction with neu-
rons. Courtesy of National Institute on Aging/National Institutes of Health,
http://www.nia.nih.gov/alzheimers/scientiﬁc-images.
The ﬁfth drug instead blocks overstimulation of NMDA receptors by glutamate, which can
lead to cell death [Lipton, 2006]. However the effects of both types of treatment are modest
[Birks and Harvey, 1996, Reisberg et al., 2003], offering small beneﬁts in terms of cognitive
function and daily living.
Future treatment will be aimed more at disrupting the underlying disease process, essen-
tially preventing neurodegeneration rather than allowing AD patients to make better use of their
remaining brain tissue. This can be done by targeting the formation of  amyloid plaques
[Lashuel et al., 2002] or aggregation of tau protein [Wischik et al., 2008]. However to max-
imise the effectiveness of these approaches, treatment would have to begin earlier in the disease
process, which is a major motivation for this work.
1.5 Alzheimer’s Disease biomarkers
Biomarkers are measurable quantities that are indicative of the presence or progress of some
underlying disease. A number of these are associated with AD and are summarised in table 1.1.
Based on longitudinal study of a large cohort of elderly subjects, it was hypothesised that
the various biomarkers do not all begin to depart from normal levels simultaneously. Rather,
the level of abnormality in each biomarker follows a sigmoidal trajectory, initially rising steeply
beforelevellingoff, withadistinctordering[Jack et al., 2010]. Anupdatedversionofthemodel1.5. Alzheimer’s Disease biomarkers 19
Biomarker Measured with
Brain atrophy/volume Structural MRI
Brain metabolism FDG-PET
A and tau protein CSF sampled with spinal tap
Amyloid plaques Amyloid PET
ApoE genotype
ε 2
ε4 Genetic testing
Table 1.1: Biomarkers for AD. Images from http://www.esciencenews.com,
http://www.alzforum.org/, www.lymphomajournal.com/, and [Nordberg et al., 2010]1.5. Alzheimer’s Disease biomarkers 20
Figure 1.3: Model of biomarker trajectories and ordering. Courtesy of [Jack et al., 2013].
[Jack et al., 2013] is shown in ﬁgure 1.3. In accordance with the notion of amyloid levels being
thecauseofAD,levelsofA becomeabnormallongbeforeanyotherbiomarker, possiblymany
years before symptoms become apparent. This is closely followed by abnormality in levels of
tau protein. After this come the downstream effects of the AD process, in the form of tissue loss
and reduced metabolism, as measured by structural MRI and FDG-PET respectively. Finally
the effect of AD on cognition becomes apparent when the condition becomes symptomatic.
This has obvious implications in the choice of data used to attempt early diagnosis. Clearly,
symptoms or cognitive scores will be of relatively little help as they will be close to normal
early in the disease process. A, and tau, conversely, will already be abnormal well before any
cognitive decline is noticed. This means that in combination they can distinguish AD subjects
from controls as accurately as clinical examination [Sunderland T et al., 2003]; however they
plateau early which means they may be less effective to track disease progression.
1.5.1 The Alzheimer’s Disease Neuroimaging Initiative
A great deal of research into AD biomarkers during the previous decade has been based on
data from the Alzheimer’s disease neuroimaging initiative (ADNI). This was launched in 2003
by the National Institute on Ageing (NIA), the National Institute of Biomedical Imaging and
Bioengineering (NIBIB), the Food and Drug Administration (FDA), private pharmaceutical
companies and non-proﬁt organisations, as a $60 million, ﬁve-year public/private partnership.
The primary goal of ADNI has been to test whether serial MRI, PET, other biological markers,
and clinical and neuropsychological assessment can be combined to measure the progression of
mild MCI and early AD. Data was obtained on subjects from more than 50 centres in the USA
and Canada. All subjects were given structural MRI scans, and partially overlapping subsets of1.5. Alzheimer’s Disease biomarkers 21
the subjects also had FDG-PET scans and samples of cerebrospinal ﬂuid taken with a lumbar
puncture for CSF biomarkers. Initial recruitment for ADNI was for a total of approximately
800 adults in the age range of 55 to 90 years. This comprised 200 cognitively normal older
individuals to be followed for three years, 400 people with MCI to be followed for three years
and 200 people with early AD to be followed for two years.
Due to the great success of ADNI, two extensions to the original initiative were begun
more recently. ADNI-Grand Opportunity (ADNI-GO) enabled extended follow-up of about
500 MCI and healthy subjects from the original ADNI cohort, and enrolled another 200 new
MCI subjects, adding amyloid PET imaging to the protocol for these new subjects. ADNI
2 aimed to recruit a further 550 subjects, with a similar proportion of healthy, MCI and AD
subjects as the original ADNI. Advanced MRI modalities including diffusion tensor imaging
(DTI), resting-state functional MRI (fMRI) and arterial spin labelling (ASL) were added to the
protocol at centres where the scanner permitted, and amyloid PET scans were performed on
all subjects. Imaging protocols for the original modalities of structural MRI and FDG-PET for
both ADNI 2 and ADNI-GO were designed to ensure compatibility with the original ADNI
data.
1.5.2 Imaging biomarkers
The primary imaging modalities used in this thesis are those available for subjects in the initial
ADNI cohort: structural MRI and FDG-PET. Broadly speaking, structural MRI gives informa-
tion about anatomy while PET yields functional information; FDG-PET is used to assess the
uptake of glucose which is seen as an indicator of metabolic activity. Both are described in
detail at the start of chapter 2.
1.5.3 CSF biomarkers
As previously stated, A and tau proteins are heavily implicated in the process of AD and
so their concentration in the body is a promising biomarker for AD. Levels of both can be
measured in blood or CSF. In ADNI, the biomarker levels are calculated from CSF sam-
ples. As these require a lumbar puncture to obtain, CSF testing is more invasive than that
of blood samples. However, it was preferred to blood testing as the CSF is in direct con-
tact with extracellular spaces in the brain and should most directly reﬂect the brain’s bio-
chemistry [Blennow, 2004] and biomarkers for CSF are better established than those for blood
[Cedazo-Minguez and Winblad, 2010]. In ADNI, levels of A, total tau and phosphorylated
tau are measured. Levels of A fall in AD as it accumulates in the brain, whereas levels of tau
in CSF rise with the onset of disease.1.6. My contribution 22
1.5.4 Other biomarkers
The rare familial form of AD is entirely genetic, but sporadic AD also has a genetic component.
The apolipoprotein E (ApoE) gene has long been known to be involved in AD. In exists in three
alleles, known as 2, 3 and 4. The most common allele is 3. However, the second most
common allele, 4 is associated with increased risk of developing AD [Corder et al., 1993]
whereas the rarest allele, 2, appears to be protective against AD [Corder et al., 1994]. ADNI
tests ApoE genotype for almost all subjects.
A number of newer imaging modalities have also produced promising biomarkers for AD.
As a complement to measuring levels of A in CSF, the radiotracer Pittsburgh compound B
(PiB) was developed speciﬁcally to bind to amyloid plaques in the brain. PiB retention has
been shown to be similar in AD and converting MCI patients, and greater in the converting than
the stable MCI patients [Forsberg et al., 2008]. Alternative MR imaging modalities such as DTI
which is sensitive to microstructural changes in white matter, and fMRI which can show which
brain regions are active in speciﬁc cognitive tasks have also shown promise in yielding new AD
biomarkers, either individually [Nir et al., 2013, Li et al., 2013] or jointly [Wee et al., 2012].
Howevermostsuchstudieshavebeensmall, andamyloid-PET,DTIandfMRIdataarecurrently
available for only a few subjects in the ADNI database.
1.6 My contribution
1.6.1 Motivation
In the previous decade, the AD biomarkers described previously have been combined with au-
tomated medical image processing (chapter 2), and machine learning (chapter 3) to automati-
cally diagnose AD. Such methods can now attain an accuracy as good as experienced clinicians;
however, exceeding this accuracy is difﬁcult as the classiﬁers are ultimately reliant on ground
truth diagnoses provided by clinicians for training data. While automated methods do not have
a clear advantage over more traditional methods of diagnosis, there is a very clear application
for them in predicting the onset of disease in subjects with less severe (or even no) symptoms.
By deﬁnition, prognosis based on test scores will be very difﬁcult as at this stage there will be
little or no difference between subjects who will go on to develop dementia and those who will
not. Moreover, distinguishing between these is a problem that has gained increasing levels of
clinical relevance as the desired time of diagnosis is pushed earlier and earlier.
This is largely due to the development of new types of treatment for AD, which will require
identiﬁcation of AD while symptoms are still very mild in order to be effective. Early identiﬁ-
cation will also make recruitment for future clinical trials for these treatments much easier and1.6. My contribution 23
cheaper.
In this thesis, we add to the literature on applying machine learning methods to neuroimag-
ing data to study and classify healthy, MCI and AD subjects. In particular, our focus is on
prediction of AD, rather than simple diagnosis. This is primarily accomplished through classi-
ﬁcation of the MCI population into converting and stable subjects.
1.6.2 Outline of the thesis
We begin by giving technical background on the major computational methods of all original
work in the chapters discussing image processing (chapter 2) and machine learning (chapter
3).
Next the literature review (chapter 4) puts the work presented here in the context of re-
search performed by others working to perform early diagnosis of AD. As the ﬁrst three chap-
ters of this thesis imply, there are three major stages at which choices can be made in building
such a classiﬁer. They are the type(s) of image or other data used, the features extracted and/or
selected from that data, and the choice of classiﬁcation strategy and algorithm. The literature
review discusses these stages and their interaction further before examining the state-of-the art
in depth.
The thesis contains some material relating to each of these three stages. However, the ﬁrst
experiment we present, in chapter 5 focuses on the last. In it, a comparison is made of GP
and SVM classiﬁcation of a small set of subjects from the ADNI study into AD patients and
controls. Exactly the same features are used for both classiﬁers, as the aim of this study was
purely a proof of concept to show that GPs could produce results with comparable accuracy to
more widely used methods. This was the ﬁrst application of GP classiﬁcation to AD although
it had previously been applied for classiﬁcation of structural MRI data in Huntington’s disease
[Chu et al., 2010].
Chapter 6 is more broad-based. It is a study of the utility of multimodal data in prediction
of conversion in MCI subjects, making use of the multiple-kernel learning (MKL) paradigm
discussedintheliteraturereview(section 4.2.7). TheadvantagesofGPsoverSVMs-chieﬂy, in
thiscase, automaticparametersettingfromtrainingdataalone-aremorefullyexploited. Again,
this is the ﬁrst use of multimodal GP classiﬁcation to medical image data. The classiﬁcation
results obtained from using MRI, FDG-PET, CSF and ApoE data are compared to each other,
and to a combination of all of them. It also compares GPs and SVMs. While there is little to
choose between them on grounds of accuracy for monomodal data, for multimodal data the GP
performs much better as it has a superior mechanism for optimally weighting the types of data.
The next two chapters of research, 7 and 8, attempt to improve results further by taking1.6. My contribution 24
a more unconventional approach to classiﬁcation strategy and feature extraction. Firstly, the
standard classiﬁcation approach is compared to using regression to predict a continuous proxy
that is known to relate to AD. This produces vastly superior results to classiﬁcation when only
a small amount of data is available, although the advantage is much smaller when more data is
available. Secondly, the MKL framework for GPs is applied to combine data from different re-
gions of the brain, rather than data from different image modalities. This combines the strengths
of deﬁning features at the voxel level and at the regional level, offering better classiﬁcation than
either alone.
Finally chapter 9 brieﬂy summarises the conclusions that can be drawn from the previous
four chapters and suggests some areas of future research.25
Chapter 2
Medical imaging and image processing
2.1 Introduction
The processing of medical image data is an extremely broad topic, and I do not go in to great
depth for every technique in this chapter. In particular, there are a wide variety of specialised
algorithms that can be seen as feature extraction methods. These are described in the articles
referenced in the literature review, and in chapters 5 to 8. However there are also lower level
procedures that are fundamental in the analysis of MR and PET images and are used in virtu-
ally every study using image data to diagnose and predict AD. The ﬁrst is image registration,
which ﬁnds the transformation that optimally aligns one image with another. This is necessary
to establish a correspondence between images so information can be transferred from one to
the other. The second is anatomical parcellation, in which one of a set of labels indexing par-
ticular anatomical structures is assigned to every voxel in an image, dividing it up into regions.
The third is tissue segmentation, where voxels are assigned a label or labels representing the
type of tissue they contain. The ﬁrst image process topic described is image registration, as
both anatomical parcellation and tissue segmentation rely on it. However before that comes an
introduction to structural MRI and PET, the two primary imaging modalities used in this thesis.
2.2 Structural MRI
MRI is an extremely ﬂexible imaging modality that can be employed to study contrasts between
a very wide variety of tissue types, or measure many physical properties of tissues. Its initial
function, however, was in the study of anatomy and this is what is most widely used in the study
of AD, in what is known as structural MRI.
MRI is dependent on the phenomenon of nuclear magnetic resonance (NMR). The physics
of NMR can only be fully described by quantum mechanics, however for these purposes the
property of nuclear spin can be seen as a physical rotation, with an orientation described by a
vector. In an MRI machine, the nuclei of objects inside the scanner (such as hydrogen nuclei2.2. Structural MRI 26
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Figure 2.1: Magnetisation in MRI.
in the human body) are subjected to a strong, static magnetic ﬁeld. A ﬁeld strength (B0) of 1.5
or 3T is typical in scanners available for clinical use; the higher the value of B0, the higher the
image quality. The nuclear spins align parallel or anti-parallel to B0. A small majority of spins
lie in the parallel conﬁguration as it has slightly lower potential energy, resulting in a small net
magnetisation Mz. The atoms also precess around B0 with an angular frequency !L = B0,
known as the Larmor frequency, where  is a property of particular atomic nuclei. This is shown
in ﬁgure 2.1.
The phase of the atoms’ precession is random, so the net magnetisation in the xy plane
transverse to B0 is zero. However, according to quantum mechanics, the spins can absorb
photons with an energy E = h, where h is Planck’s constant and  is frequency corresponding
to the the Larmor frequency,  = !L
2 . For a typical B0 this is in the radio frequency (RF) range,
so the spins can be excited by an RF pulse. If this pulse is applied perpendicular to the z axis,
the spins can be made coherent in phase and the net magnetisation is rotated through 90 degrees
into the xy plane. After the pulse is stopped, the spins resume precession in the xy plane, but as
they are in now in phase and the magnetisation is in the xy plane also, this produces a rotating
net magnetisation. This induces a voltage in the scanner’s receiver coils, which constitutes
the MR signal. The time varying signal is converted into a frequency spectrum via Fourier
transforms. The signal immediately begins to decay, which is a results of two processes: return
of net magnetisation to the z direction, with time constant T1, and decoherence of phase in the
xy plane, with time constant T2. Both time constants are dependent on tissue type, which gives
MRI its excellent contrast between tissues.
A three dimensional image is built up by spatially localising the signal source, using gradi-
ents of static magnetic ﬁeld B0. A slice along the z axis is chosen by applying a slice selection
gradient Gs that varies the magnitude of B0 along the z axis. This means that the Larmor fre-
quency will vary along z, so only nuclei in one particular slice will be excited by an RF pulse.2.3. Positron emission tomography 27
Figure 2.2: Basic Fourier transform MR sequence. From http://www.cis.rit.edu/htbooks/mri.
Two further gradients are applied to localise the signal within the slice in the x and y direc-
tions. A phase encoding gradient G is applied in one of these directions. This means that the
frequency of precession alters along the direction of the phase encoding gradient, meaning that
spins lose phase coherence in the phase encoding direction. When the phase encoding direction
is turned off, the spins will all precess at the same frequency once more, but with phase varying
along the phase encoding direction. Finally, while the signal is being measured, a frequency
encoding gradient Gs is applied in the remaining direction, causing the frequency of precession
to vary in that direction. This is shown in ﬁgure 2.2
This means the each location in the xy plane within the selected slice has a unique combi-
nation of signal phase and frequency. As a result, the strength of signals from different locations
in the slice can be identiﬁed from the Fourier transform of the signal.
It should be emphasised that this example is probably the simplest possible useful MR
sequence. The versatility of MR imaging, in terms of its ability to show many types of different
tissue contrast or even dynamic processes in the human body, stems from the enormous variety
of RF pulses, gradients, and timings that can be applied.
2.3 Positron emission tomography
Positron emission tomography (PET) is a method of imaging a speciﬁc physiological process
within the body. The patient is injected with a radioactive tracer compound, and then when
the patient is inside the scanner, the concentration of the tracer can be mapped by detecting
the effects of its radioactivity. The concentration can then be used to make inferences about
processes such as rate of uptake or total amount of particular compounds.
The tracer molecule is designed to chemically mimic a compound that occurs naturally as2.3. Positron emission tomography 28
C C
C C
O C
CH OH 2
OH
H
H
OH
OH
H
H
H
OH
H
C C
C C
O C
CH OH 2
OH
H
H OH
H
H
H
OH
H
F 18
Glucose Fluorodeoxyglucose
Figure 2.3: Molecular structure of glucose and ﬂuorodeoxyglucose. A hydroxyl group on the
glucose is replaced with a radioactive 18F atom to make it a radiotracer analogue of the original
molecule.
closely as possible, so that the behaviour of the tracer is as similar as possible to that of the
natural molecule within the body. Different tracers are designed to mimic (be an analogue for)
different compounds, and the one which is chosen depends on what physiological function the
scan is meant to measure. In ﬂuorodeoxyglucose-PET (FDG-PET), the tracer is an analogue for
glucose, which is a primary source of energy for cellular respiration. FDG-PET can therefore
be used to image the metabolism of cells with high glucose uptake, which includes those of
the brain as well as cancer cells. This makes it a common choice in both neurological and
oncological applications. However, the tracer must be radiolabelled by replacing part of the
molecule with a positron emitting radionuclide. This may be done by changing the isotopes of
an atom in the compound, such as substituting a positron emitting 11C carbon atom for a 12C
stable one. This has the desirable property as the altered molecule is chemically identical with
naturally occurring glucose. However the 11C atom has a half life of only about 20 minutes,
making tracers using it impractical in hospitals that do not have an on site cyclotron. Hence, it
is more common to use a radiotracer where one of the hydroxyl groups normally present on a
glucose molecule is replaced by an 18F ﬂuorine atom (ﬁgure 2.4).
As the 18F has a half-life of 110 minutes, the resulting ﬂuorodeoxy glucose (FDG) can be
manufactured off site and shipped to where it is needed. This, combined with wide applicability,
makes FDG-PET imaging by far the most common type of PET.
All radionuclides used in PET tracers decay by emitting a positron. The positron travels
a short distance from where it was emitted, losing kinetic energy by interactions with the sur-2.3. Positron emission tomography 29
Figure 2.4: PET pipeline. Image courtesy of http://www.sepscience.com
rounding tissue. At this point, having typically travelled a few millimetres, it has a sufﬁciently
small kinetic energy to interact with an outer shell electron of a nearby atom. The resulting
annihilation reaction produces two 511keV gamma rays which travel in exactly opposite direc-
tions. If these are not absorbed in the body, they will activate a pair of detectors, arranged in
a cylinder of concentric rings around the patient. If a pair of detectors in the same ring both
detect a gamma ray within a short window of time of each other (of the order of a few nanosec-
onds) then the gamma rays are considered to come from a single annihilation (event), which is
assumed to have occurred on the line linking that pair of detectors (line of response). In prac-
tice, neither of these assumptions is always correct, as gamma rays produced from distinct but
almost simultaneous annihilations can be counted as an event, and gamma rays can be deﬂected
by Compton scattering. Both of these are sources of noise in PET images.
Events on each line of response are counted, and then the counts for parallel lines of re-
sponse grouped together. These can then be used to form a projection image called a sinogram,
which includes information from all projections in a ring.
Image reconstruction techniques are then used to generate a map of the estimated concen-
tration of the tracer in the body from the sinogram. Filtered back projection [Natterer, 1986] is
a frequently used approach. The sinograms are used to create intensity proﬁles for each projec-
tion angle, which can then be back-projected to reconstruct the original image. More recently,
iterative approaches based on expectation maximisation have emerged as an alternative. These
try to ﬁnd the distribution of tracer most likely to have produced the observed data. This can
produce images with less severe noise and artefacts, but at much greater computational cost
[Vardi et al., 1985].2.4. Image registration 30
The probability of a gamma ray interacting with an atom in the body before being de-
tected depends on the distance it travels through tissue. Therefore structures deeper inside the
body are assigned an artiﬁcially low activity in image reconstruction. This can be addressed
with attenuation correction, based on a map of the attenuation coefﬁcient in tissue across the
body. The map can be obtained from a CT image if the PET image is from a PET/CT scanner.
Alternatively a transmission image from a radioactive source may be used. While visual assess-
ment of PET scans by a radiologist is still widespread, the scan may undergo further processing
steps to produce more objective measures that allow fairer comparison between subjects. The
standardised uptake value (SUV) [Zasadny and Wahl, 1993] normalises uptake by the subject’s
dose and body weight. For speciﬁc conditions, normalisation may also be done with reference
to a region where uptake remains relatively unaffected by disease, such as the cerebellum, or to
a customised reference cluster [Yakushev et al., 2009].
2.4 Image registration
Medical image registration is the process of aligning two medical images, so that a one to one
mapping between the coordinate systems exists and shows correspondence between equivalent
locations. This is generally done by deﬁning one image as a target or reference image, which
remains ﬁxed, and the other as a ﬂoating image which is allowed to transform. Registration
ﬁnds the transformation such that the the transformed ﬂoating image is optimally aligned with
the target image. Algorithms for registration therefore consist of three components: a trans-
formation model that deﬁnes in what ways the ﬂoating image is allowed to move, an objective
function comprising some measure of the quality of the alignment between the images, with
a regularisation term for complex transformations, and an optimiser that determines the best
parameter values for the transformation. The ﬂoating image is deformed according to the trans-
formation model, and the resulting image is compared to the target image with the optimiser
iteratively updating the transformation. This is shown schematically in ﬁgure 2.5.
Image registration may be between different subjects to compare anatomy, or between
scans taken at different timepoints for a single subject to track anatomical change, or between
scans taken close in time for a single subject but with different imaging modalities to perform
multimodal analysis or assist in further analysis of data such as PET images. These different
applications generally require particular choices for the three components listed above to obtain
the best results.2.4. Image registration 31
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Figure 2.5: Outline of registration algorithms.
2.4.1 Transformation models
A transformation model T deﬁnes a mapping for a voxel in the reference image to a coordinate
in the ﬂoating image.
The simplest transformation model is that of rigid transformations, which allows transla-
tion and rotation of the ﬂoating images but no changes of shape. This might be used to provide a
good initialisation for a more ﬂexible registration, or when very little shape difference between
images is expected.
In the two dimensional model shown in ﬁgure 2.6, a rotation about the z axis by an angle
 may be represented by a matrix R():
R() =
2
4cos()  sin()
sin() cos()
3
5 (2.1)
and a translation can be represented by a vector t. The two may be simply combined:
The effect of a rotation R() and a translation t on a point x = (x;y) is given by T(x) =
Rx + t. This can be expressed in homogeneous coordinates as a single matrix, which can be
decomposed into separate rotation and translation matrices:
T(x) =
2
4R t
0 1
3
5
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In the three dimensional case, common in medical image registration, there are three rota-
tion matrices: A rotation in the yz plane by 1 about the x axis, a rotation in the xz plane by 2
about the y axis, and a rotation in the xy plane by 3 about the z axis:2.4. Image registration 32
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Figure 2.6: Rigid transformation for registration. (a) shows a target image; (b) shows a ﬂoating
image brought into alignment with (a) by a rigid transformation consisting of a translation and
a rotation.
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Rz(3) =
2
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cos(3)  sin(3) 0 0
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The three rotations can be combined by multiplying the three separate rotation matrices
together so R = Rx(1)Ry(2)Rz(3). This can then be combined with a three dimensional
translation vector, as shown in the two dimensional case, to represent a general rigid trans-
formation in a single matrix. This will consist of six parameters - rotation angles about and
translations in the x, y and z directions.
The rigid transformation model may be generalised to afﬁne transformations by the addi-
tion of scaling and shearing. This gives a set of transformations that allow changes to shapes
and volumes but preserves colinearity and coplanarity of points.
Afﬁne transformations may also be used to initialise a nonlinear registration, or when
registering a PET image to an MRI image of the same subject, as this may involve some scaling.
A scale factor can be applied independently to each of the x, y and z axes:2.4. Image registration 33
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Figure 2.7: Afﬁne transformation for registration. (a) shows a target image; (b) shows a ﬂoating
image brought into alignment with (a) by an afﬁne transformation consisting of a scaling and
shear plus rigid transformation.
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Shears are parameterised by off diagonal components of a similar matrix. These compo-
nents represent a displacement along a particular axis by an amount proportional to the coor-
dinate in another axis. In the following matrix, for example, the term shxy is the part of shear
along the y axis dependent on the x coordinate and shyz is the displacement parallel to the z
axis that depends on y.
Tsh =
2
6 6
6 6
6 6
4
1 shxy shxz 0
shyx 1 shyz 0
shzx shzy 1 0
0 0 0 1
3
7 7
7 7
7 7
5
(2.6)
Rigid, scaling and shearing matrices may be combined to form a general afﬁne transfor-
mation matrix by multiplication, so Taff = TshTscTrigid. The resulting matrix would at ﬁrst
glance appear to have ﬁfteen components (three translation, three rotation, three scaling, six
shear) but these are not in fact independent and general afﬁne transformations in three dimen-
sions are represented by twelve components. In practice, afﬁne transforms are parameterised
by these twelve components rather than separate rotation, scaling, et cetera transformations.2.4. Image registration 34
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Figure 2.8: Nonlinear transformation for registration. (a) shows a target image; (b) shows a
ﬂoating image brought into alignment with (a) by an afﬁne, followed by a nonlinear registration.
Nonlinear transformation models are the most ﬂexible used in registration, with far more
parameters than afﬁne transformations. Nonlinear registrations are typically used to accurately
align images of different subjects, or scans of a single subject taken with a large time interval
between so the anatomy has changed substantially.
A wide variety of nonlinear transformation models exist. The transformation model may
be physically inspired, by representing the anatomy as able to deform like a viscous ﬂuid
[Bro-Nielsen and Gramkow, 1996] or an elastic material [Rohr, 2000]. This allows the trans-
formation to be highly nonlinear while hopefully remaining anatomically plausible. How-
ever the approach used in most of our work is based on free-form deformation (FFD)
[Rueckert et al., 1999]. This deﬁnes a large set of control points arranged on an axis aligned
grid; the deformation is then a set of three dimensional vectors at each control point, so the
number of parameters is three times the number of control points. To deﬁne the deforma-
tion ﬁeld over the entire image, the control points are convolved with cubic B-splines, and the
bending energy of these is included as a regularisation term to favour smooth solutions. The
updated implementation we use [Modat et al., 2010] is accelerated using graphics processing
units (GPUs) and yields a diffeomorphic transformation [Modat et al., 2012], meaning that the
resulting mapping is one-to-one with no tissue disappearing via folds in the displacement ﬁeld.
2.4.2 Interpolation methods
When the ﬂoating image is resampled to produce a version in the same space as the target
image, in general the positions of voxels in the new image will not correspond exactly to voxels
in the original ﬂoating image - instead they will coincide with points arbitrarily between voxel2.4. Image registration 35
centres. So to ﬁnd the intensities for voxels in the new image, it is necessary to interpolate
between voxels. There are a number of methods for doing so. Cubic spline interpolation offers
the most ﬂexibility; however, the resulting interpolated intensities may go outside the range
of intensities in the original image. This may be undesirable, for example if the image being
resampled is a probabilistic segmentation so intensities should be between zero and one. In this
case trilinear interpolation can be used. If the image being resampled is an anatomical atlas
or parcellation where structures are labelled with integer value intensities, nearest neighbour
interpolation is generally used.
2.4.3 Objective functions
The role of the objective function is to quantify how good the alignment between the trans-
formed ﬂoating image and the target image is. If the target image is designated It, the ﬂoating
image If and the transformation T, then the objective function is a function of It and If(T).
Each image can be regarded as a set of N corresponding voxels, (t1 tN) for the target image
and (f1 fN) for the ﬂoating image. The choice of similarity measure is largely motivated
by the modalities of the images being registered. Simpler measures are less computationally
demanding, but assume a straightforward relationship between voxel intensities which does
not hold for intermodal registration, and are less robust to noisy images or variations in scan
parameters.
The simplest, sum of squared differences (SSD), directly measures the mean-squared dif-
ference between corresponding voxels.
SSD =
1
N
N X
n=1
(tn   fn)2 (2.7)
It is an appropriate metric only when the intensities of corresponding voxels in properly
aligned images are the same. A rather more robust metric is normalised cross-correlation
(NCC), which is able to register images with a linear relationship between voxel intensities.
If the mean intensities of t and f are given by  t and  f respectively, NCC is deﬁned as
NCC =
PN
n=1(ti    t)(fi    f)
qPN
n=1(ti    t)2
qPN
n=1(fi    f)2
(2.8)
To deﬁne a similarity metric robust enough for intermodal registration, where the relation-
ship between the intensities of corresponding voxels can be complex, ideas from information
theory are used. This leads to the metric of mutual information (MI) [Wells et al., 1996]. MI
can be seen as a measure of how much information is shared by two variables, or how much2.4. Image registration 36
having one variable reduces uncertainty in the other. If the variables were completely inde-
pendent, MI would be zero, whereas if one is a function of the other MI would be maximised.
More formally, it measures the difference between the joint entropy of two variables and their
conditional entropies.
To compute MI from pairs of images, a joint histogram of the images is usually con-
structed. This is done by putting the intensities of the target image t and the ﬂoating image f
into a set of bins, each containing a range of intensity values. The joint histogram H consists
of entries representing pairs of binned intensities (t;f), and each entry counts the number of
times a particular intensity pair (t;f) has co-occurred at voxels in the same location in the two
images. Then the joint probability distribution for intensity pairs p(t;f) may be estimated as
p(t;f) =
H(t;f)
N whereNisthetotalnumberofentriesinH. Wemaythenestimatethemarginal
probabilities of binned intensity t in t and f in f, p(t) and p(f), and use them to calculate the
Shannon entropies H [Shannon, 1948] of the image intensities:
H(t) =  
X
t
(p(t)log(p(t))); H(f) =  
X
f
(p(f)log(p(f))) (2.9)
Similarly, we can deﬁne the image pair’s joint entropy:
H(t;f) =  
X
t
X
f
(p(t;f)log(p(t;f))) (2.10)
The MI can then be deﬁned as
MI(t;f) = H(t) + H(f)   H(t;f) (2.11)
which is often made more robust by using the normalised mutual information (NMI)
[Studholme et al., 1999].
2.4.4 Optimisation
An optimisation algorithm is required to ﬁnd the set of transformation parameters giving the
best registration. Typically this is done by ﬁnding the maximum of an objective function, which
is a combination of a similarity term derived from one of the metrics described in the previous
section and, for nonlinear registration, a penalty term to stop the transformation from becoming
overly complex. As stated before, the penalty term in FFD is based on the bending energy of
the transformation, whereas in other nonlinear registration methods the transformation is con-
strained by the physical model it is based on. Most optimisation algorithms used in registration
are gradient based, meaning that they require derivatives of the similarity metric and penalty2.5. Anatomical segmentation 37
Figure 2.9: Manual segmentation of brain structures with ITK-snap software. From
http://www.itksnap.org/docs/viewtutorial.php?chapter=TutorialSectionIntroduction
term, if any, with respect to the transformation parameters. The nonlinear registrations used in
the work in this thesis use conjugate gradient ascent, which is faster than the simple steepest
ascent approach [Modat et al., 2010].
2.5 Anatomical segmentation
To allow detailed analysis of medical images, it is often necessary to apply a label to all voxels
in an image, parcellating it into anatomically deﬁned structures. This can then be used to deﬁne
regions used for normalising PET images, mask out regions that we do not wish to include in
further analysis, or deﬁne features for classiﬁcation or regression at a regional (as opposed to
voxel or global) level. A number of methods can be used for anatomical segmentation, which
we present here.
2.5.1 Manual segmentation
Manual segmentation of brain images by a trained human expert can produce high quality
anatomical segmentations that are considered to be the gold standard for this process. Al-
though experience plays a major role in the process, all raters must follow a carefully drafted
protocol that exactly deﬁnes how each anatomical structure should be delineated, in order that
intra- and inter- rater variability is kept as low as possible. The term manual segmentation may
be considered something of a misnomer as software is often used to assist the process as shown
in ﬁgure 2.9.
However even with the help of specialist segmentation tools, manual anatomical segmen-
tation is a slow process. It is also subject to limited repeatability. To provide an objective,2.5. Anatomical segmentation 38
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Figure 2.10: Segmentation propagation. An atlas structural image is registered to a target struc-
tural image, and the resulting transformation is used to warp the labels into the space of the
target.
repeatable segmentation and to segment large numbers of images in a reasonable time, auto-
mated methods must be employed.
2.5.2 Automatic segmentation
Automatic anatomical segmentation methods are largely based on the concept of an atlas - a
structural brain image, coupled with a set of anatomical labels for the image voxels in the same
space. The labels in the atlas are generally provided by manual segmentation. Hence automatic
segmentation still ultimately relies on the existence of some slow to produce manually labelled
images. However, it provides a way to use a relatively small number of these to rapidly and
accurately segment a much larger number of images.
An example of a widely used brain atlas was produced by the international consortium
for brain mapping (ICBM) [Mazziotta et al., 2001]. To be more representative of the variation
in human brain anatomy, this is based on a template produced by the Montreal Neurological
Institute (MNI) by afﬁnely aligning and averaging a set of 152 healthy brain MR images. The
resulting template is known as MNI space and is also widely used as a standard space for brain
image analysis.
The atlas can be used to accurately segment a new brain image automatically by segme-
nation propagation. First of all, the structural MR image associated with the atlas is accurately
registered to the brain image to be segmented. This will typically be initialised with a rigid and
then afﬁne registration, followed by a nonlinear step to align structures locally. The resulting2.5. Anatomical segmentation 39
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Figure 2.11: Multiatlas segmentation. Anatomical segmentations from a set of N atlases are
propagated to the space of the target image. The resulting N candidate segmentations in the
target image space are then fused to produce a ﬁnal anatomical segmentation.
ﬁnal transformation is then applied to the label image, resampling with nearest neighbour in-
terpolation to maintain the correct integer labels. The result is a set of anatomical labels in the
space of the target image. The segmentation has been propagated from the space of the atlas to
the space of the target image. This process is shown in ﬁgure 2.10.
Results can be improved by registering a ’library’ consisting of multiple atlases to the
target image. Our work is based on a set of 20 atlases of healthy subjects. These were initially
parcellated into 49 anatomically deﬁned regions. The regions, and the protocols used to deﬁne
them for their initial manual segmentation, are described in [Hammers et al., 2003]. A subset
of the regions were further subdivided to create a set totalling 83 regions [Gousias et al., 2008].
This generates multiple anatomical segmentations in the space of the target image. Each
of these can be seen as a classiﬁer, assigning a class to each voxel of the target image based on
the label of its corresponding voxel. To produce a single, ﬁnal segmentation classiﬁer fusion
methods must be applied. The simplest method is majority voting, where the label of each voxel
in the ﬁnal segmentation is the most common label in the N corresponding voxels across the N
segmentations being fused. This approach was shown in [Heckemann et al., 2006] to produce a
ﬁnal segmentation of a higher quality than that made from any single atlas in the library.2.6. Tissue segmentation 40
Both the segmentation propagation and label fusion steps may be improved. If many
atlases are available, the ﬁnal segmentation can be improved by using only a subset of at-
lases, whose anatomy is most similar to the target image by some metric [Aljabar et al., 2009].
The segmentations can also be propagated across a manifold representing the variability of
brain anatomy, using intermediate anatomies between the atlas and target as stepping stones
[Wolz et al., 2010], or the manifold can be used to improve selection of a subset of atlases
[Hoang Duc et al., 2013].
For improved label fusion, the simulated truth and performance level estimation (STAPLE)
algorithm [Warﬁeld et al., 2004] has been used to form a probabilistic estimate of a correct
underlying segmentation from a set of candidate segmentations of the same structure, using
the expectation-maximisation algorithm to update the weight and estimated performance level
of each candidate segmentation. However STAPLE is designed for single label (background
or structure of interest) fusion, and so cannot be used to combine segmentations of multiple
anatomical regions. Multi-label similarity and truth estimation for propagated segmentations
[Cardoso et al., 2012] extends the STAPLE model to multiple labels and adds extra smoothness
constraints and resistance to bias due to structure size, further improving label fusion.
2.6 Tissue segmentation
Whereas anatomical segmentation is intended to parcellate the brain into anatomically mean-
ingful structures, tissue segmentation segments the brain into its major constituent tissue types.
These are normally considered to be grey matter (GM), white matter (WM) and cerebrospinal
ﬂuid (CSF). For applications in AD, atrophy in the cortex means that alterations to the structure
of GM have been the primary object of study. More recently, alterations to WM have become
of increasing interest although these are more usually studied with diffusion imaging.
2.6.1 Expectation maximisation
Tissue segmentation is almost always done by modelling the three tissue types as Gaussian
distributions of voxel intensities, and thus the entire image as a Gaussian mixture model. The
model parameters are thus the mean and standard deviation for each class of tissue. The pa-
rameters are set using the expectation-maximisation (EM) algorithm [Dempster et al., 1977].
This is a probabilistic method that alternates between an expectation step, which calculates a
function giving the expectation for the likelihood of the data based on the current estimated
model parameters, and a maximisation step that updates the parameters by maximising the the
expected likelihood found according to the previous expectation step. This continues until the
change in log likelihood between steps falls below a predeﬁned threshold. As the result of the2.6. Tissue segmentation 41
Structural MRI
GM WM CSF
Figure 2.12: A structural MR brain image (top) is segmented into three tissue components
shown on the bottom row: GM (left), WM (centre) and CSF (right). As the segmentations are
probabilistic, their voxel intensities range from 0 to 1.
EM algorithm is a Gaussian distribution for the intensities of each tissue class, the resulting
segmentation for a tissue class is often shown as a probability map, where the intensity in each
voxel represents the probability of the voxel belonging to that class. Hence segmentation into
GM, WM and CSF components gives three probability maps as shown in ﬁgure 2.12. These are
sometimes combined into a single hard segmentation by assigning each voxel to the tissue type
with the highest probability.
2.6.2 Extensions to the expectation maximisation model
As ﬁgure 2.12 shows, pure EM is not sufﬁcient to produce high quality brain tissue segmen-
tations. It is clear that a large amount of non brain material such as the skull, skin, dura and
so forth has been included as brain tissue. This is because the intensity distributions of these
strongly overlap with the tissue type we wish to include, so they cannot be distinguished with
intensity information alone. Non brain material can beremoved in a preprocessing step, or alter-
natively it can be excluded from the segmentations, and the overall quality of the segmentations
improved, by introducing spatial information in the form of priors. These are derived from a
brain atlas that contains probabilistic information on the spatial distribution of GM, WM, and
CSF. The prior is applied by multiplying the estimated segmentations for each tissue class by2.6. Tissue segmentation 42
the corresponding prior in each iteration of the EM algorithm. This means, for example, that a
voxel containing skull that would be classiﬁed as GM by intensity alone would instead be as-
signed a very low GM probability as it is in a location that is very unlikely to be GM according
to the prior. To establish the spatial correspondence in order for this to work, the priors must
be registered to the image being segmented before the algorithm is applied. In cases where the
anatomy is considerably different from the priors, they can be relaxed to prevent them from
having too strong an inﬂuence [Cardoso et al., 2011].
An early application of EM to brain image segmentation [Van Leemput et al., 1999b,
Van Leemput et al., 1999a] included two additional enhancements to the EM algorithm along-
side the use of priors. The ﬁrst of these is the use of a Markov random ﬁeld (MRF) to promote
smoothness in the segmentations, by incorporating information from the estimated segmenta-
tion of each voxel’s local neighbourhood into the EM model. This reduces the effects of noise
in the image being segmented. The second is correction for a bias ﬁeld due to EM signal inho-
mogeneities, which can result in voxels containing identical tissue having different intensities
in a manner that varies smoothly across the image. Both of these are introduced fully into the
EM model as an extra step interleaved with the expectation and maximisation steps rather than
post hoc alteration of the segmentations. Additionally, the separate segmentation, registration of
priors to the target image and bias ﬁeld correction steps can be combined in a single generative
model [Ashburner and Friston, 2005].43
Chapter 3
Machine learning
3.1 Introduction
Machine learning is a branch of artiﬁcial intelligence (AI) that deals with algorithms that can
learn from data. Whereas classical AI was concerned with developing general intelligence and
emulating human thought [Turing, 1950], machine learning is largely stripped of any philo-
sophical baggage and is instead focused on solving particular problems [Mitchell, 1997]. Such
problems can be from a very wide variety of areas, such as optical character recognition, face
recognition, and, as in the rest of this document, medical diagnosis. The usual approach is
to have a large body of example items from which the algorithm can learn, referred to as the
training data. Each example consists of a vector of d features, so each example can be seen as
a point in a d dimensional space. If the features consist of the voxels of a large, high resolu-
tion image then d can potentially be in the millions; however in the following toy examples the
dimensionality is two to allow the results of algorithms to be visualised.
3.2 Machine learning taxonomy
There are many types of machine learning algorithm; however, there is a fundamental distinc-
tion between unsupervised and supervised learning. In the former, each training example is
presented to the algorithm without any extra information about it, and the task is to discover
some structure in the training data from its distribution. A classic unsupervised learning task is
clustering - uncovering natural groupings in the data. This is shown in ﬁgure 3.1.
In supervised learning, each point in the training data also has an attached value. The
object of the algorithm is to use the training data to learn a function that, when presented with
a hitherto unseen sample, can accurately predict its corresponding value. If the value to be
predicted is continuous, then this is a regression problem, and the attached values are called
targets. Simple least squares is an example of an algorithm that can solve some regression
problems. If the value to be predicted indicates which of a set of discrete groups each example3.2. Machine learning taxonomy 44
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Figure 3.1: Clustering unlabelled data
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Figure 3.2: Classiﬁcation of labelled data
belongs to, this is a classiﬁcation problem. Most commonly, there are only two such groups, in
which case it is a binary classiﬁcation problem and the labels are generally f 1;1g. However
multiclass classiﬁcation with three or more groups is also possible; although algorithms and
performance measures are more complex in this case. Binary classiﬁcation is illustrated in
ﬁgure 3.2.
It is also possible to use a small quantity of labelled data mixed with a much larger quantity
of unlabelled data to improve classiﬁcation performance; this is known as semi-supervised
learning and has also been applied to the problems addressed in this thesis.
Finally, a relatively rare approach to some machine learning problems is known as transfer
learning. This is generally deﬁned as applying the knowledge gained in one problem domain,
and applying it to a different but related domain, with the aim of learning representations that
generalise across the problems. This thesis uses the term to describe the application of a clas-
siﬁer trained on AD and control subjects to MCI subjects, in order to predict conversion from3.3. Preprocessing of data 45
MCI to AD.
3.3 Preprocessing of data
A variety of operations can be performed on data to improve classiﬁcation or regression perfor-
mance, before a machine learning algorithm is used. These generally fall into two categories:
feature extraction, where some transformation is applied to the existing data to generate a new
set of features from the original ones, and feature selection, where a subset of the original fea-
tures are selected to be used in classiﬁcation or regression. The two types can also be combined
sequentially in either order.
3.3.1 Feature extraction
When the data being used are medical images, the line between image processing and feature
extraction can be very blurry. For example, averaging or summing over voxel intensities within
different anatomical regions could be seen as feature extraction, as could calculating cortical
thickness from a structural MRI scan, although this would normally be seen as part of the
image processing pipeline. More general feature extraction techniques involve changing the
representation of the data. For example, it is common to use a z-transform to standardise all
features to zero mean and a standard deviation of unity, to prevent features with a large range
from dominating others which have a smaller range but may be more informative. Dimension-
ality reduction techniques are frequently used as well. Principal component analysis (PCA)
[Jolliffe, 2005] is the most popular linear technique, seeking to represent the data in a lower di-
mensional linear subspace that retains most of the variance, while hopefully reducing the noise
level. Recently nonlinear techniques such as manifold learning [L J P Van Der Maaten, 2007]
have also become popular. These see the data as lying on a nonlinear manifold of low dimen-
sion, embedded in the higher dimensional original data space. Manifold learning algorithms
(themselves a type of unsupervised learning) attempt to recover the structure of the manifold,
and then data points are represented by a position in the manifold coordinate system.
3.3.2 Feature selection
Feature selection methods come into three broad categories: ﬁlters, wrappers and embedded
methods [Guyon and Elisseeff, 2003]. Filters apply a simple criterion to each individual fea-
ture in turn, and reject the features where the resulting test statistic is over a predetermined
threshold. For example, a t-test might be used to check if a feature separates the two groups
to be classiﬁed with p0:05. For regression, a feature might be selected if it correlates with the
target variable sufﬁciently strongly. Wrappers make use of the learning algorithm: a set of
features is used to learn a model, and the results are assessed and compared to other sets of3.4. Performance measurement and validation in machine learning 46
features. As the number of possible sets of features is given by 2D, D being the dimensionality,
an exhaustive search rapidly becomes intractable for more than a trivially tiny set of features.
Instead, heuristics are used to progressively add features to an empty set or remove them from
a full set, or a combination of the two. A more complex wrapper method is recursive feature
elimination [Guyon et al., 2002] which uses the weights of a trained linear model to infer and
rank the importance of corresponding features. Both ﬁlters and wrappers have the disadvantage
of needing target or label information to select features, which means great care must be taken
to avoid double dipping. This can be avoided by using other types of feature selection. Em-
bedded methods are machine learning algorithms that are designed to drive most of the weights
of a linear classiﬁer to zero. Most frequently, this is done with a sparsity favouring regularisa-
tion term, such as the `1 norm of the weight vector w as in the LASSO [Tibshirani, 1994], or
for Bayesian methods, a sparsity inducing prior can be applied to the weights. Such methods
combine the feature selection and training steps into a single operation. Perhaps the broadest
method, however, is to remove features based on prior knowledge of the problem domain. For
example, for AD classiﬁcation, we know which regions of the brain are affected by the disease
processes, so features representing other regions may be eliminated. This is probably the most
effective method of feature selection for this type of problem [Chu et al., 20].
3.4 Performance measurement and validation in machine learning
Clearly, when a classiﬁcation or regression model has been built, it is important to estimate how
well the model will perform in practice. To do this, the model must be applied to a set of data
for which the ground truth is known so it is possible to assess the performance of the model.
This is known as the test set. To minimise any bias, the test set must not contain any subjects
used to train the classiﬁer, as inclusion of these will obviously falsely inﬂate the performance
of the model. Simply dividing a set of data into training and testing points is easy, and there
are many ways to do this which are discussed in the section on validation strategies. However,
there are subtleties in which this separation can unintentionally be violated in the experimental
design, which we discuss in a later section.
3.4.1 Performance measures for classiﬁcation
The simplest and most widely used performance measure for classiﬁers is the accuracy. This
just expresses the fraction of data points in the test set which are correctly classiﬁed. In a
typical classiﬁcation experiment with a medical application, the test subjects will be divided
into patients and controls. Based on this and the classiﬁcation results, we can further split
the test set into patients who are classiﬁed as patients (true positives or TP), patients who are3.4. Performance measurement and validation in machine learning 47
results
Ground truth Prediction
patient control
patient TP FN
control FP TN
Table 3.1: Confusion matrix for classiﬁcation
incorrectly classiﬁed as controls (false negatives or FN), controls who are classiﬁed as controls
(true negatives or TN), and controls who are wrongly identiﬁed as patients (false positives or
FP). This is summarised in table 3.1.
So the accuracy can be expressed as
accuracy =
TP + TN
TP + FN + FN + TF
(3.1)
This can be broken down into individual accuracies for the ground truth patients and the
ground truth controls. In medical applications, the resulting quantities are known as the sensi-
tivity (proportion of ground truth patients, or more generally proportion of ground truth positive
class subjects, which are correctly classiﬁed) and speciﬁcity (proportion of ground truth con-
trols, or more generally proportion of ground truth negative class subjects, which are correctly
classiﬁed):
sensitivity =
TP
TP + FN
specificity =
TN
TN + FP
(3.2)
If we know the sensitivity and speciﬁcity, and the proportion of ground truth positive and
negative class subjects in the test set, we can calculate the accuracy:
accuracy =

sensitivity 
P
N + P

+

specificity 
N
N + P

(3.3)
This shows the danger in reporting accuracy alone. If the test data is very unbalanced
(having many more subjects from one class than the other) a very high accuracy may mask
a very high sensitivity and very poor speciﬁcity, or vice versa. To take an extreme case, if
a classiﬁer does not classify at all but simply assigns all test data to the positive class, then
a test data comprising 99 points from the positive class and only one from the negative class
would produce an accuracy of 99%, despite having a speciﬁcity of zero. Best practice is to
report sensitivity and speciﬁcity as well as accuracy. To give a single overall statistic, it is also3.4. Performance measurement and validation in machine learning 48
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Figure3.3: ROCcurves. Theredlineshowsthetradeoffbetweensensitivityandspeciﬁcityfora
hypothetical perfect binary classiﬁer. A random classiﬁer would be represented by the diagonal
line, and most real binary classiﬁers would have an ROC curve resembling the intermediate
solid black one.
possible to report the balanced accuracy, which is often deﬁned as the mean of sensitivity and
speciﬁcity.
Other alternatives are based on the idea of varying thresholds. All classiﬁers produce a
decision value (DV). This is a scalar which is thresholded to determine to which class a test data
point belongs. For example, support vector machines have a DV which is the signed distance to
the separating hyperplane. Normally the class of a test subject is decided by the sign of this DV,
i.e. it is thresholded at 0. However, we may trade off sensitivity against speciﬁcity by changing
this threshold. We make extensive use of this, providing an alternative balanced accuracy as the
accuracy obtained at the threshold value where the difference between sensitivity and speciﬁcity
is smallest. The same ideas are used in receiver operating characteristic (ROC) curve. This
summarises the tradeoff between sensitivity and speciﬁcity, by calculating them for all possible
thresholds.
The ROC curve may be used where there are particular costs attached to false negatives
and false positive, to ﬁnd a threshold that minimises the total expected cost. The area under the
ROC curve (AUC) is also widely used as a measure of classiﬁer performance as it is aggregated
over all thresholds. It can be interpreted as the probability that a randomly chosen test subject
from the positive class will have a greater dv than a randomly chosen subject from the negative
class [Fawcett, 2006]. In a perfect classiﬁer, all subjects in the positive class will have a greater
dv than subjects in the negative class so this is equal to one.3.4. Performance measurement and validation in machine learning 49
3.4.2 Performance measures for probabilistic classiﬁcation
All the measures deﬁned in the previous section can be applied to probabilistic classiﬁcation.
However the probabilistic predictions also enable some more options. In particular, we may
want to know if the probabilities are well calibrated - in other words, are predictions made
with a higher degree of conﬁdence more likely to be correct? This can be measured with the
Brier score [Brier, 1950]. This was originally proposed for assessing the quality of probabilistic
weather forecasts and is given by
BS =
1
N
N X
i=1
(pi   ci)
2 (3.4)
where N is the number of test subjects, and pi is the predicted probability of the ith subject
belonging to its true class ci;c 2 f0;1g. Another method is to plot an error-reject curve. If the
conﬁdence threshold below which we reject a probabilistic prediction is increased, then the
error rate among the retained predictions should smoothly decrease if the predictions are well
calibrated. We also introduce some novel metrics for probabilistic predictions in later sections.
3.4.3 Performance measures for regression
There are two simple and widely applied performance metrics for regression. They are the
Pearson correlation r between the actual target values y and predicted target values ^ y
r =
PN
i=1(yi    yi)(
PN
i=1(^ yi   ^  yi)
qPN
i=1(yi    yi)2
q
(
PN
i=1(^ yi   ^  yi)2
(3.5)
where ^ y and ^  y are the sample means of the actual and predicted targets values, and N is
the number of data points, and the root mean squared error (RMSE)
RMSE =
PN
i=1(yi   ^ yi)
N
(3.6)
3.4.4 Validation strategies
As previously stated, we must measure the performance of our learning algorithms on a test data
set that is separate from the training data. However, an independent source of test data may not
be available, or the amount of data available may be so small that splitting it into training and
testing sets would results in both being very small. The solution is to adopt cross validation. In
this, the available data points are split into k roughly equally size folds, or groups. Then, each
fold in turn is left out as a test set, and the remaining k 1 folds together form the test set. After
this procedure has been repeated k times, each data point has been used for testing once and
for training k   1 times. The results on the different test sets may then be averaged together to3.4. Performance measurement and validation in machine learning 50
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Figure 3.4: LOOCV in a set of ten data points. Each data point in turn is left out as testing data
(red) while the other nine are used for training (blue). The accuracy of an classiﬁer built using
all ten points to train on new data is estimated by the accuracy across the ten left out data points.
form an overall estimate of accuracy. This is known as k-fold cross validation. If k is equal to
the number of data points N this is known as leave-one-out cross validation (LOOCV). As the
training set for each fold is only one smaller than the entire data set, this is a nearly unbiased
estimator for the accuracy of a classiﬁer constructed from the entire data set on unseen data
[Cawley and Talbot, 2004]. However it is subject to greater variance than cross validation with
fewer folds.
For classiﬁcation, if the data set is unbalanced between classes, the folds may be stratiﬁed,
so the proportion of the classes in each fold is roughly reﬂective of the entire data set, to improve
accuracy estimation [Kohavi, 1995]. Cross validation can also be applied to estimate accuracy
for the purpose of parameter tuning. In this case, tenfold cross validation is preferable due to
its better lower variance than LOOCV. When doing this, however, care must be taken to avoid
double dipping.
An alternative to k-fold cross validation is Monte Carlo cross validation [Xu et al., 2004].
This randomly partitions the data into training and test sets of a size determined by the user,
and can be repeated as many times as desired. This has a lower variance than k-fold cross
validation, but may be more biased as there is no guarantee each data point is used in training
and testing.
Comparing, asopposedtoestimatingtheaccuraciesofclassiﬁersisstilladifﬁcultproblem.
McNemar’s test [McNemar, 1947] may be used to calculate a p-value for the difference in
accuracies for two classiﬁcation methods applied to the same set of test data, by generating a
2 statistic from the number of datapoints switching from rightly to wrongly classiﬁed and vice
versa between the two methods. Alternatively conﬁdence intervals may be constructed around
the estimated accuracy [Newcombe, 1998].3.5. Pitfalls of machine learning experiments 51
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Figure 3.5: Levels of ﬁtting of a function f(x) to a sample of points. Plot (a) shows underﬁtting;
the linear model is insufﬁciently ﬂexible to capture the variation in the underlying function that
generates the points. Plot (b) shows a correct level of ﬁt. Plot (c) shows overﬁtting; error on the
sampled points is zero but the model will likely generalise very poorly to new data.
3.5 Pitfalls of machine learning experiments
Two common errors in performing machine learning experiments are discussed here; the ﬁrst
concerns an error which leads to poor predictive performance and the second to positively bi-
ased predictions of performance. The two are, however, quite closely related. In the neuroimag-
ing domain, which typically has relatively few data points of possibly very large dimensionality,
the potential for both to cause problems is potentially grave.
3.5.1 Overﬁtting
Overﬁtting describes a situation in which an overly complex model no longer ﬁts the (unknown)
underlying function that describes the training data, and instead ﬁts the noise characteristics of
the training data. It is illustrated in ﬁgure 3.5.
Many successful machine learning techniques are designed around a method to combat
overﬁtting, such as maximising the margin in support vector machines, or model averaging and
maximum likelihood parameter setting in Gaussian processes. Determining when overﬁtting is
happening is challenging as it is difﬁcult to detect in training data alone. In fact the hallmark of
overﬁtting is regime where increasing the model’s ﬂexibility continues to reduce training error,
but error on an independent test set begins to rise.
3.5.2 Double dipping
As previously stated, good estimates of generalisation performance in supervised learning come
from applying a model to a set of test data that were not used in training. While this statement is
self evident and apparently simple, it is possible for it to be violated in surprisingly subtle ways,
as some experimental designs accidentally introduce circularity into the analysis by allowing3.5. Pitfalls of machine learning experiments 52
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Figure 3.6: As the complexity of a model is increased, the training error (blue curve) may
approach or reach zero. However after initially decreasing, the testing error (red curve) will
begin to rise as an overly complex model begins to overﬁt the training data. Testing error is
minimised at the appropriate level of complexity (dashed vertical line).
the labels or targets of test data to be used in generating the model, allowing information to
leak from the test set to the training set. Most commonly, this occurs when a method requires
a number of parameters to be set, or when supervised feature selection or extraction methods
are applied. An experimenter may, for example, apply a feature selection method to choose
features based on all data points and their labels. After this is done, the accuracy of the resulting
classiﬁer is assessed in 10-fold CV. This introduces circularity to the data, as the labels of data
points used to evaluate the classiﬁer are also used in constructing the classiﬁer. The result is
inﬂated accuracy estimates as it results in testing a hypothesis suggested by the data, which
can lead to the detection of spurious effects [Kriegeskorte et al., 2009]. The same effect has
been noticed in a number of papers directly relevant to this thesis, inﬂating the accuracy of
AD classiﬁcation [Eskildsen et al., 2013]. Double dipping may be understood by expanding the
deﬁnition of training to also include parameter setting feature selection or extraction, or training
data selection (which may be grouped under model selection), as well as model optimisation.
Seen in this way, it clearly violates separation of training and testing data.
In practice, the problem can be avoided by modifying the experimental design. For exam-
ple, an experimenter may use three groups of disjoint data, for training, tuning and testing an
algorithm, rather than training and testing groups alone. If cross validation is being used, then
the situation is a little more complex. A common approach is to perform a separate CV loop
within the training set of each fold of a CV loop. The inner CV loop can be used for parame-3.6. Support vector machines 53
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Figure 3.7: Many hyperplanes can divide two linearly separable groups of points.
ter tuning et cetera and the outer loop for accuracy estimation, a method known as nested CV
loops [Varma and Simon, 2006]. Many different validation strategies may even be combined in
a complex pipeline, as long as separation of model selection and training data from testing data
is maintained.
3.6 Support vector machines
The support vector machine (SVM) is possibly the most widely used algorithm for classiﬁca-
tion. If the training subjects represent points in a d-dimensional space, the SVM constructs a
d   1 dimensional surface (a hyperplane) that separates the two classes of training points. In
general, as shown in ﬁgure 3.7, there will be an inﬁnite set of possible hyperplanes that do this.
SVMs select a separating hyperplane based on the principle of structural risk minimisation
[Cortes and Vapnik, 1995]. This controls the tradeoff between ﬁtting the training data well and
also offering good generalisation behaviour, that is making high quality predictions on samples
outside of the training set. In the framework of SVMs, this translates to a simple geometrical
intuition: the best hyperplane is the one which maximises the distance to the closest points in
each class. This distance is known as the margin; hence SVMs are maximum-margin classiﬁers.
The hyperplane is a function only of the subset of training points which lie on the margin. These
are known as the support vectors, from which the SVM takes its name. This is illustrated in
ﬁgure 3.8.
More formally, a training data point may be seen as vector x = (x1;x2;:::;xd) in a d
dimensional space. The aim of the SVM is to produce a function y(x), so that the sign of y(x)
indicates on which side of the separating hyperplane x lies, and hence its class.3.6. Support vector machines 54
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Figure 3.8: The SVM chooses the hyperplane that maximises the margin.
3.6.1 Linear SVMs
Support vector machines were originally conceived as a purely linear classiﬁer for separable
data [V. Vapnik, 1963]. The equation for the separating hyperplane is y(x) = w>x + b = 0,
where w is a vector normal to the separating hyperplane and b a bias term. The margin is
then deﬁned by the hyperplanes y(x) = 1 and y(x) =  1. We can then see that the distance
between these planes, which is the size of the margin, is given as 2=kwk. Hence we want to
minimise kwk without allowing any points to fall inside the margin. If N training data points of
dimensionality D xi 2 RD have corresponding labels y = (y1;y2;:::;yN), yi 2 f 1; 1gN
i=1
this gives the following optimisation problem:
min
w;b
kwk
subject to yi(w>xi + b)  1
(3.7)
which is equivalent to
min
w;b
1
2
kwk2
subject to yi(w>xi + b)  1
(3.8)
By introducing Lagrange multipliers  this can be expressed as
min
w;b
max

(
1
2
kwk2  
N X
i=1
i
h
yi(w>x   b)   1
i
)
subject to   0
(3.9)
Which can be solved using standard quadratic programming methods, yielding a solution
for w as a linear combination of the training data points, w =
PN
i=1 iyixi. This identiﬁes3.6. Support vector machines 55
which training points are the support vectors, as they are the only ones whose corresponding 
is nonzero. The bias b can be found from a single support vector, but a more reliable method is
to average over all of them:
b =
1
NSV
NSV X
i=1
(w>xi   yi) (3.10)
By substituting the expression for w back in to equation 3.9 we can write the optimisation
problem in its dual form:
max

~ L() = max

8
<
:
i  
1
2
N X
i;j
ijyiyjk(xi;xj)
9
=
;
subject to i  0 and
N X
i=1
iyi = 0
(3.11)
Here the kernel function k is just the dot product so k(xi;xj) = x>
i xj.
3.6.2 Soft-margin SVMs
If the distributions of the two classes in training data overlap, then the classes are not linearly
separable and the SVM algorithm will fail. A modiﬁed formulation, the soft margin SVM
[Cortes and Vapnik, 1995], was introduced. This was done by adding slack variables i which
measure the amount of error in classiﬁcation of training data. Clearly allowing a greater error in
the training set will allow a larger margin among the training points that are not misclassiﬁed,
and this tradeoff between margin size and training error is controlled by a parameter C. The
optimisation then becomes
min
w;;b
(
1
2
kwk2 + C
N X
i=1
i
)
subject to yi(w>xi)   b  1   i and i  0
(3.12)
Applying Lagrange multipliers and converting to dual form as before, the problem is then
expressed as
max

~ L() = max

8
<
:
i  
1
2
N X
i;j
ijyiyjk(xi;xj)
9
=
;
subject to 0  i  C and
N X
i=1
iyi = 0
(3.13)
Conveniently, the slack variables i disappear from the dual problem and the constant C
appears only in the constraints. C is however a free parameter than can be difﬁcult or costly3.6. Support vector machines 56
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Figure 3.9: Data that are not linearly separable in the input space x become linearly separable
in the feature space (x). However we do not have to explicitly calculate (x) as only dot
products between transformed feature vectors appear, forming the kernel matrix.
to optimise. Often it is set by a heuristic or a grid search for the value providing the best
performance.
3.6.3 Kernels and nonlinear SVMs
Note that in the dual problems, the data points x only appear in the form of a kernel function
k(xi;xi). This means that an SVM built from N training data points is based on an N by N
kernel matrix of dot products. However the dot product can be replaced with a nonlinear kernel
function (x) [Aizerman et al., 1964]. This means that the hyperplane is ﬁt in some higher
dimensional feature space, enabling data which are not linearly separable in their original form
(the input space) space to be easily separated in the transformed space (the feature space) with
a nonlinear SVM [Boser et al., 1992].
As the data only affects the optimisation problem via the kernel matrix, we do not need to
explicitly calculate the feature space, but only the dot product of training samples in the feature
space. Any function k(xi;xi) that produces a valid (symmetric positive deﬁnite) kernel matrix
can be used as a kernel function. This also means that any linear combination of valid kernels is
itself a valid kernel, a fact which we make extensive use of. More generally, the kernel can be
seen as a matrix of pairwise similarities between data points. The radial basis function (RBF)
kernel for example, a widely used choice, is based on a function of the Euclidean distance
between points:
k(xi;xj) = exp

 
kxi   xjk2
22

(3.14)
This implicitly makes use of an inﬁnite dimensional feature space. Although it can be very3.7. Gaussian processes 57
powerful, the ﬂexibility of nonlinear classiﬁers can make them more prone to overﬁtting when
there is little training data available. In the case of SVMs, the RBF kernel also adds another
parameter to be tuned, the kernel width .
3.7 Gaussian processes
Gaussian Processes (GPs) provide an alternative method for machine learning that, like SVMs,
can be used for both classiﬁcation and regression. GPs have some features in common with
SVMs - they provide similar predictive accuracy, and are also well suited to very high dimen-
sional data. This is because, again like SVMs, they are based on a kernel, making them very
efﬁcient in the domain where the data dimensionality is much greater than the number of sam-
ples (as is very common in neuroimaging applications). SVMs also make use of the principle
of structural risk minimisation [Cortes and Vapnik, 1995], where the criterion of ﬁnding the
largest possible margin helps to prevent overﬁtting.
Furthermore, the interpretation of the kernel matrix is different; rather than summarising
the similarity between points it represents the covariance matrix of a multivariate Gaussian prior
over the classiﬁcation or regression model parameters. This implies that GPs are a probabilistic
method, which distinguishes them from SVMs. Prevention of overﬁtting in GPs is done by
probabilistic model averaging, rather than optimisation of a single model as in SVMs.
Bishop [Bishop, 2007] describes probabilistic methods as having four advantages over non
probabilistic ones:
 Easy risk minimisation when the costs of making a mistake (the loss) change;
 Allowing a reject option where a classiﬁer only gives a decision for test data it is can
categorise with conﬁdence;
 Easy compensation for class priors, where one class is much more common than the
other(s);
 Models can be combined in an existing framework - the laws of probability.
To this we can add automatic setting of parameters from training data only, which we make
extensive use of.
What follows is a brief introduction to the application of GPs to machine learning prob-
lems. For a much more rigorous treatment, [Rasmussen and Williams, 2006] is recommended.
We begin by showing how GPs are used in regression, as this is the simplest case, and then
extend the model to binary classiﬁcation. But ﬁrst of all we must introduce Bayes’ rule, which3.7. Gaussian processes 58
describes conditional probability. Consider two random variables, A and B. From the laws of
probability, we know that the joint distribution of A and B, p(A;B), can be written as either
p(A;B) = p(AjB)p(B) or p(A;B) = p(BjA)p(A). So we can write
p(AjB)p(B) = p(BjA)p(A) (3.15)
which by dividing through gives us
p(AjB) =
p(BjA)p(A)
p(B)
(3.16)
Which relates the conditional probabilities p(AjB) and p(BjA). p(AjB) is known as
the posterior (as it describes our beliefs about A after having observed B), p(A) the prior (as
it describes our beliefs about A prior to observing B), p(BjA) the likelihood and p(B) the
marginal likelihood.
3.7.1 Gaussian process priors
Formally speaking, a GP is a generalisation of ordinary multivariate Gaussian distributions to
the case of an inﬁnite number of variables, with the condition that any ﬁnite subset of the vari-
ables form a multivariate Gaussian. It is this latter property - that any marginal distribution
of the GP is also Gaussian - which is the key to GPs’ applicability to machine learning prob-
lems, given the somewhat abstract deﬁnition. Again generalising from familiar multivariate
Gaussians, which are parameterised by a mean vector and a covariance matrix, a GP can be
described only by its mean function m(x) and covariance function k(x;x0). So we can write
GP  N(m;K) (3.17)
where
m =
2
4m(x)
m(x0)
3
5, K =
2
4k(x;x0) k(x;x0)
k(x0;x) k(x0;x)
3
5 (3.18)
The matrix K is a kernel matrix identical in form to those used in SVMs, and the allowed
kernel functions are the same as can be used with an SVM. A linear (dot product) covariance
function can be used, but we can also apply the kernel trick to use kernel functions such as radial
basis functions (sometimes referred to in GP literature as squared exponentials) to perform
nonlinear regression or classiﬁcation, again like an SVM. However, the interpretation of the
kernel function is different in SVMs and GPs. In an SVM, the kernel function measures the
similarity between vectors in an inner product space, whereas in a GP it measures a component3.7. Gaussian processes 59
of the covariance of a prior over functions. Hence the terms kernel function and covariance
function are equivalent in the GP literature.
By itself, the GP cannot be used for machine learning. However, it can be applied as a
prior to models of regression and classiﬁcation. There are two ways of seeing how this can
be done, which are different conceptually but can be shown to be equivalent mathematically
[Rasmussen and Williams, 2006]. These are introduced in sections 3.7.2 and 3.7.3.
3.7.2 Gaussian process regression - weight space view
One way of understanding GP regression is known as the weight space view. This is introduced
ﬁrst as it involves using the GP as a prior on the weights w of a familiar linear regression model.
In ordinary linear regression, the target vector y is modelled as a linear function1 of data
X with zero mean Gaussian noise of standard deviation : y = w>X + , with   N(0;2).
Now consider placing a GP prior (with, for simplicity, zero mean) over the weights w. By
substituting this GP for the prior, and Gaussian noise as the likelihood into Bayes’ rule (equa-
tion 3.16) we obtain the following equation for the posterior for the weights:
p(wjX;y;) =
p(wj)p(yjX;w)
p(yjX;)
(3.19)
where the (GP) prior is p(wj), the (Gaussian) likelihood is p(yjX;w) and  is a set
of hyperparameters that determine the exact form of the prior. The denominator p(yjX;)
represents a marginal likelihood equal to
R
p(wj)p(yjX;w). The Gaussian form of the prior
provides a form of regularisation, favouring weights that are not too large. To make predictions,
we do not usually select a single set of weights but instead integrate over the posterior to average
over all possible values for w. If we are presented with a new data point x, we make a
prediction for the corresponding y by integrating over 3.19, effectively averaging across all
possible values for w, weighted by their posterior probability.
p(yjX;y;x;) =
Z
p(yjw;x)p(wjX;y;)dw (3.20)
As the prior and likelihood are both Gaussian, the marginal likelihood and posterior
are also Gaussian. This means a closed form solution for equation 3.20 can be found
[Rasmussen and Williams, 2006]:
p(yjX;y;x;)  N

1
2x>A 1X>y;x>A 1x

(3.21)
1Note that for simplicity, the bias term, b, has been subsumed into the weights, w.3.7. Gaussian processes 60
Figure 3.10: The GP prior (left) is vague and permits a wide range of linear functions admitted
by the prior (blue) and high uncertainty (grey). After introducing data points (red), the posterior
allows a much narrower range of linear functions and reduced uncertainty.
Where A = 1
2X>X + K 1 and K is the kernel matrix representing the covariance of
the GP prior.
3.7.3 Gaussian process regression - function space view
The function space view of GP regression initially seems more unfamiliar as it dispenses with
the entirely use of weights, apparently breaking the link with linear regression. However it
provides a more natural and concise way to describe GP regression, by instead applying the GP
as a prior directly over functions f(x). This means that the mean vector m has inﬁnite length
and the kernel matrix K has inﬁnite size, as it forms a prior over all possible linear functions.
However by introducing a set of training data vectors X and a vector of corresponding target
values y we can calculate a posterior distribution for f(x). This is illustrated for the simple case
of one dimensional, linear regression in ﬁgure 3.10. In the left hand diagram, the GP prior is
across the space of all possible linear functions, shown in blue, and is correspondingly broad. In
the right hand ﬁgure, some training (one dimensional) data vectors X and target values y have
been introduced, shown as the red dots. Pairs of data vectors and their corresponding target
values (x;y) can be seen as samples from the distribution of f(x). By the properties of GPs,
this ﬁnite sample is a (ﬁnite sized) multivariate Gaussian. It can therefore be used with Bayes
rule to calculate a posterior for f(x), giving a much tighter distribution which can be used to
make high quality predictions.
For the regression case, as in the weight space view we model the targets y as being a
linear function of the data vectors x plus zero mean Gaussian noise. The difference between
the weight space and function space view is that we apply the prior directly to the value of f(x)
rather than the weight. Again as in the weight space view, for simplicity we assume the GP is3.7. Gaussian processes 61
zero mean. We apply the GP as a prior and and Gaussian noise as the likelihood, so the model
is given by
yi = f(xi) + 
f  N( = 0;K)
  N(0;2)
(3.22)
As before, we can substitute these terms into equation 3.16 and simplify. The resulting
posterior gives the core predictive equations for GPs. The posterior is, again, also a multivariate
Gaussian. For training data X and training targets y, and an unseen test data vector x the
predictive distribution for the value of f(x) is given by
p(f(x)jX;y;x;)  N(;2)
 = k>C 1y
2 = k(x;x) = k>C 1k
(3.23)
Where C = K + 2I. K is the covariance matrix derived from the covariance function k,
training data X and covariance hyperparameters , so Ki;j = k(xi;xj;), and k is a vector of
covariances between the test data point x and all the training data points.
As previously stated, the weight space and function space views of GP regression can be
shown to be equivalent. However, a subtle difference is that the function space formulation
makes use of the kernel trick. Compare the predictive equations for the weight space and
function space views, equations 3.21 and 3.23 respectively. In the former, predictions are made
by inverting the matrix A which is size d  d where d is the data dimensionality. In the latter,
making predictions involves inverting C, which is size N  N, where N is the number of
subjects. For neuroimaging applications, where very frequently d is much larger than N, this
can be a great advantage, especially if precomputed kernel matrices are used.
3.7.4 Gaussian process classiﬁcation
In order to perform classiﬁcation, rather than regression, we must modify the likelihood func-
tion of the GP. If we are given a set of data points x and corresponding vector of labels y:
f(xi;yi)N
i=1g with binary class labels yi 2 f 1;+1g then we can use a sigmoidal function 
such as the logistic or probit function as the likelihood, so p(yi = 1jxi) = (f(xi)). This then
maps f(xi) to the [0;1] interval, representing the probability that the label for xi, yi, is equal to
1.
Gaussian process classiﬁcation could therefore be seen as similar to logistic or probit re-
gression with a GP prior. In binary classiﬁcation, the class probabilities must sum to unity so3.7. Gaussian processes 62
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Figure 3.11: Sigmoidal functions link the value of the latent function f(x) to class membership
probabilities.
p(y = 1jxi) = 1   p(y =  1jxi), and the sigmoid functions  are symmetric so (x) =
1   (x). This means the likelihood terms can be rewritten as p(yijf(xi)) = p(yif(xi)).
Plugging this into equation 3.16 we can rewrite Bayes’ rule as
p(fjX;y;) =
p(fj)
p(yjX;)
N Y
i=1
(yif(xi) (3.24)
whereas for regression p(fj) is the prior over the latent function f and p(yjX;) is the
marginal likelihood. The likelihood over training samples is factorised as they can safely be
treated as independent.
Unfortunately, the non-Gaussian likelihood function means that the marginal likelihood
and posterior are also non-Gaussian in the classiﬁcation case. An exact evaluation of the in-
tegrals of these distributions cannot be obtained analytically. However Monte-Carlo Markov
Chain (MCMC) methods may be used to give an extremely accurate evaluation of them, which
in the limit of an inﬁnite number of samples would be exact. Alternatively, although the re-
sulting posterior distributions are non-Gaussian, they can be shown to be unimodal and can
be reasonably approximated by a Gaussian. A number of methods can be used to ﬁt a Gaus-
sian; these include the Laplace approximation [Williams and Barber, 1998], variational Bayes
[Gibbs and MacKay, 2000] and expectation propagation (EP) [Minka, 2001]. All three of these
were compared against an MCMC ’gold standard’ in [Nickisch and Rasmussen, 2008], and EP
was found to be almost as accurate as MCMC while being much faster to run in practice. We
therefore use EP as the approximation method in all GP classiﬁcation experiments. Brieﬂy,
it calculates the parameters  and  of the approximating multivariate Gaussian by approxi-3.7. Gaussian processes 63
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Figure 3.12: Gaussian process classiﬁcation with two dimensional toy data, with linear (left)
and squared exponential (right) kernels. Red dots indicates the +1 labelled training data and
blue dots the  1 labelled ones. Contours show the locus of equal p(y = 1jx) as indicated by
the colour bar.
mating the likelihood hood terms with unnormalised Gaussian site functions, and then cycling
between the site function, updating each in turn with moment matching, until a convergence
criteria is met. No formal proof of convergence has been found for EP but it usually terminates
successfully in practice [Nickisch and Rasmussen, 2008].
All methods are explained in more detail in the references above. A very detailed math-
ematical explanation of their application to GPs is given in [Rasmussen and Williams, 2006].
Once the posterior has been found, predictions can be made in a similar manner to GP regres-
sion. GP classiﬁcation generally gives us similar accuracies to SVMs. However it has a number
of advantages. As well as being easily extended to multiclass classiﬁcation and offering auto-
matic hyperparameter tuning (described in the next section) it can quantify the predictive un-
certainty by providing a probability of class membership of test subjects. GP classiﬁcation does
not explicitly calculate a separating boundary between the two classes in the input space. How-
ever as ﬁgure 3.12 shows, for a linear kernel, the p(yjx) = 0:5 contour very much resembles
one. However unlike an SVM the class membership predictions will always be probabilistic.
For a nonlinear kernel, an SVM would nonlinearly divide the input space into two regions, but
GP classiﬁcation with a nonlinear kernel produces a posterior distribution that tends to the class
prevalance prior far away from training data.
3.7.5 Gaussian process regression and classiﬁcation in practice
As described above, GPs for regression could be implemented only a few lines of code. How-
ever, we may want to use approximations for classiﬁcation, use complex covariance and mean3.7. Gaussian processes 64
functions, select different likelihood functions, and choose the best value for hyperparameters.
Because of this, all of our experiments are done using the GPML toolbox 2 for Matlab, which
provides functionality for all of these. While a very simple GP classiﬁcation might have no
hyperparameters at all, almost all real problems will include some describing the covariance
function (such as kernel width for an SE kernel), the posterior mean, and the noise variance in
regression problems. A fully Bayesian way to deal with these is to deﬁne prior distributions on
their values (hyperpriors) and integrate over the hyperpriors in a hierarchical model. However,
the resulting posterior distributions can only be computed using MCMC methods, which can
be very slow.
Fortunately there is a practical and only slightly less effective alternative. We can instead
maximise the marginal log likelihood of the training data and labels with respect to the set of
hyperparameters. The marginal log likelihood is given by
ln(p(yjX;) = ln
Z
p(yjX;f)p(fj)df (3.25)
where f is a vector of predictive function values for all the training points. The above
expression can be shown to be equal to  1
2y>C 1y   1
2 lnjCj + const, where C is again
K + 2
nI. This expression can then be differentiated. The resulting derivative can be used with
a standard gradient based optimisation to maximise the log likelihood with respect to the noise
variance 2 (directly) or covariance and mean hyperparameters (via application of the chain
rule, to the derivatives of the covariance matrix or mean vector elements with respect to the
hyperparameters). The motivation for setting hyperparameters with this method is best under-
stood by viewing it as a model selection problem: which model (set of hyperparameter values)
best explains the observations (data)? The model that maximises the likelihood is the one with
just enough complexity to describe the data, but no more. This is shown in ﬁgure 3.13. Three
models are shown - a simple one in green, a complex one in blue, and one of intermediate com-
plexity in red. The simple model can only describe a narrow range of possible data, so assigns
the data we have (the vertical line) a very low likelihood. The most complex one gives a rea-
sonably high likelihood to the data, but also to many other sets of data. The intermediate model
gives the data a higher likelihood than either other model. Hence maximising the marginal like-
lihood gives the most parsimonious model that explains the data, obeying Occam’s razor 3 and
helping to avoid overﬁtting. This can also be seen in equation 3.25 - the ﬁrst term measures the
ﬁt to the data, and the second penalises model complexity.
2http://www.gaussianprocess.org/gpml/code/matlab/doc/
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Figure 3.13: The most simple model in green is not ﬂexible enough to describe the data and
assigns it a low likelihood. The most ﬂexibile model (blue) can explain many possible data and
so assigns each a low likelihood. The model with the correct degree of complexity (red) assigns
the data a higher likelihood than either of the others.
The likelihood as a function of the hyperparameters is not convex, so there is a danger this
method will ﬁnd only a local maximum. However, in practice good results are usually obtained.
3.8 Precomputed kernels
As is noted above, both GP classiﬁcation and regression and SVM classiﬁcation are kernel
based techniques. In neuroimaging problems, we typically have images for only a few dozen
to at most about a thousand or so subjects. Meanwhile each image may consist over a mil-
lion features, if we are using voxels as features, so d  N. The N by N kernel matrix K is
therefore much easier to work with than the N by d training data matrix X. In an SVM, the
data only appears in the optimisation problem as the kernel matrix. We can therefore greatly
reduce memory requirements and speed up calculation by calculating K once and then throw-
ing X away. If all the images we want to use cannot ﬁt into memory at once, we can also
calculate K element by element, storing only a few images at a time. The SVM library we use,
LIBSVM [Chang and Lin, 2011], allows us to do this as an option. For GPs, things are a little
more difﬁcult. Strictly speaking, the ﬁnal kernel matrix is likely to be a function of covariance
hyperparameters that must be set as well as of the data. However, in many cases the hyperpa-
rameters can be applied in the kernel space. For example, when the ﬁnal kernel is deﬁned as
a linear combination of linear subkernels, the covariance hyperparameters represent the weight
of each subkernel in the sum, and so we can precompute each subkernel from data. Then dur-
ing hyperparameter optimisation, the subkernels are multiplied directly by the weights, rather3.8. Precomputed kernels 66
than multiplying the data for each subkernel by the weights and then recalculating the subker-
nel. GPML does not include a facility to do this so it was modiﬁed to add one. The resulting
representation is very ﬂexible. For example, cross validation or training and test sets can be
performed by selecting the relevant rows and columns of master kernel matrices, rather than
having to reload images and form new kernel matrices from scratch.67
Chapter 4
Literature review
4.1 Introduction to the existing literature
Early diagnosis is often studied by applying classiﬁcation methods to MCI subjects, trying to
predict which subjects will convert to AD (designated MCI converters, or MCI-c), and which
will remain stable (MCI-s) over some ﬁxed period of time, usually 18 to 36 months. Comparing
results between experiments predicting conversion in MCI subjects is particularly difﬁcult as
this follow up period varies and both a diagnosis of MCI and conversion status may be hard to
verify.
Methods used in automated diagnosis and prediction of AD vary quite widely in the types
of data and learning algorithms used; nevertheless the vast majority can be summarised as
following the same basic pipeline. The starting point is a number of training subjects, usually
of AD patients and healthy controls, together with a set of labels that indicate to which group
each subject belongs. Next comes a feature extraction step, in which the images are processed
so that each subject is represented by a vector of features, which (hopefully) are relevant to
the classiﬁcation problem. Feature extraction procedures vary greatly, and the features can be
very similar to the original image (where the features are in fact voxel intensities) or quite
abstract and far removed from the images they are derived from if complex transformation and
dimensionality reduction procedures are applied. The training feature vectors and labels are
then fed into a learning algorithm, where again a great deal of variation is possible in the choice
of algorithm, as well as the methods to set parameters. Finally, to assess generalisation ability
the learned model is applied to previously unseen testing subjects, which have been put through
the same feature extraction procedure as the training subjects. The results are then evaluated,
and again a choice of statistics can be used to summarise the performance of the pipeline.
The distinction between features and learning algorithm in the context of brain im-
age classiﬁcation for a variety of neurological conditions is the focus of a recent study4.2. Review of the existing literature 68
[Sabuncu and Konukoglu, 2014]. The authors divide the factors on classiﬁcation into three.
The ﬁrst is what the authors call biological footprint, which is the effect size of the difference
between classes. The second and third are the choice of measurements (features) and classiﬁer
algorithm. The authors ﬁnd that the biological footprint and choice of feature have a much
greater inﬂucence on accuracy than the choice of algorithm. A similiar point, made in refer-
ence to machine learning problems in general, is made in [Domingos, 2012], which stresses the
importance of feature engineering. This is perhaps not surprising in the context of the no free
lunch theorem [Wolpert, 1996].
As this literature review looks only at diagnosis and prediction of AD, the biological foot-
print is ﬁxed. Hence the existing studies discussed in this section are broadly grouped by the
type of data and features used in classiﬁcation, as this the stage of the pipeline having both the
widest choice of possible options and the greatest effect on results.
4.2 Review of the existing literature
4.2.1 Voxel-based features
Methods using voxel-based features for classiﬁcation are among the simplest in terms of feature
extraction as the feature vectors can be viewed as a type of image. Such approaches are exem-
pliﬁed by [Kl¨ oppel et al., 2008]. This study was on three different cohorts, each of which was
scanned at a single centre. Groups I and II each consisted of equal numbers of age and gender
matched AD patients and healthy controls. Signiﬁcantly, the AD patients in these two groups
had neuropathological conﬁrmation of their disease status. Group III was both larger overall
and had a greater number of controls than AD patients, however the patients were diagnosed
clinically leading them to be described as having probable mild AD. The image data used con-
sisted of T1 weighted structural MRI scans of all subjects. These images were segmented using
SPM5 into grey matter (GM), white matter (WM) and cerebrospinal ﬂuid (CSF) components.
The GM segments were used as features in classiﬁcation. To enable this, it was necessary
to establish correspondence among voxels across subjects, so that those in the same position
represent similar anatomical areas. To do this, a custom template was constructed from the im-
ages of all subjects using the DARTEL [Ashburner, 2007] nonlinear registration algorithm. A
Jacobian-scaling (“modulation”) step was incorporated to ensure the total amount of each tissue
type remained the same after registration [Ashburner and Friston, 2000]. The resulting three di-
mensional grey matter maps were then treated as vectors and classiﬁcation was performed with
an SVM, using a linear kernel with default parameter settings. Generalisation accuracy was as-
sessed with leave-one-out cross validation (LOOCV) for each experiment. Accuracy on groups4.2. Review of the existing literature 69
I and II was similar at 95% and 93% respectively; when the two groups were pooled accuracy
increased to 95.6%, showing that having a larger overall training set overcame differences be-
tween the groups due to different centres and scanners. However accuracy in group III was only
85.6%, probably as a result of misdiagnosis due to lack of post-mortem conﬁrmation.
A much more recent and very different voxel-based approach was introduced in
[Coup´ e et al., 2012]. This study used all 834 baseline scans from the ADNI dataset. The
images were pre-processed, which involved registration to the ICBM152 template and cross
normalisation of MRI intensity between subjects. The hippocampi and entorhinal cortices
of ten randomly selected AD and ten control subjects were then manually segmented by an
expert. These segmentations were then propagated to the remaining AD and control subjects to
generate a training set. Classiﬁcation in test subjects was then performed by a grading process,
which simultaneously segmented the structures of interest. For each test subject, the ten closest
subjects in each disease group were selected by a sum of squared differences (SSD) measure. A
nonlocal means ﬁlter was then used to assign a weight comparing each voxel in the test subject
to each voxel in each training subject. If the voxels in the training subjects are labelled with 1
for structure and 0 for background, the weights can be used to create a weighted sum to label
each test subject voxel, segmenting it. Following this, a very similar procedure was used to
propagate a new label indicating the disease state of each training subject to each voxel in the
newly segmented structure in the test subject. This label was averaged across the structure to
create an overall score. Using this approach it was possible to distinguish between AD patients
and controls with 91% accuracy, and between MCI-c and MCI-s with 74% accuracy.
4.2.2 Region-based features
As an alternative to using individual voxels as features, they can instead be grouped together
into regions with some anatomical meaning. These regions can be deﬁned adaptively or on
a manually labelled atlas which is propagated onto individual MRI images. Features are de-
ﬁned as the average value of voxel level quantities such as intensities within each region.
For the former approach of adaptive feature extraction, the most commonly used procedure
is COMPARE (Classiﬁcation Of Morphological Patterns using Adaptive Regional Elements)
[Fan et al., 2007]. This is a complex process consisting of multiple steps. Brieﬂy, the MRI im-
ages are ﬁrst aligned non-rigidly to a template using HAMMER [Shen and Davatzikos, 2002].
For each voxel, the robust correlation with class label across tissue types is calculated along
with a spatial consistency measure. These are combined to produce a map of the separability
scores across voxels for each tissue type. These are then smoothed and regions are generated
with a watershed algorithm. Within each region, features are generated using a region growing4.2. Review of the existing literature 70
method, starting at the most discriminative voxel and adding neighbours until no more can be
added. Even after this, the number of features is still high, so a selection is made using a rank-
ing based on correlation and a method based on SVM-RFE (Recursive Feature Elimination)
[Guyon et al., 2002]. The selected regional features can then be used in SVM classiﬁcation.
The initial application was to schizophrenia patients, but the method has also been applied to
a number of problems related to AD, including predicting conversion of MCI patients within
15 months [Misra et al., 2009] with about 80% accuracy. For ADNI data with a three year
follow-up period for conversion, it provides a sensitivity of 94.7% but only 37.8% speciﬁcity
[Davatzikos et al., 2008].
The atlas based feature extraction procedures are much simpler. The method of
[Magnin et al., 2009] propagates labels obtained from [Tzourio-Mazoyer et al., 2002] to their
subjects. This was done by registering their subjects and the atlas to standard MNI space, and
then inverting the transformations to create a labelled parcellation of 116 anatomical regions
in the native space of each subject. In each region for each subject, the image histogram
was separated into GM, WM and CSF components with the expectation maximisation (EM)
algorithm and the relative weight of GM compared to the other tissue types was chosen as a
feature to summarise each ROI. Classiﬁcation was then performed using an SVM and bootstrap
to assess generalisation accuracy; the result was an average accuracy of 94.5% for classifying
AD subjects and healthy controls. However, this ﬁgure is most likely optimistically biased as
testing data were used to select optimal SVM parameters within the bootstrap.
4.2.3 Cortical thickness features
CorticalthicknessisadirectmeasureoftheatrophythatiscausedbyAD[Dickerson et al., 2008]
and is thus a powerful feature for disease classiﬁcation that has been used in many stud-
ies. As in the previous section, features can represent the average thickness over anatomical
regions or represent individual vertices of a cortical segmentation. Cortical thickness measure-
ments are frequently derived from the FreeSurfer toolkit [Dale et al., 1999, Fischl et al., 1999a,
Fischl et al., 1999b, Fischl and Dale, 2000]. [Querbes et al., 2009] however used a different
approach, segmenting brain images into GM, WM and CSF. Within the cortical GM ribbon, the
method based on Laplace’s equation [Jones et al., 2000] was used to calculate cortical thickness
in the native space of each subject’s brain. These were then rigidly registered to MNI space.
The cortical thickness maps were then parcellated into 96 areas using a Brodman area 3D map,
which were then grouped into 22 zones. The ﬁnal features were the mean cortical thickness
in each zone. A normalised thickness index (NTI) was calculated from an optimally discrim-
inative subset of these features as a linear discriminant. The reported AUC for discriminating4.2. Review of the existing literature 71
MCI-c and MCI-s subjects from the ADNI study was 0.76, with follow-up of 24 months.
Aninnovativemethodofusingcorticalthicknesswasemployedby[Cho et al., 2012]. This
study used a total of 491 MRI scans from the ADNI database. FreeSurfer was used to extract
meshes, representing the inner and outer boundaries of the cortex, for each subject. To establish
correspondence among subjects, all cortical surfaces were registered to FreeSurfer’s cortical
atlas. The meshes were then made isomorphic to each other, and thickness maps were derived
from distances between corresponding inner and outer points. The resulting cortical maps were
then denoised by removing high frequency components. Mapping onto a frequency domain
was done using the manifold harmonic transform, which represents a signal by a linear com-
bination of eigenfunctions of the Laplace-Beltrami operator. After removing high frequency
components, 2400 frequency components were left for each brain hemisphere. Principal com-
ponent analysis (PCA) was used to further reduce the dimensionality of the data, with compo-
nents representing 70% of the variance retained. Finally, Fisher’s linear discriminant analysis
[Fisher, 1936] was used for classiﬁcation. This method obtained a sensitivity of 63% and speci-
ﬁcity of 76% for predicting MCI conversion within a follow-up period of 18 months.
[Eskildsen et al., 2013] also made use of cortical thickness features to predict conver-
sion. Scans of converting and nonconverting MCI subjects from the ADNI database were
used, including scans from all follow-up timepoints rather than baseline only. The MCI-c sub-
jects were stratiﬁed by the time after baseline scan when they converted (up to 36 months).
All images were corrected for noise and bias ﬁeld, and then registered to MNI space and
skull stripped. Cortical thickness was calculated with FACE (Fast Accurate Cortex Extrac-
tion) [Eskildsen and Ostergaard, 2006] and mapped to the cortical surface of a custom tem-
plate. 51 scans were then removed for quality control. As each subject was represented by
the cortical thickness at over 100,000 vertices, feature selection was then performed. This
was done by computing t-tests at each vertex for the groups in question (eg MCI-s versus
MCI-c at 12 months), ﬁnding local maxima in the resulting t-maps and then using these
as seeds for a region growing procedure. Features were the mean thickness in each result-
ing region. The ten best features as chosen by maximum relevance, minimum redundancy
(MRMR) [Peng et al., 2005] were retained for classiﬁcation with LDA. Care was taken to per-
form the entire feature extraction and selection procedure independently in each iteration of
an LOOCV loop, to avoid optimistic bias in the resulting estimated generalisation accuracy
[Kriegeskorte et al., 2009, Varma and Simon, 2006]. The overall accuracy for predicting con-
version was 67.3% with well balanced sensitivity and speciﬁcity when putting all converting
subjects into a single group regardless of conversion timepoint. However, by constructing sep-4.2. Review of the existing literature 72
arate stratiﬁed classiﬁers for MCI-s subjects vs MCI-c for each conversion timepoint, and then
classifying new subjects with the combined maximum posterior probability from all four strat-
iﬁed classiﬁers, this was increased to 73.5%. This improvement, however, did result in a less
well balanced classiﬁer.
4.2.4 Hippocampal features
As the hippocampus is one of the ﬁrst brain structures to be affected by atrophy in Alzheimer’s
disease [Braak and Braak, 1995], many studies have focused on features derived from the hip-
pocampus only to do early diagnosis of AD or to predict conversion to AD in MCI subjects.
These studies all begin by segmenting the hippocampi in all subjects. Features as simple as
the volume of the hippocampus, normalised by intracranial volume (ICV) can then be used.
As hippocampal volume results in a feature dimensionality of only one, or two if both left and
right hippocampi are used, advanced classiﬁers such as the SVM are not necessary. Hence
hippocampal volumetry has been used for a relatively long period in early diagnosis of AD,
with manual segmentation of the hippocampi [Jack et al., 1999]. More recently, automated hip-
pocampal segmentation methods have become more widespread. The SACHA (Segmentation
Automatique Competitive de l’Hippocampe et de l’Amygdale) method [Chupin et al., 2007] is
based on competitive region growing to simultaneously segment the hippocampus and amyg-
dala, constrained by anatomical and probabilistic priors. It was applied to a set of 210 MCI
subjects from the ADNI database, 76 of whom converted to AD within the chosen 18 month
follow-up period, in [Chupin et al., 2009]. Classiﬁcation between MCI-s and MCI-c based on
hippocampal volume in these subjects had an accuracy of 64%, which is somewhat disappoint-
ing - especially considering the short follow-up period. The authors suggest this may be im-
proved by including shape analysis information rather than only volume. The same idea is
suggested in [Csernansky et al., 2000], noting that in early AD the CA1 subﬁeld of the hip-
pocampus is particularly affected. Differential atrophy rates across the hippocampus mean it
will change in shape as well as gross volume, allowing the authors to ﬁnd areas of signiﬁcant
difference between AD patients and controls within the hippocampus; however, they did not test
the diagnostic ability of shape for individual subjects. Parameterisations of hippocampal shape
can, however be used as features for classiﬁcation. For example, in [Gerardin et al., 2009], the
SPHARM (SPherical HARMonics) toolkit [Gerig et al., 2001] was used to generate such a pa-
rameterisation, representing shapes as a sum of spherical harmonic basis functions in what can
be considered a three dimensional analogue of Fourier analysis. The coefﬁcients of the resulting
series can be used as features themselves, or used to establish correspondence between sets of
points representing the hippocampi, which are then used as features. The study used the coef-4.2. Review of the existing literature 73
ﬁcients as the author claimed they offered better discrimination. Univariate t-tests and bagging
were used to rank the coefﬁcients as features, with a variable number of highest ranking fea-
tures retained. Feature rankings and an optimal number of features and SVM parameters were
determined by LOOCV on a cohort of locally scanned subjects, then the resulting optimised
classiﬁer was applied to a group of subjects from the ADNI database. Accuracy was 88% for
classifying AD patients and controls, and 80% for classifying MCI patients and controls, but
their method was not applied to predict conversion in MCIs. Other studies have applied shape
features to predicting MCI conversion.
For example, [Costafreda et al., 2011] trained a classiﬁer using AD and control subjects
from the AddNeuroMed study [Lovestone et al., 2009]. Hippocampi were segmented using the
method described in [Morra et al., 2008], which itself treats segmentation as a classiﬁcation
problem on a voxel by voxel basis. The segmentations were converted to 3D meshes, then
a common triangulation with correspondence between points was obtained using direct hip-
pocampal mapping (DHM) [Shi et al., 2007]. Radial distances from the hippocampal medial
core to vertices, normalised by the cube root of ICV, were taken as features for training a SVM
using a RBF kernel. The model was then tested on the same features derived from MCI subjects,
also from the AddNeuroMed database. The assumption behind this approach was that MCI-c
subjects will appear more AD-like and MCI-s ones more control-like, so a classiﬁer trained on
AD patients and controls could be applied to predict conversion in MCI subjects. The resulting
accuracy was 80%, but the follow-up period for deﬁning conversion was only one year.
The methods used in [Ferrarini et al., 2009] took a similar approach. The authors used a
set of 50 locally scanned AD subjects and 50 controls, and a set of 15 MCI-c and 50 MCI-
s subjects with a mean follow-up period of 33 months. All subjects’ brain MR images were
rigidly registered to a standard template, and both hippocampi were manually segmented. The
most representative subject from the AD and control subjects was found and designated as
a standard space; all other subjects were then rigidly registered to this and the transforma-
tions applied to the hippocampal surface points. The GAME (Growing and Adaptive MEshes)
method [Ferrarini et al., 2007] was used to model the hippocampal shapes, making use of self-
organising maps [Kohonen, 1990] to adapt the meshes, moving nodes and edges to increase
the similarity to other subjects. Feature selection was done by permutation testing to assess
the signiﬁcance and consistency of each node in the ﬁnal set, and then thresholded by p-value.
This step was done using AD and control subjects only. To classify MCI-c and MCI-s, an
LOOCV loop was used, with an RBF SVM. The SVM parameters were tuned with a grid
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[Costafreda et al., 2011] at 80%, although the result here is more impressive given the longer
follow-up time.
4.2.5 Side-by-side assessment of features
Direct comparison between results obtained by the methods described up to this point is dif-
ﬁcult, as they all involve different subjects, from both multicentre studies such as ADNI
and local scanners, different criteria to deﬁne MCI convertering and stable subjects, and dif-
ferent statistics used to assess predictive accuracy. To address this problem, Cuingnet et
al [Cuingnet et al., 2010] conducted a large study assessing a number of methods alongside
each other, using the same set of ADNI subjects and the same method of assessing the re-
sults. Furthermore, as the emphasis was on ﬁnding the best features, rather than classiﬁ-
cation methods and a linear SVM was used in all experiments except those using a single
measure of hippocampal volume. The work compared the effects of varying preprocessing
steps, such as registration algorithm, and whole brain versus volume of interest analysis. The
methods assessed included variants of ones already discussed, including [Kl¨ oppel et al., 2008,
Fan et al., 2007, Magnin et al., 2009, Chupin et al., 2007, Gerardin et al., 2009]. Also used
were the STAND (STructural Abnormality iNDex) score method [Vemuri et al., 2008], which
is similar to [Kl¨ oppel et al., 2008] but with an extra image downsampling and features selection
step, and the cortical thickness method described in [Desikan et al., 2009], which is similar to
[Querbes et al., 2009]. Each method was used for three clinically relevant classiﬁcation prob-
lems: AD versus control, MCI-c versus control, and MCI-converter versus MCI-s, with an 18
month follow-up period deﬁning the conversion. For the ﬁrst task, all methods performed sta-
tistically signiﬁcantly better than chance and for the second task all but two did. By contrast,
none at all signiﬁcantly better than chance for predicting conversion in MCI subjects, although
some did achieve over 50% in both speciﬁcity and sensitivity so this was probably a conse-
quence of the small number of test subjects. Many methods offered 0% sensitivity and 100%
speciﬁcity, or were almost as unbalanced. This was probably caused by the combination of
the numerically unbalanced training set (39 MCI-c, 67 MCI-s) and highly overlapping feature
distributions of the two classes forcing the classiﬁers to assign all training subjects to a single
class as this offered the best overall accuracy. Overall, performance of methods in this compar-
ative study was generally much lower than in the original papers where they were introduced.
This may be caused by [Cuingnet et al., 2010] deliberately putting less effort into parameter
tuning, feature selection, et cetera in order to focus on comparing feature extraction methods.
It also may be because the authors were more rigorous in avoiding the type of optimistic bias
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is a combination of the two, as it is parameter tuning and feature selection steps that offer the
opportunity to introduce this bias.
Because of these complicating factors, it is necessary to be cautious when deriving general
conclusions from the results. However, based on the results from the AD versus control and
MCI-c versus control, it appears that there is some beneﬁt to using a more modern, accurate
registration method. It also seems that whole brain methods are more effective for separating
patients from controls, but for tasks involving MCI subjects, methods using the hippocampus
only remain competitive. This is not unexpected as the hippocampus is one of the structures
affected earliest in the disease process, but when AD is at a more advanced stage, atrophy
is more widespread in the brain [Braak and Braak, 1995]. Methods incorporating data driven
feature selection do not appear to bring any signiﬁcant advantage and take much longer to run
given the number of extra tunable parameters that they introduce. The authors suggest that
making use of prior knowledge of the disease (such as focusing on a predetermined volume of
interest) is a more robust way to reduce the dimensionality of the features. They also note that
classiﬁers using combinations with other markers seem to be necessary to detect prodromal AD
with high accuracy.
4.2.6 Multi-MRI features
This is the approach taken in [Westman et al., 2012], using a large set of control, AD and MCI
subjects from the ADNI database. In the MCI subjects, conversion was deﬁned with an 18
month follow-up period. The images were processed using FreeSurfer, rather than registering
them to a template, which parcellated all the images into 68 cortical and 46 subcortical re-
gions. A number of subcortical regions were excluded from the analysis, and the volumes of
the remaining ones were averaged between hemispheres to leave a total of 21 subcortical vol-
ume features. For the cortical regions, FreeSurfer generated a large basket of features: thick-
ness and volume, and also surface area, mean curvature, Gaussian curvature, folding index
and curvature index. All these were averaged between left and right hemisphere parcellations
to leave a total of seven measures for 34 cortical regions, giving 238 cortical features, and
259 features of eight different types in total. Classiﬁcation was done by orthogonal partial
least squares, also sometimes known as orthogonal projection onto latent structures (OPLS)
[Trygg and Wold, 2002, Bylesj¨ o et al., 2006]. This created a model with one predictive com-
ponent and one or more orthogonal components representing variation in the training data that
is not related to class differences. Before building the models, the data were preprocessed by
centring and then scaling to unit variance. This is a common step, especially in models com-
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Without the scaling, data with a large range could dominate even if it is not the most discrim-
inative. Initially eight models were created, using each type of feature alone. Three types of
feature (cortical thickness, cortical volume and subcortical volume) were shown to perform well
for classiﬁcation. Mean curvature and surface did a little less well, while Gaussian curvature,
folding index and curvature index did not perform signiﬁcantly better than chance and were
dropped from further analysis. The next step was to assess the effectiveness of different types
of feature in combination, which was done by creating hierarchical models from each possible
pair of remaining types of features (except for the combination of the less well performing pair,
mean curvature and surface area). Finally, a hierarchical model was created using all three of
the best performing feature types (cortical thickness, cortical volume and subcortical volume).
This entire exercise was done twice, once using raw features and the second time using all fea-
tures normalised by the subjects’ ICV. In both cases, all the models using two types of features
outperformed any single feature type, and the model using three feature types outperformed all
the ones using two. AD subjects and healthy controls could be separated with 90.5% accuracy
in this way. This was further increased to 91.5% in a ’mixed model’ when normalised thickness
was used with raw volume features. This model could also predict conversion, when applied to
the MCI subjects, with 68.5% accuracy.
A similar approach was used in [Wolz et al., 2011b]. The authors used all ADNI subjects
that were available at the time their study was conducted, giving a very large group of 231
controls, 238 stable and 167 converting MCI patients (conversion being deﬁned simply up to
the point when the images were obtained in July 2011), and 198 AD patients. Four types of
features were used for each subject. The ﬁrst feature used was univariate hippocampal volume,
as calculated from segmentations generated by label propagation from a set of atlases selected
from a larger pool and merged [L¨ otj¨ onen et al., 2010]. The second was cortical thickness mea-
sured by the CLASP (Constrained Laplacian-based Automated Segmentation with Proximities)
algorithm [Kim et al., 2005], with the vertex-wise thickness measures smoothed with a Gaus-
sian ﬁlter. The third feature was tensor-based morphometry (TBM) maps. A set of 30 randomly
selected images (10 control, 10 AD, and 10 MCI) were chosen as templates and nonlinearly
registered to all study images. The Jacobian determinants of the resulting deformation ﬁelds,
representing local expansion or contraction in each voxel were calculated. To combine multiple
results, all template images were registered to their own anatomical mean, and the resulting
deformations applied to the appropriate Jacobian maps. The maps for each subject were then
averaged to leave one overall Jacobian map per subject. The fourth feature was the coordinates
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of the Laplacian eigenmaps manifold learning algorithm [Belkin and Niyogi, 2003]. To reduce
the dimensionality of the thickness and TBM data, both were aggregated into ROIs based on
groupwise statistical tests in each vertex or voxel. This was done separately for each exper-
iment, that is different regions were chosen for AD versus controls classiﬁcation than MCI-s
versus MCI-c. Three classiﬁcation experiments were done: control versus AD, control versus
MCI-c, and MCI-s versus MCI-c. For all of these, a combination of all features was more accu-
rate than any single feature type when using LDA as a classiﬁer, although this was not always
the case when using an RBF SVM. LDA also tended to produce a better balance of sensitivity
and speciﬁcity. The authors did not mention any feature normalisation step, so presumably the
feature types were combined by simply concatenating the non-normalised feature vectors. For
converting versus stable MCI subjects, sensitivity was 67% and speciﬁcity 69%.
4.2.7 Multimodal classiﬁcation
An obvious extension to the idea of using multiple measurements derived from MRI is to com-
bine MRI features with others from different imaging or non-imaging data. The most common
other imaging modality is positron emission tomography (PET). Tracer radionuclides can be
attached to molecules with a speciﬁc function in brain chemistry to image different aspects of
brain function. For example, ﬂuoro-deoxyglucose PET (FDG-PET) gives information on brain
metabolism. As the degeneration caused by AD reduces brain metabolism, this can be a useful
biomarker, and can also be used by itself in classiﬁcation studies very much analogously to the
ones already discussed, such as in [Herholz et al., 2002]. A variety of non-imaging data can
also be used. The results of psychological tests that we have already introduced can be used.
Additionally, there are genetic risk factors for the sporadic form of AD. In particular, it has
been demonstrated that the variants of the apolipoprotein E (APOE) gene affect the chance of
developing AD, with the 2 allele conferring some degree of protection [Corder et al., 1994]
whereas the 4 allele increases risk [Corder et al., 1993]. Finally, levels of proteins can be mea-
sured in the cerebrospinal ﬂuid (CSF), a liquid surrounding the brain and spinal cord, from
which a sample can be drawn with a lumbar puncture. In particular, CSF levels of total tau
protein (t-tau) and phosphorylated tau (p-tau) proteins, known to be implicated in the formation
of neuroﬁbrillary tangles that cause atrophy in AD, are elevated in AD patients, while levels of
the amyloid-42 (a42) peptide in CSF fall [Fjell et al., 2010a, Holtzman, 2011].
The simplest method of combining features extracted from different types of data is to just
concatenate the feature vectors for each subject into one long vector, possibly after rescal-
ing all features to zero mean and standard deviation of one. This is the approach used in
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based on structural MRI [Vemuri et al., 2008], with that of CSF biomarker levels for predicting
time to conversion of MCI subjects via Cox proportional hazard models. Their conclusion was
that the CSF biomarkers and STAND scores are complementary. The two imaging types of
structural MRI and FDG-PET were combined with CSF biomarkers in [Walhovd et al., 2010].
A large number of subjects from the ADNI database was used. FreeSurfer was used to par-
cellate the MRI images and the hippocampal volume, and the mean thickness in a number of
cortical regions selected for having shown sensitivity to AD in other studies were retained as
features. For the PET features, the same regions of interest were used; PET activity within each
region was averaged, and then normalised by the activity within each subject’s pons. For CSF
features, a42, t-tau and p-tau were included in the analysis alongside the ratios p-tau/a42
and t-tau/a42. Stepwise logistic regression was used to perform classiﬁcation of AD versus
controls, in three separate experiments using only features of each type. The selected MRI,
PET and CSF features were then used in a multimodal stepwise regression to again classify
AD versus controls. The ﬁnal multimodal model showed a small improvement in accuracy and
AUC when compared against the unimodal classiﬁers, although the ﬁnal classiﬁer did not se-
lect any PET features. The feature concatenation approach is also used in [Nho et al., 2010]
to combine regional volumes and mean cortical thicknesses, mean regional grey matter den-
sities (both derived from structural MRI with FreeSurfer and SPM5 respectively) and APOE
genotype, performing classiﬁcation with an RBF SVM. Results here were quite good, with an
accuracy in predicting MCI conversion within three years of 72.3%. This was using a classiﬁer
trained on AD and control subjects, using a pool of all FreeSurfer, SPM and APOE features
to which a feature selection procedure was applied. The optimal set of features contained both
APOE 2 and 4 status and some regions from both SPM and FreeSurfer. Concatenation was
also used in [Cui et al., 2011] to predict MCI conversion within a 24 month follow-up period.
FreeSurfer was again used to generated features, with the volume of subcortical regions and the
volume, mean and standard deviation of thickness, volume and surface area of cortical regions
used. CSF features were the same protein levels and ratios as [Nho et al., 2010], and a variety
of neuropsychological test scores were also used as features. A separate feature selection step
was done for the CSF and for the MRI features using MRMR [Peng et al., 2005], and for the
test scores using both MRMR and AUC in discriminating between AD and control subjects.
Classiﬁcation was performed using an RBF SVM, with parameters optimised on a training set
of AD and control subjects. The optimised classiﬁer was then applied to MCI subjects. The
resulting accuracy was a 67.1%, but this masked quite poor balance as sensitivity was over 96%
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StructuralMRIbiomarkerswerealsocombinedwithCSFin[Davatzikos et al., 2008], with
a slightly different method. The COMPARE framework [Fan et al., 2007] was used to generate
a set of regions sensitive to AD, and the result of classifying subjects using these regions was
a score representing the degree to which they had AD-like patterns, called SPARE-AD (Spatial
Pattern of Abnormalities for Recognition of Early AD) by the authors. These SPARE-AD
scores were then combined with CSF biomarkers for the subset of ADNI subjects for which
they were available. This results in a two or three dimensional feature set (SPARE-AD score
and/or one or two CSF biomarkers) to which a second SVM classiﬁer is applied. The results
from the combination of SPARE-AD score and t-tau provide the best accuracy, but this is only
61.7% and again is a very unbalanced result, as sensitivity is much higher than speciﬁcity.
Better results have been obtained with a multi-kernel learning (MKL) framework. Many
types of classiﬁers, including SVMs, make use of a kernel, which is a matrix of pairwise sim-
ilarities between subjects. In a linear SVM, the kernel is made up of the inner products of
pairs of feature vectors. As the sum of valid kernels is itself a valid kernel, this can be used to
integrate multiple types of feature. Separate kernels are formed using the features from each
data modality, and then an optimally weighted sum is used to produce a combined kernel. This
combined kernel is then used to train a classiﬁer. There are several methods to ﬁnd the op-
timal weighting of the kernels, one of which is to ﬁnd the weights that maximise the margin
alongside other parameters, in an optimisation that is a modiﬁcation of a standard SVM. This
speciﬁc algorithm [Bach and Lanckriet, 2004] is also sometimes referred to as MKL. This is
the method used in [Hinrichs et al., 2011]. Their study used subjects from the ADNI database
and made use of a wide variety of features. For structural MRI images, SPM was used to
segment all subjects’ baseline and 24 month follow-up scans. A custom template was then
created from all subjects’ baseline scans, and the GM and WM segmentations warped into the
template space and smoothed. Additionally, all subjects’ baseline and 24 month scans were
nonlinearly registered, and the Jacobian maps of the resulting deformations were also warped
into the template space. FDG-PET images were registered to their corresponding structural
MRI images, normalised by the mean activity within the pons, and then warped to the custom
template spaces. CSF biomarker levels, APOE genotype, and cognitive scores were also used in
the analysis. Three kernels were used: One using imaging data, one using biological measures
(APOE and CSF), and one using cognitive scores. A classiﬁer was trained on AD and control
subjects and then applied to MCI subjects to predict conversion. The best result was an AUC
of 0.791, which translates to an accuracy of 72% based on a leave-one-out loop of classiﬁer
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The classiﬁer using only baseline imaging performed less well; what is more surprising is that
a classiﬁer based on all modalities also failed to perform as well as longitudinal image data
alone. Furthermore, although the follow-up period for MCI conversion here was three years,
the requirement for 24 month follow-up imaging means that in effect prediction is only up to a
year in advance. This also applies to other studies offering superﬁcially excellent results such
as [Vounou et al., 2012].
A much simpler variant of MKL was used in [Zhang et al., 2011]. Their method also made
use of multiple kernel SVMs, but rather than simultaneously optimising the kernel weights and
other SVM parameters, a (linear) kernel was explicitly generated for each modality. A grid
search was then performed over kernel weights. At each point in the grid a combined ker-
nel was generated, and used with a conventional SVM to assess accuracy in a cross validation
loop. Three kernels were used, representing MRI, FDG-PET and CSF data, and as the kernel
weights were constrained to be positive and sum to one the grid search was two dimensional
only. MRI features consisted of volumes of GM tissue in 93 ROIs. These were generated by
aligning all images rigidly, skull stripping, and registering with [Shen and Davatzikos, 2002] to
a labelled atlas. The labels were then propagated to each subject’s GM segmentation to calcu-
late the features. For FDG-PET data, the images were rigidly aligned to the corresponding MRI
for each subject. The FDG-PET images were then parcellated into the same 93 regions from
the atlas, and the mean intensity within each region was taken as a feature. For the CSF data,
a42, t-tau and p-tau levels were used as features. All features were then normalised to zero
mean and unit standard deviation. In addition to the MKL procedure just described, the authors
attempted two other multimodal classiﬁcation schemes: simple feature concatenating, and an
ensemble approach where separate classiﬁers were constructed for MRI, FDG-PET and CSF
data and the results were combined by majority voting. Validation was by tenfold cross vali-
dation, with a second tenfold cross validation in each iteration to determine the kernel weights.
For classifying AD and control subjects, the MKL method performed substantially better than
any single modality, and slightly better than feature concatenation or ensemble multimodal
methods. When classifying MCI subjects versus controls, the same pattern was found, albeit
with smaller margins. The authors went on to apply their method to predicting conversion in
the MCI subjects, with 18 months of follow-up. Sensitivity was 91.5% and speciﬁcity 73.4%.
However the authors do not state whether this was done in a cross validation using MCI subjects
to train, or training a single classiﬁer on AD and controls subjects and applying it to the MCI
ones. They also do not say how many MCI subjects were converters so we cannot calculate the
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the authors in some of their subsequent work, such as integration of structural and functional
connectivity data in [Wee et al., 2012].
4.2.8 Other approaches
A very common result in all the studies is that separating MCI subjects from AD patients or
controls is much more difﬁcult than separating AD patients from controls, and separating con-
verting and stable MCI subjects is more difﬁcult still. This is unsurprising given that we would
expect smaller differences between the groups in disease severity to be reﬂected in smaller dif-
ferences in image features. However the MCI subjects, and in particular the converters, form
a very heterogeneous group. Many of them will in fact have conditions other than AD, but
which ones these are cannot be ascertained given the general lack of postmortem conﬁrmation
of diagnosis. Meanwhile, the identiﬁcation of stable MCI subjects is hampered by a limited
follow-up period. Many subjects designated as stable would doubtless convert to AD within a
slightly longer period. The authors of [Aksu et al., 2011] go so far as to say there are no deﬁni-
tively labelled examples of MCI converters. They proposed to circumvent this by constructing
their own ground truth for MCI subjects. This was done by ﬁrst training an AD versus controls
classiﬁer. This was then applied to subjects who were labelled MCI at baseline, for their MRI
scans at every follow-up timepoint. This enabled a trajectory to be established for each baseline
MCI subject, based on whether their follow-up images were consistently classiﬁed as normal or
AD. The trajectories were used to label MCI subjects as MCI-c or MCI-s, which were then used
to build a second classiﬁer for the MCI subjects. Unfortunately the results were validated with
respect to the ’by trajectory’ deﬁnition of conversion or nonconversion, introducing a form of
circular logic: MCI subjects were classiﬁed as converters because they look more like convert-
ers by trajectory, but converters by trajectory were labelled as such because they resemble each
other. Introducing validation labels based on an actual clinical criterion would have made this
much more valuable, and would still allow training labels to be based on something different
such as conversion by trajectory.
The notion of using different criteria to train and test is taken to a greater extreme in
[Gaser et al., 2013]. This abandons the idea of what the authors call a disease-speciﬁc pat-
tern entirely. Instead of using discrete labels representing different disease states in a classi-
ﬁcation problem, they made use of their BrainAGE score [Franke et al., 2010] in a regression
framework. This used a sparse Bayesian, kernel based method, the relevance vector machine
(RVM) [Tipping, 2001]. The model was trained on 320 healthy subjects aged 50 or over, taken4.3. Summary 82
from the IXI 1 and OASIS 2 databases. Test subjects comprised 195 MCI subjects from the
ADNI database. The regression targets were the subjects’ ages. All images were segmented
into GM, WM and CSF and spatially normalised with afﬁne registration. The GM segmenta-
tions were smoothed and retained for training and testing. The trained regression model was
then applied to the test subjects’ GM segmentations, to produce an estimated age for them
based on the distribution of GM in their brain. This estimated age minus their chronologi-
cal age is the subject’s BrainAGE, indicating the degree to which they are aging abnormally.
This has already been shown to correlate with disease severity and poorer cognitive function
[Franke and Gaser, 2012]. By varying the threshold of BrainAGE scores for the MCI subjects, a
classiﬁcation accuracy of 75% was obtained for predicting conversion with a three year follow-
up period. This was signiﬁcantly more accurate than CSF, cognitive scores or hippocampal
volumes for the same subjects. This may however include some optimistic bias as it appears
that the threshold setting was not done inside an LOOCV loop.
4.3 Summary
As is made clear from the great variety of approaches discussed in the previous sections, the
problem of predicting conversion of MCI patients to AD is one that has attracted wide in-
terest due to both its challenging nature and clinical relevance. A major side-by-side com-
parison of some of these methods concluded that none could predict conversion with an ac-
curacy signiﬁcantly greater than chance [Cuingnet et al., 2010]. Nevertheless, a number of
other publications have reported statistically signiﬁcant accuracies, and while comparison of
results is difﬁcult, it appears that there has been an upward trend in accuracy. Excluding results
from methodologically dubious procedures such as double dipping, it appears that for predict-
ing conversion within three years from MRI data, the maximum accuracy is about 70-75%
[Eskildsen and Ostergaard, 2006, Coup´ e et al., 2012, Ye et al., 2012]. It is notable that all three
of these are somewhat unconventional in their approach, respectively using multiple classiﬁers
stratiﬁed by conversion time, hippocampal grading, and sparse stability selection of features,
but the classiﬁcation algorithm used by all is standard or even very simple. This is an accor-
dance with the conclusion in [Sabuncu and Konukoglu, 2014] that the type of classiﬁer itself
is relatively unimportant. Meanwhile, a number of recent publications have introduced much
more sophisticated learning methods such as deep learning [Suk and Shen, 2013] and autoen-
coders [Suk et al., 2013] without noticeably increasing the resulting accuracy. Because of this,
my thesis begins by introducing an application of GP classiﬁcation to a simple problem as a
1http://www.brain-development.org
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proof-of-concept. However rather than applying ever more elaborate variants of the classiﬁer,
we show how we can use the same algorithm - or in the case of GP regression, a slightly simpler
one - to achieve better results by framing the problem of predicting MCI conversion in novel
ways. The following chapters show how GPs can be applied to multimodal classiﬁcation, learn-
ing a continuous proxy for disease state rather than binary labels, or automatically weighting
the importance of anatomical brain regions in classiﬁcation. These are shown to advance the
state-of-the art accuracy for predicting MCI conversion.84
Chapter 5
Classiﬁcation of Alzheimer’s disease patients
and controls with gaussian processes
5.1 Introduction
This chapter presents a comparison of GP and SVM methods for the classiﬁcation of AD and
control subjects. A variety of different imaging modalities have been used in previous at-
tempts to perform this, including PET [Gray et al., 2012], and more recently both diffusion
weighted and functional MRI [Wee et al., 2012], but the majority have used structural MRI
[Barnes et al., 2004, Lerch et al., 2008, Kl¨ oppel et al., 2008]. This is because it is known that
the early stages of AD are characterised by a pattern of atrophy in grey matter that is readily as-
sessed and quantiﬁed on such images. For example, the hippocampus is known to be one of the
structures most affected by the disease process so the volume of the segmented hippocampus,
normalised by intracranial volume, can distinguish between AD patients and controls with high
accuracy [Barnes et al., 2004]. Measurements of cortical thickness across the entire brain offer
similar accuracy [Lerch et al., 2008]. This study follows [Kl¨ oppel et al., 2008] in using maps of
grey matter density across the entire brain, as this approach includes all known areas of atrophy
associated with AD.
Use of such images implies very high dimensionality in the data, as the dimensionality is
equal to the number of voxels in the images. Various methods have been used to cope with this,
such as using complex feature extraction procedures [Davatzikos et al., 2008] or well known
methodssuchasprincipalcomponentsanalysistoreducethedimensionalityoftheimageswhile
attempting to preserve discriminative information, or selecting a subset consisting of the most
discriminative features according to some statistical criterion. The most widely used classiﬁer
in these types of studies, however, is the support vector machine (SVM), which treats all the
training images as points in a (potentially very) high dimensional space and attempts to ﬁnd a
hyperplane separating two labelled groups in the training data. It selects the hyperplane such5.2. Materials and methods 85
that the distance to the closest training data on either side is maximised. Such classiﬁers can
deal directly with images of the entire brain without having to reduce dimensionality.
However, as discriminative classiﬁers, SVMs produce a simple decision value. Probabilis-
tic predictions have a number of advantages. Firstly, they enable some clinically useful options
such as a reject option for uncertain cases and use of decision theory to optimise classiﬁcation
rules. Furthermore, the paradigm of evidence based medicine can be viewed as an example of
Bayesian reasoning [Ashby and Smith, 2000]. As a more practical consideration, in a proba-
bilistic setting, classiﬁcation parameters can be tuned via type-II maximum likelihood rather
than computationally expensive cross-validation. This chapter describes the Gaussian process
(GP) regression and classiﬁcation method, which is fully Bayesian, and applies it to classiﬁca-
tion of AD from structural MRI images.
5.2 Materials and methods
5.2.1 Images
The data used in this study consisted of 60 T1 weighted structural MRI images of healthy
controls, and 60 T1 weighted scans of subjects diagnosed clinically with probable AD. All
images were obtained from the ADNI database. The two groups were matched for age and
sex. This was done by ﬁrst randomly selecting 60 subjects from the clinical group with fewer
subjects overall (AD patients). Then for each selected AD patient, a matching control was
selected as a subject from the pool of controls of the same sex and age. If there were multiple
subjects with both sex and age matching, one of these was chosen at random, and if there were
no subjects matching on both sex and age then the nearest age match was selected. Then the
selected 60 subjects in each disease category was further split into 40 subjects for training the
classiﬁers and 20 images to test them. The age and sex matching was preserved during this split
by maintaining the pairing between AD and control subjects.
5.2.2 Image processing
To enable a classiﬁer to be constructed using the training images, they were ﬁrst transformed
into the same space. The images were masked to remove non-brain material, the masks gen-
erated from brain MAPS [Leung et al., 2011] and then used to perform groupwise registration.
All images were repeatedly registered to a target image in an iterative procedure. At the end of
each iteration, all registered images were averaged together to create an updated target image,
with a randomly chosen image serving as the target in the ﬁrst iteration. Initially, all images
were rigidly registered to avoid bias to the target image. This was followed by a round of afﬁne
registrations, and then by 10 rounds of nonrigid registrations. All registrations were performed5.2. Materials and methods 86
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Figure 5.1: Pipeline to produce modulated GM images in a common space. Native T1 images
are warped into a common space via a groupwise registration procedure. Native GM density
maps are also produced from the native T1 images, and are then also warped in to the common
space to generate images whose voxels serve as features in classiﬁcation.
by NiftyReg [Modat et al., 2010], a registration toolkit that performs fast diffeomorphic non-
rigid registrations. The native space images were probabilistically segmented using the Nifty-
Seg [Cardoso et al., 2011] tool into ﬁve tissue types: white matter, cortical grey matter, external
cerebrospinal ﬂuid, deep grey matter and internal cerebrospinal ﬂuid. The transformations from
each image’s native space to the space of the ﬁnal groupwise template were then applied to the
segmented native space images to warp the segmentations to the template space. Finally, the
segmentations were modulated by multiplying each voxel by the Jacobian determinant of the
deformation ﬁeld transforming it from its native space to the template space. This step ensures
the total volume of tissue remains constant. Spatial smoothing of the image was not performed
as part of this study.
The pipeline is summarised in ﬁgure 5.1.
5.2.3 Gaussian process regression and classiﬁcation
The primary purpose of this work is to demonstrate that GP classiﬁcation can provide equivalent
results to an SVM. We make use of the GPML implementation of GP classiﬁcation (http://
www.gaussianprocess.org/gpml/code/matlab/doc/). A detailed explanation of
GP regression and classiﬁcation is given in an earlier section ( 3.7), and in the documentation
accompanying the GPML software [Rasmussen and Williams, 2006]. GP classiﬁcation was
applied in two stages; ﬁrstly hyperparameters were learned from the training data, and then the5.3. Results 87
log probabilities of the test data having labels equal to 1 (that is, having AD) were calculated
using GPs. These log probabilities were then exponentiated and thresholded at 0.5 to provide a
hard classiﬁcation.
5.2.4 SVM calculations
To provide a baseline classiﬁcation accuracy for these data, classiﬁcation was also performed
with the widely used LIBSVM library (http://www.csie.ntu.edu.tw/˜cjlin/
libsvm) implementation of the support vector machine. These are also explained in more
detail in section 3.6. All analysis was conducted in MATLAB (The MathWorks Inc., Natick,
MA, 2011).
5.3 Results
Two sets of results are presented, those obtained from GP classiﬁcation and those from SVM
classiﬁcation. Both sets of results were generated by training a classiﬁer on the 80 designated
training subjects, and then evaluating the accuracy of the resulting model in classifying the 40
subjects set aside for testing. The SVM correctly classiﬁed 31 out of the 40 test subjects, giving
an accuracy of 77.5%. The GP model correctly classiﬁed 33 out of the 40 test subjects, equal
to an accuracy of 82.5%. However, the difference in absolute classiﬁcation accuracy is not
statistically signiﬁcant. Both classiﬁers appeared to be well balanced, with the SVM having
a sensitivity (assuming AD = positive) of 75% and speciﬁcity of 80%, and the GP having a
sensitivity of 80% and speciﬁcity of 85%. The results using SVM classiﬁcation are also in
line with those given in [Cuingnet et al., 2010], a large study comparing various methods of
classifying Alzheimer’s disease that included a procedure very similar to this one. ROC curves
and the associated areas under the curve are given in ﬁgure 5.2.
As the ﬁgure shows, the ROC curves for the two classiﬁcation methods are virtually iden-
tical. The areas under the two ROC curves are also very similar, at 0.890 for the SVM and 0.888
for the GP.
5.4 Discussion
This chapter presented the ﬁrst application of Gaussian process classiﬁers to distinguish be-
tween healthy elderly controls and subjects with AD. While many previous studies have
achieved similar accuracy on this type of data [Kl¨ oppel et al., 2008, Cuingnet et al., 2010], they
have all used classiﬁcation algorithms that simply produce a binary decision between two
classes, mostly using support vector machines. While the output of SVMs can be converted
to probabilities, the methods for doing so are somewhat ad-hoc due to the SVM’s non proba-5.4. Discussion 88
1-specificity
s
e
n
s
i
t
i
v
i
t
y
Figure 5.2: AUC curves for classiﬁcation of 40 AD and control subjects with GP and SVM.
bilistic objective function [Platt, 2000]. The probabilistic predictions made by the GP classiﬁer
were thresholded at p(y = 1) = 0:5 to produce a binary decision that can be directly compared
to results from an SVM. The results from the two methods are extremely similar, showing that
it is possible to switch to the probabilistic framework without a signiﬁcant loss of accuracy.
Moreover, all the subjects wrongly classiﬁed by the GP were also wrongly classiﬁed by the
SVM, suggesting that the decision boundaries applied by the two classiﬁers are similar. How-
ever, it would be a waste to limit ourselves to the use of probabilistic predictions in this way.
This formulation allows automatic variable selection via maximum likelihood that avoids the
effects of overﬁtting. The equivalent feature selection must be done via computationally ex-
pensive cross validation or inaccurate ﬁltering for other methods. While it was not possible to
fully apply such techniques in this method, using a labelled atlas to aggregate the grey matter
within anatomical regions as in [Chu et al., 2010] would allow ARD to be used. Alternatively,
the feature dimensionality could be reduced by focusing on a small region of interest such as the
area around the hippocampus as was also done in [Barnes et al., 2004], or by aggregating voxels
into anatomical regions [Chu et al., 2010]. In the context of multikernel learning, a probabilistic
formulation also offers the automatic tuning of the kernel mixing weights. Probabilistic predic-
tions also open up possibilities that cannot be easily done otherwise, such as a reject option in
which more uncertain classiﬁcations are passed to a different classiﬁer or human expert, and
tuning of the probability threshold to maximise positive predictive value of the test in a clinical5.5. Conclusions 89
context [Ashby and Smith, 2000].
5.5 Conclusions
This experiment achieved its aim of successfully performing GP classiﬁcation of AD patients
and controls. As the data used for classiﬁcation were GM density maps across the whole brain,
they were extremely high dimensional. While SVMs have traditionally been used in the result-
ing regime of high dimensionality and low sample size, this study has demonstrated that GP
classiﬁcation is equally able to cope with this problem and yields a binary accuracy statistically
indistinguishable from an SVM. The following chapter goes on to show how we can further
utilise the advantages of GPs over SVMs using more sophisticated techniques.90
Chapter 6
Multiple kernel learning for prediction of
conversion to AD
6.1 Introduction
This chapter presents a study of early diagnosis of AD with multiple kernel learning. As
in many previous studies, it focuses on patients with mild cognitive impairment (MCI)
[Petersen et al., 1999]. MCI is typically deﬁned as a state where patients have isolated mem-
ory deﬁcits that are not severe enough to affect normal living. Studies have shown that MCI
patients convert to AD at an annual rate of 10-15% per year [Braak and Braak, 1995]. MCI
patients who do not convert to AD either develop other forms of dementia, remain stable, or
in a small minority, revert to a nondemented state. Therefore predicting which MCI patients
will develop AD in the short term (i.e. within a few years) and which will remain stable is ex-
tremely relevant to future treatments. Although a deﬁnitive diagnosis of AD can be made only
at autopsy, in practice expert clinicians diagnose AD based on clinical history and batteries of
cognitive tests. However these standard clinical tests are not able to identify the more subtle
patterns of the disease process at this early stage, so more advanced methods are required.
The automated methods used to discriminate between stable (MCI-s) and converter
(MCI-c) patients are similar to those used for diagnosis of AD. These automated tests use
imaging and other biomarker data, and can now diagnose AD with an accuracy of about
90%, as well as expert clinicians can using more traditional methods [Beach et al., 2012].
While a number of different imaging modalities have been proposed for this applica-
tion, the majority have used structural MRI, as atrophy in speciﬁc brain regions is one
of the most established hallmarks of AD. The features used in classiﬁcation derived
from structural MRI can take a number of forms, including voxel level maps of grey
matter density [Nho et al., 2010, Kl¨ oppel et al., 2008, Fan et al., 2007], volume or shape
[Barnes et al., 2004, Gerardin et al., 2009, Zhang et al., 2011], or cortical thickness measure-6.1. Introduction 91
ments [Desikan et al., 2009, Eskildsen et al., 2013, Lerch et al., 2008, Querbes et al., 2009].
These features can be calculated over the whole brain or speciﬁc structures known to be af-
fected by AD, such as the hippocampus. A comprehensive review and comparison of these
methods, focused mainly on the type of MRI-derived features used rather than which machine
learning algorithm was implemented, is given in [Cuingnet et al., 2010].
Looking beyond structural MRI, FDG-PET is capable of measuring the level of glucose
metabolism in the brain. Studies have shown that glucose metabolism is reduced in some re-
gions in patients before they develop AD [Drzezga et al., 2003, Mosconi et al., 2010] and this
may be used to classify AD patients from controls or predict conversion from MCI to AD
[Gray et al., 2012]. Biomarkers extracted from cerebrospinal ﬂuid (CSF) have shown utility in
the diagnosis of AD or MCI. In particular, CSF levels of total tau protein (t-tau) and phosphory-
lated tau (p-tau) proteins, known to be implicated in the formation of neuroﬁbrillary tangles that
causeatrophyinAD,areelevatedinADpatients, whilelevelsoftheamyloid-42(a42)peptidein
CSF fall [Fjell et al., 2010a, Holtzman, 2011]. Measurements of amyloid load in the brain using
amyloid PET have shown similar results [Rowe et al., 2010]. Also, variants of the apolipopro-
tein E (ApoE) gene affect the risk of developing AD [Corder et al., 1993, Corder et al., 1994].
These different types of biomarker data have been shown to be complementary, meaning
that they provide superior classiﬁcation when used in combination than when either is used in-
dividually, even if they are correlated [Fjell et al., 2010b, Landau et al., 2010]. Thus a number
of studies have sought to make use of multiple biomarker types in classiﬁcation. Structural MRI
is used in combination with genetic data in [Vemuri et al., 2008] and with CSF biomarkers in
[Vemuri et al., 2009] and [Davatzikos et al., 2008]. Structural MRI data, FDG-PET and CSF
data are used in [Hinrichs et al., 2011, Walhovd et al., 2010, Zhang et al., 2011]. A noteworthy
disadvantage of multimodal methods is that the problem of missing data is multiplied, as a sub-
ject must be discarded entirely or the missing data must be synthesised if it is not present in any
one of the modalities used. An approach to tackle this issue is presented in [Yuan et al., 2012].
The most popular classiﬁcation method is the support vector machine (SVM), due to its ac-
curacy and ability to cope with very high dimensional data. Another advantage of the SVM is its
ability to use the kernel, a matrix of size N by N that summarises the distances or covariances
among N training subjects. This can be applied to learn from multimodal data. Rather than sim-
ply concatenatingthe featuresfrom different modalities into asingle vector, anindividual kernel
can be formed from each modality and then a combined kernel generated as a weighted sum
of the individual ones. Both [Zhang et al., 2011] and [Hinrichs et al., 2011] use this approach,
but ﬁnd the individual kernel weights in a different fashion. The former chooses them by a grid6.1. Introduction 92
search for the weights giving the best accuracy in a nested cross validation loop. This method
is reused in a number of subsequent publications by the same authors, generally being applied
after a more sophisticated feature selection process. For example, in [Liu et al., 2014], the fea-
ture selection step is used to jointly select a sparse set of features from MRI and FDG-PET data
using a multi-task objective function designed to preserve the inter-modality relationship. The
resulting features are then used to generate separate MRI and FDG-PET kernels, which are op-
timally combined using the existing grid search method. By contrast, in [Hinrichs et al., 2011]
the subkernel weights are set by optimising them alongside the standard SVM parameters and
with the standard SVM objective function. This speciﬁc algorithm is sometimes referred to as
multiple kernel learning [Bach and Lanckriet, 2004], but the term is often used more broadly to
refer to all methods that combine multiple subkernels to produce a ﬁnal kernel.
The study presented in this chapter is a different method using a combination of struc-
tural MRI, FDG-PET, CSF and ApoE data to classify MCI-s and MCI-c patients. Primarily,
this uses Gaussian process (GP) classiﬁcation, which is a probabilistic classiﬁcation algorithm.
Bishop [Bishop, 2007] lists four general advantages of a probabilistic framework, however, for
this particular study we would add two more which we feel to be particularly relevant: ﬁrstly,
the option to tune free parameters automatically from the training data, avoiding the need for
computationally expensive cross-validation loops, and secondly, that the probabilistic decisions
produced by GP classiﬁcation allow a great deal of ﬂexibility in their interpretation. Despite
the fact that for convenience, disease is frequently characterised as a binary distinction, such as
healthy or AD patient, each subject in fact occupies a point on a continuous spectrum of disease
severity, as is reﬂected by the concept of MCI. Probabilistic classiﬁcation allows us to identify
the position of subjects on this spectrum, enabling disease staging, stratiﬁcation, or event based
modelling [Fonteijn et al., 2012]. Probabilistic decisions can also be made into a binary classi-
ﬁcation simply by thresholding, and our previous work shows that this method offers accuracy
as good as an SVM on voxel level data for the diagnosis of AD [Young et al., 2012]; hence
no diagnostic information is lost by choosing a probabilistic classiﬁcation algorithm. While
an SVM’s output can be interpreted probabilistically by transforming the decision value with a
sigmoid function, this method is a rather ad hoc modiﬁcation to a binary classiﬁer, and does not
offer the principled formulation and automatic parameter tuning of GP classiﬁcation.
This previous work is, to my knowledge, the only previous application of GP classi-
ﬁcation to AD. GPs have been used previously in a regression context with fMRI data in
[Marquand et al., 2010], and for classiﬁcation of structural MRI data in Huntington’s disease
by [Chu et al., 2010]. They have not been previously applied for multimodal medical image6.2. Materials and methods 93
classiﬁcation. Here we use four types of data are used, as well as a comparison of two meth-
ods of setting the kernel weight, one very similar to that given by [Zhang et al., 2011] and
the other a probabilistic method that is more natural within the GP paradigm. Finally the re-
sults are compared to those obtained by an SVM on the same data, again using the method of
[Zhang et al., 2011] for setting kernel weights in the multikernel paradigm.
The training population comprises healthy controls and AD patients, allowing us to inter-
pret the results in the MCI population as a risk score for conversion to AD. We introduce a new
method for the validation of probabilistic predictions, which show that the predicted probability
of conversion is a good estimate of the actual chances of conversion. As well as interpreting
the results probabilistically, we also obtained a binary classiﬁcation into MCI-s and MCI-c by
adaptively thresholding the probabilities, resulting in a highly accurate prediction of conversion.
6.2 Materials and methods
All data were obtained from theAlzheimer’s Disease Neuroimaging Initiative (ADNI) database.
This is described in detail in section 1.5.1. For up-to-date information, see http://www.
adni-info.org.
6.2.1 MRI data
Images were all T1 weighted structural MRI scans from 1.5T scanners acquired using a 3D
MPRAGE sequence, taken at the baseline time point for each subject. Back-to-back scans were
takenforeachsubject, andthebestscanofthepairforeachsubjectdeterminedbyvisualinspec-
tion. The images were then post-processed to correct for gradient warping, B1 non-uniformity
and intensity non-uniformity and underwent phantom based scaling correction. Postprocessed
images were downloaded as DICOM ﬁles, and were then converted to NIfTI format for further
processing.
6.2.2 PET data
Images were again all taken from the baseline scan for each included subject. Images were
acquired by scanning 30-60 minutes post injection using scanner-speciﬁc protocols. Six ﬁve
minuteframeswereacquiredforeachsubject, andthenco-registeredandaveraged. Theaverage
images were then rigidly registered to a standard space, and the individual native space frames
registered to the standard space average and averaged and intensity normalised in the standard
space. Finally, the average images in the standard space were smoothed with a scanner-speciﬁc
kernel [Joshi et al., 2009] to a uniform isotropic resolution of 8mm FWHM, which is approxi-
mately the resolution of the lowest resolution scanners used in ADNI. The postprocessed scans
were downloaded as DICOM images.6.2. Materials and methods 94
6.2.3 ApoE data
Variants of the Apolipoprotein E (ApoE) genotype are known to affect the risk of developing
sporadic AD in their carriers. Each individual has two copies of this gene, one inherited from
each parent. The most common allele is ApoE 3, but carriers of the ApoE 4 variant are
at heightened risk of AD, whereas the ApoE 2 variant confers some protection on carriers
[Corder et al., 1993, Corder et al., 1994]. The ApoE genotype of each subject was recorded as
a pair of numbers indicating which two alleles were present. ApoE genotype is determined
from a 10 ml blood sample taken at screening time, and sent overnight to the University of
Pennsylvania AD Biomarker Fluid Bank Laboratory for analysis. ApoE genotype was available
for all subjects for which we had imaging data.
6.2.4 CSF data
CSF samples of 20ml volume were obtained from subjects by a lumbar puncture with a 24 or
25 gauge atraumatic needle around the time of their baseline scan. All samples were sent on
dry ice on the same day as they were drawn to the University of Pennsylvania AD Biomarker
Fluid Bank Laboratory, where levels of the proteins (a42, total tau, and phosphorylated tau)
were measured and recorded. By design, only a subset of ADNI subjects had measurement of
CSF levels. All three measured protein levels (t-tau, p-tau, and a42) were used in constructing
a CSF kernel.
6.2.5 Subjects
All ADNI subjects were between 55 and 90 years old, spoke English or Spanish, and had a
study partner able to provide an independent assessment of functioning. All subjects were
willing to undergo neuroimaging and agreed to longitudinal follow up, and a subset was willing
to undergo lumbar punctures. Subjects with speciﬁc psychoactive medication were excluded.
Inclusion criteria for healthy controls (HC) are MMSE scores between 24 and 30, a CDR of
0, non-depressed and non-demented. Ages of the HC subjects were roughly matched to those
of the AD and MCI subjects. For MCI subjects, the criteria are an MMSE score between 24
and 30, a memory complaint, objective memory loss measured by education adjusted scores on
the Wechsler Memory Scale Logical Memory II, a CDR of 0.5, absence of signiﬁcant levels of
impairment in other cognitive domains, essentially preserved activities of daily living, and an
absence of dementia.
For AD subjects, the criteria are an MMSE score between 20 and 26, CDR of 0.5 or 1.0,
and meeting NINCDS/ADRDA criteria for probable AD. Subjects are designated as HC, AD or
MCI at the time of the baseline scan, and for the purposes of this study MCI conversion status6.2. Materials and methods 95
Disease status n (n female) mean age (sd) mean MMSE (sd)
NC 73 (27) 75.9 (4.6) 28.9 (1.2)
MCI-s 96 (34) 75.6 (7.0) 27.2 (1.7)
MCI-c 47 (17) 74.5 (7.4) 26.9 (1.8)
AD 63 (24) 75.2 (6.6) 23.6 (2.0)
Table 6.1: Demographics of PET group. NC = normal control, MCI-s = stable MCI,MCI-c =
converting MCI, n = number of subjects, sd = standard deviation
Disease status n (n female) mean age (sd) mean MMSE (sd)
NC 36 (12) 74.2 (4.2) 28.8 (1.3)
MCI-s 42 (16) 75.4 (7.0) 27.3 (1.6)
MCI-c 30 (11) 75.5 (7.6) 26.5 (1.8)
AD 35 (12) 75.2 (6.7) 23.9 (2.0)
Table 6.2: Demographics of PET-CSF group. NC = normal control, MCI-s = stable MCI,MCI-c
= converting MCI, n = number of subjects, sd = standard deviation
is decided by whether subjects who were MCI at baseline were subsequently diagnosed as AD
at any stage during the subsequent 36 month follow-up period.
A total of 682 subjects with baseline 1.5T MRI scans were available. Of these, the image
parcellation procedure was run on 679, the manually generated brain masks required for the
parcellation being unavailable for three. Of these 679 subjects, FDG-PET scans were also
available for 286. Seven of these were diagnosed as MCI at baseline but as healthy at follow-
up time points and were excluded as reverters, leaving a total of 279 subjects available for the
study. The demographics of this group (referred to as the PET group) are given in table 6.1.
This experiment also examined the effect of using CSF in the multimodal classiﬁcation. As
there was relatively little overlap between the groups of patients given CSF biomarker testing
as well as FDG-PET scans, the subset of the PET group for which full CSF data was also
available (referred to as the PET-CSF group) was much smaller at a total of 143 subjects. The
demographics of the PET-CSF group are given in table 6.2
In the PET group, 47 out of 143 (33%) of MCI subjects are converters. As conversion is
deﬁned over a three year follow-up period, this is equivalent to an annualised conversion rate
of 12.5% per year, in line with other studies. Subjects diagnosed as MCI at baseline in ADNI
are reassessed after approximately 6, 12, 18, 24 and 36 months, which allows us to roughly ﬁnd
the time after which they converted. The conversion times for the 47 MCI-c subjects in the PET6.2. Materials and methods 96
t n
t <6 5
6 <t <12 15
12 <t <18 9
18 <t <24 14
24 <t <36 4
Table 6.3: Times of conversion t, in months, for subjects in the PET group.
group are listed in 6.3
6.2.6 MRI image processing
To produce GM probability maps in a common space for classiﬁcation, roughly the same pro-
cedure as [Kl¨ oppel et al., 2008] was used. However the processing was done using different
image processing software, and with an additional step of masking the images to include only
regions known to be affected by AD.
Initially the native space, preprocessed scans were probabilistically segmented using the
open source NiftySeg tool [Cardoso et al., 2011]. Based on the expectation maximisation algo-
rithm, this method produces probabilistic maps for ﬁve tissue types: white matter, cortical GM,
external cerebrospinal ﬂuid, deep GM and internal cerebrospinal ﬂuid.
The native space, preprocessed scans were also anatomically parcellated into 83 regions.
This was with a multi atlas segmentation propagation algorithm [Cardoso et al., 2012]. A li-
brary of 30 atlases manually labelled with 83 anatomical regions [Gousias et al., 2008] was
used as a basis for the segmentations. In order to segment a new image, all the atlases and
respective manual labels were ﬁrst nonrigidly registered to this image. After registration, the
manual labels of the locally most similar atlases were fused using a label fusion strategy based
on an extension of the STAPLE algorithm [Warﬁeld et al., 2004] to produce a ﬁnal parcella-
tion. The regions used in the classiﬁcation process were chosen according to Braak and Braak
[Braak and Braak, 1995] and are listed in 6.4. These regions were then intersected with the
GM tissue segmentations obtained above.
All images were transformed into the same anatomical space in order to provide consistent
anatomy at each voxel for the classiﬁer. The images were masked to remove non brain mate-
rial, and then used to perform groupwise registration. All images were repeatedly registered to
the same target image in an iterative procedure. At the end of each iteration, all registered im-
ages were averaged together to create an updated target image, with a randomly chosen image
serving as the target in the ﬁrst iteration. Initially, all images were rigidly registered to avoid6.2. Materials and methods 97
Label numbers Regions
1, 2 Hippocampus (R and L)
3, 4 Amygdala (R and L)
5, 6 Anterior temporal lobe, medial part (R and L)
7, 8 Anterior temporal lobe, lateral part (R and L)
9, 10 Parahippocampal and ambient gyri (R and L)
11, 12 Superior temporal gyrus, posterior part (R and L)
13, 14 Middle and inferior temporal gyrus (R and L)
15, 16 Fusiform gyrus (R and L)
24, 25 Cingulate gyrus, anterior part (R and L)
26, 27 Cingulate gyrus, posterior part (R and L)
Table 6.4: Regions included in GM segmentations. Label numbers are taken from the atlas
used to perform the parcellation [Gousias et al., 2008]. R and L designated the hemisphere
(Right and Left).
bias towards the chosen target. This was followed by a single round of afﬁne registration, and
then by 10 rounds of nonrigid registrations. All registrations were performed using NiftyReg
[Modat et al., 2010], a registration toolkit that performs fast diffeomorphic nonrigid registra-
tions. When the registrations had all been completed, the resulting deformations from each
image’s native space to the ﬁnal average image were applied to the anatomically masked na-
tive space segmentations to bring them into the groupwise space. The registered, anatomically
masked segmentations were modulated by the Jacobian determinants of this ﬁnal deformation.
This ensures the total volume of tissue remains constant [Ashburner and Friston, 2000]. As a
ﬁnal step, the registered, anatomically masked and Jacobian modulated cortical GM and deep
GM segmentations were summed to produce an overall GM density map for the AD relevant
regions in a common space for all subjects.
6.2.7 PET image processing
ThePETimageshadalreadybeenthroughsubstantialpostprocessing, asdiscussedabove. After
downloading, they were registered to the native space MRI image of the same subject, again
using the NiftyReg software. Then masks generated from the structural MRI parcellations were
overlaid on each subject to calculate the total activity within each region from the PET image.
The mean activity within each region was then used as a feature for classiﬁcation.6.2. Materials and methods 98
6.2.8 Gaussian process classiﬁcation
The resulting high dimensional image and biomarker data were then used to construct a GP
classiﬁer based on HC and AD subjects. For a full explanation of GP classiﬁcation, we refer
the reader to section 3.7 and [Rasmussen and Williams, 2006]. Here, we give a brief recapit-
ulation of GP classiﬁcation and give further details on the aspects that pertain to multimodal
classiﬁcation. All learning of hyperparameters and GP calculations were done using the GPML
toolbox for MATLAB which was also used to analyse results.
Gaussian process classiﬁcation can be seen as kernelised Bayesian extension of logistic
regression. A Gaussian process, essentially a multivariate Gaussian, forms the prior on the
value of a latent function, which is then mapped to the (0,1) interval through a sigmoid, which
represents the probability of a subject belonging to a particular class. The exact prior is a
functionofthetrainingdataandlabels, andasetofhyperparametersthatcontroltheshapeofthe
prior. During the training phase, the hyperparameters are learnt from the training data and labels
bytype-IImaximumlikelihood. Thelikelihoodofthetrainingdataandlabelswithrespecttothe
hyperparameters is maximised using a conjugate gradient descent optimisation method. Once
the hyperparameters have been set, predictions on unseen data are made by integrating across
this prior. In the regression case, this is analytically tractable, but for classiﬁcation it is not,
due to the sigmoidal response function, so an approximation must be made instead. A number
of different approximation schemes can be used, but all our experiments use the expectation
propagation algorithm [Minka, 2001]. This has been shown to offer a good compromise of
accuracy and computation time for GP classiﬁcation [Nickisch and Rasmussen, 2008].
6.2.9 Gaussian process classiﬁcation as a multimodal kernel method
Note that the GP classiﬁer is based on a kernel matrix, K, representing the covariance among
training subjects. This is a symmetric positive deﬁnite matrix where entry (i;j) is a covariance
or some function of distance between training subjects i and j. As such, this means that GP
classiﬁcation belongs to the family of kernel methods, as do SVMs, and all the rules for con-
structing valid kernels apply: in particular, a positive sum of valid kernels is a valid kernel, and
a valid kernel multiplied by a positive scalar is also a valid kernel. The covariance between the
ith and jth subject, Kij, is a kernel function of the feature vectors for the ith and jth subject,
xi and xj and a hyperparameter or set of hyperparameters , which are learnt from the train-
ing data by type-II maximum likelihood. For multimodal classiﬁcation, the rules for producing
new kernels mean that we can deﬁne our kernel function as the weighted sum of a number of
subkernels, each of which has been calculated from the feature vectors representing a particular
type of data or modality for each subject. Each subkernel is constructed from a linear kernel6.2. Materials and methods 99
function, which is the scalar product of xi and xj: kij = xi  xj. Each subkernel has a scaling
hyperparameter representing the modality’s weight in the overall kernel, and there is also a sin-
gle bias term. So in the case of multimodal classiﬁcation using each subject’s MRI, PET and
ApoE data the overall kernel is
Kij = MRxMR
i  xMR
j + PETxPET
i  xPET
j + ApoEx
ApoE
i  x
ApoE
j +  (6.1)
where  are hyperparameters representing the weight given to each modality subkernel, and 
is a hyperparameter representing the bias in the combined kernel. Thus  is now a set of four
hyperparameters which are learnt from the training data by maximum likelihood. In this way
we can automatically set the kernel weights without needing to resort to a grid search with cross
validation. This is possible as the GPML software allows complex covariance functions to be
speciﬁed. It allows us to apply masks to include only certain columns of the training data to be
used in a covariance function, so we can learn separate covariance kernels for the MRI, PET
and ApoE data. The ApoE kernel is based on representing each subject as a vector of length
two, encoding each allele as an element of the vector, so for a example a subject with one copy
of the 3 allele and one of the 4 would be encoded as (3;4). More sophisticated kernels have
been developed for genetic data and these may improve results further.
For the PET group, we also do a grid search for the kernel weights to compare the re-
sults of this method of setting the kernel weights to the maximum likelihood method and to
[Zhang et al., 2011]. Each MCI test subject in turn is left out, and a GP classiﬁer is trained on
all AD and control training subjects for each legitimate combination of . The best values of 
are chosen empirically as the ones offering the most accurate classiﬁcation on the n 1 remain-
ing MCI test subjects. As accuracy is a coarse measure, any ties are broken with the information
theory based metric of classiﬁcation quality suggested in [Rasmussen and Williams, 2006]. Fi-
nally the classiﬁer offering the best accuracy was tested on the left out MCI subject, and the
process repeated until all MCI test subjects had been classiﬁed. Due to the leave-one-out loop
and the need to do one tuning classiﬁcation for every combination of parameters within each
iteration of the loop, this method is very time consuming if more than a handful of parameters
have to be tuned. Hence to make the whole classiﬁcation procedure tractable, values of  are
constrained to be positive and sum to one, with no bias term, as in [Zhang et al., 2011]. The
resulting two-dimensional parameter space is searched with increments of 0:1 for both param-
eters. Figure 6.1 represents the multikernel approach.6.2. Materials and methods 100
Combined
kernel
MRI FDG PET APOE
 genotype
Seperate
kernels
Figure 6.1: Pipeline by which kernels are constructed from features extracted from each type
of data, before being summed to produce a combined kernel.
6.2.10 SVM classiﬁcation
To put the results obtained by GP classiﬁcation in context and compare them to a more widely
used method, SVM classiﬁcation on the same datasets was also performed. This was done with
use of the open source libsvm library, with the C parameter left at its default setting and linear
kernels, but used precomputed kernels both for the sake of speed and to facilitate multikernel
classiﬁcation. Training and testing kernels were constructed for all three modalities in the
PET group (MRI, PET and ApoE) and all four in the PET-CSF group (MRI, PET, ApoE and
CSF). Kernel weights are again set using the method of [Zhang et al., 2011] as described in
section 6.2.9. The weight setting is done within a leave one out scheme, where the testing (MCI-
s and MCI-c) subjects are repeatedly split into one subject used for testing and the remaining
ones used for tuning the kernel weights until each MCI subject has been left out; in this way it is
possible to tune on the training population and thus avoid introducing optimistic bias. We also
tried to set the kernel weights using the training (NC and AD) subjects for tuning, by performing
aleave-one-outcrossvalidationonthetrainingsubjectsateachlegitimatecombinationofkernel
weights. To break ties between parameter settings showing equal accuracy, we use the mean
distance from the margin of correctly classiﬁed test subjects minus the mean distance from the
margin of incorrectly classiﬁed test subjects as a metric of SVM quality. We also experimented
with normalising training and testing data using a z-score to help combine different modalities
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Figure 6.2: Relationship between AD and MCI classiﬁcation. As AD, control and MCI subjects
exist on a spectrum of disease severity, MCI-s subjects can be seen as control-like and MCI-c
ones more AD-like. Hence a classiﬁer trained to separate AD and control subjects may also be
applied to separate MCI-c and MCI-s subjects.
6.2.11 Classiﬁcation strategy
Rather than both training and testing the classiﬁer on MCI-s and MCI-c subjects in a cross-
validation loop, training data consists of AD and healthy subjects, and then results are obtained
by applying the resulting classiﬁer to the MCI population. This approach to classiﬁcation of
MCI subjects is widely used and was adopted here as it obtained substantially better results
than those obtained by the training on MCI regime in all our preliminary work. The hypothesis
justifying this is that the subpopulation of MCI subjects that are stable are more healthy-like
(although some will go on to convert beyond the follow up period used for deﬁning conversion,
which is probably a factor in the limited accuracy of predictions of MCI conversion), while
those who go on to develop dementia are more AD-like, as is consistent with our contention
that discrete disease states are an approximation to a continuous disease spectrum.
This means a classiﬁer that successfully separates AD and control subjects will also be
able to distinguish between MCI-c and MCI-s to some degree. This notion, illustrated in ﬁg-
ure 6.2 has been used with some success for this problem previously [Ferrarini et al., 2009,
Singh et al., 2012]. As previously mentioned, however, when using a combined kernel with
grid search we can use the MCI subjects not being classiﬁed to tune the kernel mixing parame-
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6.2.12 Validation
The results of GP classiﬁcation are numbers between 0 and 1 representing the estimated prob-
ability that a test subject belongs to a particular class, in our case the class of MCI-c. A simple
way to binarise these probabilities is to threshold them at 0.5. We do this, and report the result-
ing accuracy, sensitivity and speciﬁcity. However this approach has two disadvantages. Firstly,
as the model is trained on one population (AD and control) and tested on another (MCI-s and
MCI-c), this would be the correct threshold value if the test population were in some sense
exactly half way between the two classes of the training population, but there is no reason to
believe this is necessarily the case. Secondly, setting the cut point at 0.5 leads to varying bal-
ances between sensitivity and speciﬁcity among the different methods, making them hard to
compare. Because of this, the test probabilities are used to determine the cut point that results
in the closest possible value of sensitivity and speciﬁcity. Then the overall correct classiﬁca-
tion rate at this cut point is found and reported, as by deﬁnition it will be very close to both
the sensitivity and speciﬁcity. This is done in a leave-one-out framework to avoid optimistic
bias in the balanced accuracy. Finally, the probabilities are used to calculate the AUC, for easy
comparison with results from other studies. For both PET and PET-CSF groups we also report
the balanced accuracy for classiﬁcation using each modality alone, except for the ApoE. This
is left out because ApoE data consists of pairs of alleles labelled 2, 3 or 4. As order does not
matter this means each subject can be at one of only six points in two-dimensional ApoE data
space (in practice ﬁve points as one combination does not occur in our data), so an ApoE only
classiﬁer would produce probabilities that could only be one of ﬁve discrete values, making
further analysis meaningless. The signiﬁcance of the difference in balanced accuracy between
multimodal classiﬁcation and unimodal classiﬁcation is assessed for both the PET group and
PET-CSF group with McNemar’s test [McNemar, 1947] if there appears to be a substantial dif-
ference. The balanced accuracies are derived from the probabilities before they are corrected for
bias with the procedure described in section 6.3.2. We found that balanced binary accuracies
derived from the corrected probabilities tended to be slightly lower.
However, to only do this would be to neglect the probabilistic information contained in the
output of the GP. The probabilities can also be treated as risk scores for conversion to AD, and
then used to determine how well they function as estimates of the actual chances of conversion.
As each subject either does or does not convert to AD, this cannot be assessed at the individual
level. Instead all MCI subjects are binned into eight equal intervals covering the range (0,1)
by their risk score. For each of the eight intervals, the centre value of the interval is labelled
the predicted risk. Then the empirical risk is calculated for each interval as the proportion of6.3. Results 103
Modality acc (%) sens (%) spec (%) bal acc (%) AUC p(M) p(P)
MRI 64.30 53.20 69.8 61.50 0.643 - -
PET 65.00 66.00 64.60 65.70 0.767 - -
All (ML) 69.90 78.70 65.60 74.10 0.795 0.0162 0.0247
All (GS) 67.10 76.60 62.50 70.60 0.751 0.0865 0.2301
Table 6.5: Accuracy of methods in the PET group with GP classiﬁcation. ’All’ modalities
indicates MKL with MRI, PET and ApoE kernels. ML and GS are, respectively, the maximum
likelihood and grid search methods of setting the subkernel weights . p values are of difference
in classiﬁcation vs. indicated single modality, M for MRI and P for PET.
patients in the interval that do in fact convert. Finally, the root mean square error between
predicted and empirical risk is calculated as a measure of how well the risk scores from GP
classiﬁcation predict the actual risk of conversion. The number of intervals was chosen to
provide the best balance between the demands for good statistics both within and between the
bins.
The decision values obtained from SVM classiﬁcation represent a signed distance from
the optimal hyperplane determined from the training data, the sign indicating on which side
of the hyperplane a test subject falls and thus to which class it is predicted to belong. We
report the accuracy, sensitivity and speciﬁcity from the sign of the decision values (equivalent
to thresholding the decision values at 0). We also perform a procedure to ﬁnd the threshold
producing the accuracy that best balances sensitivity and speciﬁcity in the same manner as we
did for GP posterior probabilities, and ﬁnally calculate an AUC from the decision values.
6.3 Results
6.3.1 Accuracy of binary classiﬁcation
The balanced accuracy, AUC, and p-value for comparison of multimodal methods with uni-
modal ones for the PET group are shown in table 6.5 for the GP results, and in table 6.6 for
the SVM results.
The result in the last row of table 6.6 was obtained by using the MCI subjects as a tuning
set, and normalising training data with a z-score, and then normalising testing data using the
mean and standard deviations from the un-normalised training data. All other combinations of
choices of tuning set and normalisation produced inferior results.
The same accuracy measures for the PET-CSF group are shown in table 6.7 for GP clas-
siﬁcation and table 6.8 for SVM. For the GP, we do not perform the grid search method due to6.3. Results 104
Modality acc (%) sens (%) spec (%) bal acc (%) AUC
MRI 58.70 53.20 61.50 58.70 0.629
PET 69.90 55.30 77.10 67.10 0.762
All (GS) 65.70 68.10 64.60 67.80 0.731
Table 6.6: Accuracy of methods on the PET group with SVM classiﬁcation. ’All’ modalities
indicates MKL with MRI, PET and ApoE kernels. Only the grid search (GS) method of setting
the subkernel weights  can be used with SVM.
Modality acc (%) sens (%) spec (%) bal acc (%) AUC p(M) p(P) p(C)
MRI 63.9 76.7 54.8 61.1 0.682 - - -
PET 66.7 80.0 57.1 69.4 0.789 - - -
CSF 55.6 73.3 42.9 56.9 0.575 - - -
Im, ApoE 68.1 83.3 57.1 72.2 0.823 0.186 0.773 0.072
All 68.1 90.0 52.4 72.2 0.763 0.201 0.823 0.015
Table 6.7: Accuracy of methods on the PET-CSF group with GP classiﬁcation. All modalities
indicates MKL with MRI, PET, CSF and ApoE kernels, Im + ApoE is the image data (MRI
and PET) and ApoE data without CSF. p values are of difference in classiﬁcation vs. indicated
single modality, M for MRI, P for PET and C for CSF.
the increased computational demands of having to do a three dimensional grid search for four
modalities, rather than a two dimensional grid search for three modalities as in the previous
experiment. However, the results for multimodal classiﬁcation both with and without the CSF
data are reported so it is possible to see its effect on classiﬁcation with a consistent set of test
subjects.
Again, the last two rows of table 6.8 present results obtained using MCI subjects for tuning
the kernel weights, and with the data normalised with a z-score as these provided the best
accuracy.
The results show a clear advantage in accuracy for multimodal imaging. In the larger
PET group, both multimodal algorithms are better than any single modality alone. This advan-
tage is statistically signiﬁcant at the 5% level for the type-II maximum likelihood method with
GP classiﬁcation, which outperforms the grid search method and outperforms the best single
modality by over 8%. The AUC measure of accuracy shows how results must be interpreted
with caution, as the multimodal grid search method has a higher balanced accuracy than us-
ing PET alone, but offers a slightly lower AUC. In the smaller group for which both PET and6.3. Results 105
Modality acc(%) sens(%) spec(%) bal acc(%) AUC
MRI 65.3 76.7 57.1 63.9 0.685
PET 69.4 63.3 73.8 65.3 0.782
CSF 56.9 73.3 45.2 55.6 0.575
Im + ApoE (GS) 68.1 76.7 61.9 68.1 0.745
All (GS) 66.7 76.7 59.5 69.4 0.727
Table 6.8: Accuracy of methods on the PET-CSF group with SVM classiﬁcation. All modalities
indicates MKL with MRI, PET, CSF and ApoE kernels, Im + ApoE is the image data (MRI and
PET) and ApoE data without CSF.
CSF data were available in all subjects, the same pattern applied in that multimodal methods
outperformed all single modality methods.
To enable a side-by-side comparison, table 6.9 shows the balanced accuracy for GP and
SVM classiﬁcation together with a p-value for the difference in accuracy. The p-value is gen-
erated by classifying all test subjects with the leave-one-out procedure used to generate the
balanced accuracy ﬁgures, and comparing the resulting classiﬁcations, again using McNemar’s
test.
6.3.2 Accuracy of probabilistic classiﬁcation
The predicted risk ﬁgures produced in the manner described in section 6.2.12 exhibit some bias,
in that the classiﬁers tend to overestimate the chances of conversion in general. This appears
to be because of the transfer learning approach we use, where the classiﬁer is trained on the
AD and healthy population, and then applied to the MCI subjects. As the MCI subjects, in
terms of the biomarker data we use, are not midway between the AD and control population
but slightly closer to the AD subjects, this results in the classiﬁer being somewhat biased in
favour of predicting conversion. In order to remove this, we perform a correction procedure on
the GP probabilities similar in approach to the one used to produce a balanced accuracy. We
perform a logistic regression, using a leave-one-out approach again to avoid unduly optimistic
results, on the GP probabilities and the labels indicating converter or stable status for the MCI
subjects, with the label 0 indicating stable and 1 indicating converter. In this way we can learn
the relationship between GP predicted risk and actual risk for the MCI subjects to correct for
the bias. The resulting plots of empirical risk versus adjusted predicted risk for the PET and
PET-CSF groups are shown in ﬁgures 6.3 and 6.4. Plotted points are labelled with the number
of subjects in the corresponding bin. As not all the bins contain subjects, some empty bins are6.4. Discussion 106
Group Modality bal acc (% )(GP) bal acc (%)(SVM) p-value
PET MRI 61.5 58.7 0.387
PET PET 65.7 67.1 0.789
PET MRI,PET, ApoE 74.1 67.8 0.151
PET-CSF MRI 61.1 63.9 0.683
PET-CSF PET 69.4 65.3 0.450
PET-CSF CSF 56.9 55.6 1
PET-CSF MRI, PET, ApoE 72.2 68.1 0.450
PET-CSF MRI, PET, ApoE, CSF 72.2 69.4 0.803
Table 6.9: Statistical comparison of GP and SVM classiﬁcation results for different subjects
groups and combinations of modalities. MKL weights  are set by maximum likelihood for GP
and grid search for PET. p-values are for signiﬁcance of difference in accuracy between SVM
and GP for a particular set of subjects and modalities used.
not plotted.
In these plots, a classiﬁer producing accurate probabilities should have points plotted close
to the diagonal. By inspection, the multimodal methods appear to perform well by this measure,
and it is important to note that most points lying far away from the diagonal represent bins
containing few subjects, making the empirical risk calculated for them less reliable. More
broadly, the probabilities produced by the GP classiﬁcation procedure appear to be accurate in
the sense that increased predicted risk of conversion does generally imply an increased chance
of conversion actually taking place. The adjustment appears to be effective, with little bias
exhibited in the predicted risks. Note the only plotted points very far from the diagonal, and
thus showing a large difference between empirical and predicted risk, are of risk bins containing
only one or two subjects and are simply the results of outliers.
6.4 Discussion
As previously stated, a clear advantage can be seen both for multimodal classiﬁcation, and
for the use of GP classiﬁcation over the more widely used SVM. This applied to results for
both the PET and PET-CSF groups. Moreover, there appears to be quite a strong interaction
between the utility of multimodal classiﬁcation and the type of classiﬁer used. Looking at
the balanced accuracy of classiﬁcation on single modalities of data, there is little to choose
betweenGPandSVMclassiﬁcation, withdifferencesofoneortwopercentinaccuracyineither
direction. Thus, it seems reasonable to conclude by this measure that there is little difference in6.4. Discussion 107
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discriminativeabilityonidenticalsetsofdata. However, theGPframeworkappearstobeableto
take much greater advantage of the availability of multimodal data. GPs offer much larger gains
for multimodal versus unimodal classiﬁcation, with gains of eight per cent in the PET group
against the best single data (PET) as against only a 0.7 per cent gain for the SVM approach.
Similarly, the head-to-head comparisons between the GP and SVM methods using the same
subjects and modalities, in table 9, show the greatest differences in classiﬁcation accuracy and
greatest statistical signiﬁcance are for the multimodal methods. While the difference is not
quite signiﬁcant at the 0.05 level, due to the relatively small number of subjects in the study, the
advantage for GP against SVM classiﬁcation is clear and consistent across all three multimodal
classiﬁcation experiments and we plan to verify it with a larger dataset.
The improvement is most likely because the GP framework is better at ﬁnding a set of
kernel weights for optimum classiﬁcation. With an SVM we are restricted to ﬁnding these
through agrid search, which hasan inherently limited rangeand resolution if itis to be tractable,
and is dependent on rather crude measures of accuracy to select an optimal parameter set. GPs
offer tuning via the likelihood function, which seems to be more robust and also allows a wider
search space - however this is not available for SVM classiﬁcation, highlighting one of the
advantages of a probabilistic framework mentioned in the introduction.
Adding CSF to multimodal classiﬁcation did not increase the accuracy by any signiﬁcant
amount and in fact decreased the AUC, which is not surprising as CSF is the poorest single
modality, offering accuracy little better than chance. The poor performance of CSF biomarkers6.4. Discussion 108
alone, andtheirfailuretoadddiagnosticvaluewhenusedalongsideotherbiomarkers, isperhaps
explained by the fact that about a third of controls have a high amyloid load, suggesting they
may be in fact at a presymptomatic stage of AD. In this case CSF is still a potentially valuable
biomarker, but our choice of deﬁning AD and control subjects purely by current symptoms
and cognitive test results limits its applicability. This again suggests the need to treat AD as a
spectrum rather than a set of discrete states, or at least to very carefully deﬁne such states.
Comparing the results presented here to other attempts to predict conversion in MCI pa-
tients is difﬁcult. This is because, while the problem has been addressed in a large number of
studies, these vary widely in how MCI groups are deﬁned, and the metric by which classiﬁ-
cation accuracy is assessed. However the method presented here certainly offers a high level
of classiﬁcation accuracy, especially considering studies that use ADNI data and offer higher
accuracy make predictions over a time span of less than three years or make use of longitudinal
data, which our algorithm does not need.
For MRI data, the most comparable methods are in [Cuingnet et al., 2010]. This study
included a wide variety of types of feature, but those which used voxel level GM maps are quite
similar to our work. Even within this deﬁnition, a wide range of options in image processing
and feature extraction were used but the closest in methodology to ours is what they label as
the Voxel-Direct-D-GM method. When applied to predicting MCI conversion this was found to
have a speciﬁcity of 100% and sensitivity of 0%, i.e. The classiﬁer simply assigned all subjects
to the majority MCI-s class, possibly as a function of having trained on MCI-s and MCI-c
rather than control and AD subjects. This paper did also ﬁnd that the voxel based method in
[Fan et al., 2007] achieved a sensitivity of 62% and speciﬁcity of 67%, although this was found
not to be signiﬁcantly greater than chance. Our method achieves much greater accuracy than
any in [Cuingnet et al., 2010] for predicting MCI conversion, and moreover our accuracy is
statistically signiﬁcantly better than chance, which none of the methods assessed in that study
managed to achieve.
Other studies, however, have had much greater success in predicting conversion. For
example, [Coup´ e et al., 2012] and [Eskildsen et al., 2013] have presented methods capable of
predicting conversion with accuracies similar to ours. The former uses a novel hippocampal
grading biomarker. Using their most rigorous validation method, accuracy was slightly lower at
71% but their method needs no FDG-PET data and less computationally intensive image pro-
cessing than the one presented here. The latter also achieves 74% accuracy by stratifying MCI-c
subjects by conversion time and then combining the results of classifying each MCI-c subgroup
against the MCI-s subjects. The classiﬁer is rather unbalanced, with substantially higher speci-6.4. Discussion 109
ﬁcity than sensitivity, a common problem with MCI classiﬁcation, but again only structural
image data is needed. Reported AUC values in [Ye et al., 2012] are up to 0.85 using MRI data,
ApoE genotypes, and a variety of cognitive measures with a sparse logistic regression proce-
dure but the authors do not list classiﬁcation accuracy. In [Wee et al., 2012] features based
on correlations between mean thicknesses of cortical regions of interest are used with SVM
classiﬁcation, and obtain 75% accuracy and an AUC of 0.8426. Among multimodal methods,
[Zhang et al., 2011] reports a speciﬁcity of 91.5% and speciﬁcity of 73.4% for prediction of
MCI conversion. While they do not report the proportions of MCI-s and MCI-c in their subjects
and hence we cannot calculate the overall accuracy, it must be greater than our best result of
74%. However, they deﬁne conversion as a subject converting within 18 months rather than
three years. Predicting over a short future timespan is an easier problem than over a longer one
[Eskildsen et al., 2013] and less clinically useful. Moreover, deﬁning conversion over a shorter
time means a smaller proportion of MCI subjects will be converters, reducing the positive pre-
dictive value of even a good classiﬁcation result. Additionally, their work uses CSF data in
addition to MRI and FDG-PET, whereas our best performing classiﬁer uses genetic data in-
stead of CSF, which is less invasively obtained. We are able to set our kernel weights by type-II
maximum likelihood, avoiding the need for a computationally expensive grid search. The other
previously published multikernel method to predict MCI conversion is [Hinrichs et al., 2011].
Although they do deﬁne converters with a three year time span, direct comparison of results
is again difﬁcult, as they report only an AUC rather than accuracy. The best reported AUC
was 0.791, similar to ours but this used longitudinal data, again effectively reducing the time
span to predict conversion. They also found the method using only longitudinal image data was
more effective than including non-imaging data in their multikernel learning approach. Meth-
ods based on features structural imaging alone are also capable of achieving high accuracy.
Table 6.10 summarises these results in comparison with our own.
Table 6.10 clearly show the difﬁculty in making direct comparisons between results. For
example, the time within which MCI conversion is deﬁned has a strong effect on results. In
[Vounou et al., 2012], tensor based morphometry was used to deﬁne a set of voxels that are
highly indicative of MCI conversion, and then applied an SVM to these. This method was
able to predict conversion with an accuracy of 82%. As this method uses both baseline MRI
scans and 24 month follow-up MRI scans to generate Jacobian maps, it is effectively predicting
conversion in only a 12 month period rather than three years as we do, and longitudinal data
may not be available in all cases.
Parameterisations of the shape of the hippocampus have achieved a greater accu-6.4. Discussion 110
Article Data used n (MCI-s,MCI-c) t acc (%) AUC
[Young et al., 2013c] MRI, FDG-
PET, ApoE
143 (96, 47) 36 74.10 0.795
[Eskildsen et al., 2013] MRI 388 (227, 161) 36 73.5 -
[Ye et al., 2012] MRI, ApoE,
cognitive scores
319 (177, 142) 48 - 0.8587
[Wee et al., 2012] MRI 200 (111, 89) 36 75.05 0.8426
[Zhang et al., 2011] MRI, FDG-
PET, CSF
99 (56, 43) 18 sens
91.5,
spec 73.4
-
[Hinrichs et al., 2011] longitudinal
MRI, baseline
MRI, longitudi-
nal FDG-PET,
baseline FDG-
PET, CSF,
ApoE, cognitive
scores
119 36 - 0.7911
[Coup´ e et al., 2012] MRI 405 (238, 167) 36 73.0 -
[Wolz et al., 2011b] MRI 405 (238, 167) 36 68.00 -
[Nho et al., 2010] MRI, ApoE,
family history
355 (205, 150) 36 71.6 -
[Davatzikos et al., 2008] MRI, CSF 239 (170, 69) 36 61.7 0.734
Table 6.10: Reported results from a variety of studies for predicting MCI conversion on ADNI
data. n = number of subjects, t = number of months over which MCI conversion is deﬁned, acc
= accuracy in predicting conversion, if reported, AUC = area under ROC curve of predictions
of conversion, if reported.6.5. Conclusion 111
racy than our approach with conversion deﬁned over three years [Costafreda et al., 2011,
Ferrarini et al., 2009], however these used a small number of subjects scanned at a single
centre, and also had autopsy conﬁrmed AD subjects available, removing any uncertainty in
the training labels. If conversion is deﬁned over a three year period, we believe our method
presented here has obtained an accuracy very competitive with the best methods yet published
for prediction of conversion to date on ADNI data.
Moreover, our method offers the advantages of probabilistic classiﬁcation listed in 6.1.
The reject option is especially relevant in the case of computer-aided diagnosis. Having a
probabilistic classiﬁcation means that each diagnosis includes an attached degree of conﬁdence
rather than a simple binary decision. Clinical decision making is frequently hampered by over-
conﬁdence [Berner and Graber, 2008], so an estimate of the certainty of a diagnosis could be of
great help, if only as a supplement to decisions made by more traditional methods.
6.5 Conclusion
We have shown that multimodal Gaussian process classiﬁers can be successfully applied to the
prediction of conversion to AD in MCI patients. Prediction of conversion is signiﬁcantly better
for multimodal classiﬁcation than for any single modality, and also better for GP compared to
SVM classiﬁcation, largely due to the GP’s superior ability to exploit multimodal data. Accu-
racy is state-of-the-art, and to this we can add the advantages of probabilistic classiﬁcation. A
number of extensions to this work are possible. The simplest is to take advantage of new sub-
jects with FDG-PET and CSF data being added to the ADNI database and apply these methods
to a larger group of subjects to show greater statistical signiﬁcance for the advantage of our
methods. We perform more sophisticated feature extraction on FDG-PET data and to make use
of more complex kernel covariance functions, as described in the following two chapters ( 7
and 8). We also examine methods to overcome the problem of misdiagnosis leading to noisy
training labels in ADNI data in chapter 8 and [Young et al., 2013a].112
Chapter 7
Continuous proxies for AD diagnosis and
prognosis
7.1 Introduction
In this chapter, we explore an alternative to the classiﬁcation approach to predicting conversion
in MCI subjects, described in the previous two chapters. A classiﬁer to predict conversion in
MCI subjects can be trained on labelled examples of MCI-s and MCI-c images, or alternatively
on examples of AD patients and healthy controls, under the assumption that MCI-s subjects are
more control-like and MCI-c subjects are more AD-like. However, either method ultimately
relies on discrete labels designating each subject used for training as being a member of a
particular diagnostic group.
This does bring some disadvantages. The labels for training data are, in the cases above,
assumedtobealwayscorrect. However, alimitingfactorintheaccuracyofclassiﬁcationstudies
may be mislabelling of training subjects. The gold standard for diagnosis of AD is autopsy, but
most studies use training subjects whose diagnosis has been determined by standard clinical
diagnosis, which has been shown to have an error rate of at least 10% [Beach et al., 2012] when
compared to retrospective diagnosis when the subjects died and it was consequently possible to
conﬁrm (or disconﬁrm) their earlier diagnosis by autopsy. Furthermore, the same study found
that the rate of misdiagnosis varies wildly between AD centres in a multicentre setting very
similar to ADNI. This is an issue that has not been widely addressed. The most effective way to
do so would be to use only subjects whose diagnosis is conﬁrmed by autopsy; but these are only
available in much smaller numbers than those diagnosed in the clinic. An alternative method to
estimate the effects of mislabelled data is to use some other classiﬁcation for which the ground
truth is readily available, such as sex, and perform experiments by deliberately changing the
labels of some subjects [Young et al., 2013a].
Another problem is that labels for MCI-s and MCI-c subjects are also affected by limited7.1. Introduction 113
follow-up time; many subjects deemed as stable may in fact convert after a study has ﬁnished.
For a study examining conversion, this is not a problem when assessing the accuracy on the test
set as it is generally limited to subjects who do or do not convert within a ﬁxed length of time,
but may well mean that a training set consisting of MCI-s and MCI-c subjects is suboptimal.
For this reason, MCI-s and MCI-c labels are not used in [Aksu et al., 2011]. Pointing out
that training labels for MCI-s and MCI-c are uncertain, they go on to generate their own MCI
training labels by following the classiﬁcation of MCI subjects by an HC versus AD classiﬁer
across multiple timepoints. However even this neglects the uncertainty in the HC and AD labels
that this scheme ultimately depends on. BrainAge [Gaser et al., 2013] switches the problem to
one of regression, with a model being built to predict the chronological age of a large cohort of
healthysubjects. ThismodelisthenappliedtoADandMCIsubjects, withtheBrainAgedeﬁned
as the difference between chronological and predicted age. This can then be thresholded to
classify subjects into groups such as healthy and AD, or MCI-s and MCI-c with high accuracy.
Our proposed method follows [Gaser et al., 2013] in abandoning discrete disease state la-
bels for training altogether. Like them, it involves performing a regression to predict a con-
tinuous proxy for disease status, but instead of age, initially atrophy over a period of one
year as measured by the boundary shift integral (BSI) [Leung et al., 2012] is used. This then
provides a predicted atrophy rate for each test subject. Gaussian process (GP) regression
[Rasmussen and Williams, 2006], with a multiple kernel framework is used to optimally com-
bine MRI, FDG-PET and CSF data. This results in a measure that can predict MCI conversion
within three years with a balanced accuracy of 74.6%, as good as state-of-the-art techniques
having a much larger training set, including our own previous work using multikernel GPs for
classiﬁcation [Young et al., 2013c]. We refer to this as the BSI experiment, which is previously
published in [Young et al., 2013b].
Encouraged by this, we go on to modify the approach and apply it to a much larger group
of subjects. In this second experiment instead of age, the target variable for regression is cog-
nitive test scores from the mini-mental state examination (MMSE) [Folstein et al., 1975]. This
appears to give better results and is available in a larger number of subjects. This latter point is
also due to incorporating data from the ADNI 2 and ADNI-GO databases as well as the original
ADNI. We ﬁnd that we can predict conversion within three years with a balanced accuracy rate
of nearly 82% for subjects with FDG-PET scans, and nearly 80% for subjects with structural
MRI scans only. This accuracy is amongst the highest yet seen for this problem. We also show
that it is heavily dependent on the ﬁeld strength of the subjects’ structural MRI scans, even
if only FDG-PET data was used in the regression problem. This is referred to as the MMSE7.2. Materials and methods 114
Disease status Number Female Mean age (sd)
HC 28 19 74.1 (4.5)
MCI-s 38 22 75.3 (7.3)
MCI-c 29 18 75.1 (7.4)
AD 34 23 75.1 (6.8)
Table 7.1: Subject groups and demographics for the BSI experiment.
experiment.
7.2 Materials and methods
7.2.1 Subjects
All ADNI subjects are between 55 and 90 years old, speak English or Spanish, and have a study
partner able to provide an independent assessment of functioning. All subjects are willing to
undergo neuroimaging and agree to longitudinal follow up, and a subset are willing to undergo
lumbar punctures. Subjects with speciﬁc psychoactive medication are excluded. Inclusion cri-
teria for normal subjects are MMSE scores between 24 and 30, a CDR of 0, non-depressed and
non-demented. Ages are roughly matched to those of AD and MCI subjects. For MCI subjects,
the criteria are an MMSE score between 24 and 30, a memory complaint, objective memory loss
measured by education adjusted scores on the Wechsler Memory Scale Logical Memory II, a
CDR of 0.5, absence of signiﬁcant levels of impairment in other cognitive domains, essentially
preserved activities of daily living, and an absence of dementia. For AD subjects, the criteria are
an MMSE scores between 20 and 26, CDR of 0.5 or 1.0, and meeting NINCDS/ADRDA crite-
ria for probable AD. Subjects are designated as HC, AD or MCI at the time of the baseline scan,
and for the purposes of this study MCI conversion status is decided by whether subjects who
were MCI at baseline were subsequently diagnosed as AD at any stage during the subsequent
36 month follow-up period.
For the BSI experiment, only subjects from the original ADNI study were used. This
collected baseline structural MRI scans for all subjects. However FDG-PET scanning and col-
lection of CSF data were only done on partially overlapping subsets of these subjects. Fur-
thermore, calculation of BSI requires a 12-month follow-up structural MRI, which were also
missing for some subjects. As our method requires FDG-PET and CSF and a 12-month BSI as
well as structural MRI data, only 129 subjects could be included in the study. The details of
these are shown in table 7.1.
For the MMSE experiment, we also made use of data from the extensions to the original7.2. Materials and methods 115
Disease status n (n female, n 1.5T) Mean age (SD) Mean MMSE (SD)
Healthy 243 (119, 84) 73.9 (5.9) 29.0 (1.2)
MCI-s 81 (26, 54) 72.0 (7.5) 27.9 (1.6)
MCI-c 91 (37, 57) 72.7 (7.0) 26.9 (1.8)
MCI-other 347 (156, 35) 71.5 (7.4) 28.1 (1.7)
AD 121 (54, 60) 74.7 (7.8) 23.1 (2.0)
Table 7.2: Subject groups and demographics for the PET group in the MMSE experiment.
Disease status n (n female, n 1.5T) Mean age (SD) Mean MMSE (SD)
Healthy 338 (173, 142) 74.4 (5.7) 29.1 (1.1)
MCI-s 133 (46, 84) 72.5 (7.7) 27.8 (1.7)
MCI-c 153 (67, 97) 72.8 (7.3) 26.6 (1.8)
MCI-other 375 (168, 49) 71.8 (7.5) 28.0 (1.8
AD 185 (87, 101) 74.8 (7.8) 23.1 (2.0)
Table 7.3: Subject groups and demographics for the MRI group in the MMSE experiment.
ADNI project, ADNI 2 and ADNI-GO. ADNI 2 aims to recruit an extra 550 subjects, with a
similar proportion of healthy, MCI and AD subjects as the original ADNI. ADNI-GO enables
extended follow-up of nearly 500 of the original ADNI participants, as well as recruiting further
MCI participants. Imaging protocols for both ADNI 2 and ADNI-GO were designed to ensure
compatibility with ADNI data. This mean that the pool of subjects for the MMSE experiment
was much larger. Furthermore, we removed the requirement for the subjects to have CSF data
to use MRI and FDG-PET only, and as we were using MMSE rather than one year BSI as
a regression target, only a small number of subjects for which baseline MMSE scores were
missing had to be excluded. As a result there were a total of 883 subjects. This is referred to as
the PET group, with details given in table 7.2.
We also explored how well MMSE prediction works using MRI data alone, using an even
larger set of 1184 subjects by adding those for which FDG-PET data was not available. This
set of subjects is referred to as the MRI group, with details given in tables 7.3.
Bothofthesesetscontainedamixtureofsubjectsscannedat1.5Tand3T.Subjectsenrolled
in ADNI-GO and ADNI 2 were all scanned at 3T; whereas the majority of ADNI 1 participants
were at 1.5T. As many of the ADNI 2 and GO subjects were recently enrolled at the time of
writing, they had less than 36 months of follow-up. It was not therefore possible to reliably label7.2. Materials and methods 116
these subjects as MCI-s or MCI-c. Hence they are not included in the MCI subjects for which
accuracy of prediction of conversion is reported. However, unless their corresponding MMSE
score was missing they were included in training the regression model. The same applies to
the small number of MCI subjects that reverted to healthy status during follow-up. Collectively
these subjects are labelled as MCI-other.
7.2.2 MRI data
Images were all T1 weighted structural MRI scans from 1.5T or 3T scanners acquired using the
3D MPRAGE sequence, taken at the baseline time point for each subject. For the subjects in
the BSI group, the 12 month follow up scan was also downloaded and used to calculate the at-
rophy rate. DICOM images were downloaded from the ADNI archive, having been designated
the best of back-to-back scans for each subject, and then post-processed to correct for gradient
warping, B1 non-uniformity and intensity non-uniformity and undergone phantom based scal-
ing correction. Once downloaded, the images were then converted to NIfTI format for further
processing.
7.2.3 MRI image processing
Our MRI features for classiﬁcation and regression were voxels of whole-brain tissue density
maps. To produce these, we followed a similar procedure to [Kl¨ oppel et al., 2008] although
using slightly different software. Also, the groupwise registration procedure was done initially
only for the subjects in the BSI experiment. Once many more subjects’ images had been down-
loaded to make up the group for the MMSE experiment, the groupwise registration procedure
was rerun using all the newly obtained subjects.
The ﬁrst step was to segment the native space, preprocessed scans to produce a GM den-
sity map. This was done using NiftySeg [Cardoso et al., 2011] for the subjects in the BSI group
and with the ’new segment’ module of SPM12, with the maximum cleanup option set, for all
subjects in the MMSE experiment. A brain mask produced from the original structural image
was then applied to remove any non-brain material. The native space images were also anatom-
ically parcellated into 83 regions with a novel label fusion algorithm [Cardoso et al., 2012] in
a multi-atlas label propagation scheme. The resulting parcellations were used to mask out the
brainstem and cerebellum from the native space GM segmentations.
The groupwise registration was employed to move all the GM images into a common
space. Initially, all T1 weighted images were rigidly registered to a randomly chosen sample,
and then averaged together to produce a new target image. This was then repeated with a single
round of afﬁne registration of all images to the target, which was then followed by ten rounds7.2. Materials and methods 117
of nonlinear registration, with the updating of the target image also repeated after each round
of registrations. This was all done using tools from NiftyReg [Modat et al., 2010]. After this
procedure was ﬁnished, the transformation from each native T1 weighted image to the ﬁnal
target were applied to the native GM segmentations to resample them into the groupwise space,
using trilinear interpolation to maintain the voxel GM densities in the zero to one range. Finally,
the GM segmentations in the groupwise space were modulated by the Jacobian determinants of
the corresponding ﬁnal transformations to ensure the total tissue volume remained constant.
The result was all GM segmentations in the groupwise space of the BSI experiment subjects or
MMSE experiment subjects.
7.2.4 PET image data
Images were again all taken from the baseline scan for each included subject. Images were
acquired by scanning 30-60 minutes post injection using scanner-speciﬁc protocols. Six ﬁve
minuteframeswereacquiredforeachsubject, andthenco-registeredandaveraged. Theaverage
images were then rigidly registered to a standard space, and the individual native space frames
registered to the standard space average and averaged and intensity normalised in the standard
space. Finally, the average images in the standard space were smoothed with a scanner-speciﬁc
kernel (Joshi et al., 2009) to a uniform isotropic resolution of 8mm FWHM, which is approxi-
mately the resolution of the lowest resolution scanners used in ADNI. The postprocessed scans
were downloaded as DICOM images.
7.2.5 PET image processing
As previously mentioned, the PET images had already been through substantial processing
before being downloaded from the ADNI database. Following this, each native PET image
was registered to the corresponding native structural MRI. At this point, the processing used
to generate features from the PET images varied between the BSI and MMSE experiments.
For the BSI experiments, the native space anatomical parcellations were also transferred to
the space of the FDG-PET images for the corresponding subjects. The parcellation was used
to normalise each FDG-PET image by its mean cerebellar activity, and then to calculate the
mean activity within each anatomical region, generating a set of 83 features for each FDG-PET
image. For the MMSE experiment, the PET images were again normalised by the mean activity
within the subject’s cerebellum. However the PET images were then moved into the groupwise
space by again applying the transformations from the native space of each subject to the ﬁnal
groupwise target image, using the same software. Thus for the MMSE experiment the PET
features comprised voxel level rather than regional level features.7.2. Materials and methods 118
7.2.6 CSF data
CSF data was only used for subjects in the BSI experiment. CSF samples were obtained from
subjects by a lumbar puncture around the time of their baseline scan. Levels of the proteins
amyloid-42 (a42), tau, and phosphorylated tau were measured and recorded.
7.2.7 Boundary shift integral
The BSI is a method for robustly assessing volume loss of whole brains or brain regions. It
calculates a change in volume by integrating across the longitudinal change in position of the
boundary between CSF and GM surrounding the region of interest. Preprocessing is needed
to extract the region of interest (which in our case is the whole brain) from each image, lin-
early align the baseline and follow-up images, and correct for intensity inhomogeneity between
scans. We use the latest version of BSI [Leung et al., 2012] which uses a symmetric registration
scheme to minimise bias and maximise desirable qualities for an atrophy measurement such as
inverse consistency and transitivity between multiple timepoints.
Wenormalisetheresultingvolumechangesbythebaselinebrainvolumesandbytheactual
interval between baseline and follow-up scans (as the nominal 12 months varies quite widely
in practice), and multiply by 100. This produces a normalised brain atrophy rate (BAR) in
percentage of original brain volume per year for each subject. These are then used as targets
for regression analysis in the BSI experiment. We also experimented with using BSI of the
left hippocampus only as a regression target, but found it produced markedly inferior results,
largely as a result of reducing the size of the training set due to missing data.
7.2.8 MMSE scores
We used the MMSE scores for each subject at baseline as the targets for our regression problem.
MMSE is derived from a questionnaire widely used in screening for dementia and to track cog-
nitive decline, with questions covering a variety of cognitive domains. Scores are given as an
integer score up to a maximum of 30. The scores were obtained along with the corresponding
images from the ADNI database. Additional experiments were performed using both an alter-
native neuropsychological test score, ADAS-Cog, and longitudinal measures based on decline
in MMSE scores from baseline to one and three year follow-up timepoints as alternative targets
for regression. For both of these cases, results were markedly inferior to simply using baseline
MMSE and so are not presented here. In the case of longitudinal MMSE, this is because of a
much smaller training set due to missing follow-up data and increased noise compared to using
baseline MMSE. For baseline ADAS-Cog, the difference is more difﬁcult to explain but possi-
bly it is a noisier measure than MMSE or simply less informative about the underlying disease7.2. Materials and methods 119
severity.
7.2.9 Gaussian processes
The learning portion of the procedure - both classiﬁcation and regression - was done using GPs.
These provide a kernelised, Bayesian framework for both these tasks. For a full explanation of
GPs for regression, we refer the reader to [Rasmussen and Williams, 2006] for a much more in
depth treatment.
As in chapter 6, for the subjects in the BSI experiment, we combine the MRI, PET and
CSF data in a multikernel framework to perform multimodal classiﬁcation and regression. This
means each element of the kernel matrix K is a linear combination of three subkernels repre-
senting the covariance between the MRI, PET and CSF data a pair of subjects, with weights
. A bias term  is also included in the sum. So in the case of multimodal classiﬁcation using
information derived from the MRI, PET and CSF data for each subject the overall kernel is
Kij = MRxMR
i  xMR
j + PETxPET
i  xPET
j + CSFxCSF
i  xCSF
j +  (7.1)
For a more detailed look at multikernel learning, see section 6.2.9.
7.2.10 Classiﬁcation and validation in BSI experiment
Predicted BARs for all 129 subjects in the PET experiment were generated regardless of their
disease status. This was done in a leave-one-out (LOO) procedure across the entire set. We then
used the predicted BAR of MCI subjects to classify them as MCI-s or MCI-c by thresholding.
As there was not an a priori reason to threshold at any particular value of the predicted BAR
(unlike probabilistic binary classiﬁcation, where thresholding at 0.5 may be chosen as a starting
point) we chose the threshold as the value that best balances sensitivity and speciﬁcity. This was
done in a second, inner LOO loop nested inside each iteration, to avoid introducing optimistic
bias.
We also compared our method to performing direct binary classiﬁcation on the conversion
status, again using GPs. There were three different choices of training group here: train on the
MCI-s and MCI-c subjects and labels in an LOO loop, training on AD and control subjects and
applying the resulting classiﬁer to the whole MCI population, and a shared label approach. This
attempted to increase the amount of training data by having one training group comprise both
the control and MCI-s subjects treated as a single class, and another training group comprising
both the AD and MCI-c subjects treated as a separate single class. The shared label approach
was again done inside an LOOCV loop.7.3. Results for BSI experiment 120
7.2.11 Classiﬁcation and validation in MMSE experiment
For the regression experiments, predicted MMSE scores were generated for all subjects in a
LOO loop in a manner very similar to that used in the BSI experiment. We report the resulting
balanced accuracy, as well as area under the receiver operating characteristic curve (AUC).
Although this was not the primary focus of our experiments, we also compared predicted to
actual MMSE scores as a measure of how well GP regression modelled the data.
To compare the utility of predicted MMSE scores against the more conventional approach
to predicting conversion, we also again performed GP classiﬁcation on the same set of subjects
used for the MMSE regression experiment.
To do this, we took the healthy and AD subjects as training data, and then applied the
resulting classiﬁer to the MCI-s and MCI-c subjects. This idea relies on the assumption that
MCI-s subjects are more healthy-like and MCI-c subjects are more AD-like. In our previous
work, we found it produced much better results than training on labelled MCI-s and MCI-c
subjects. It also had the advantage of not requiring cross-validation as the training and testing
subjects were drawn from different populations. Again we report balanced accuracies (gener-
ated with the same LOO thresholding method used with the predicted MMSE scores, applied
to the predicted class membership probabilities) and AUC, as well as accuracy, sensitivity and
speciﬁcity obtained by thresholding at 0.5. Finally, we assess the signiﬁcance of differences in
classiﬁcation accuracy for the two methods using McNemar’s test [McNemar, 1947].
7.3 Results for BSI experiment
The correlation coefﬁcient between predicted and measured BARs for the subjects is 0.38 (p
< 0.0001) and the root mean squared error is 0.61. However our primary focus is not on the
predicted brain atrophy rates themselves, but on whether they can be used to predict conversion
in MCI subjects. Figures 7.1 and 7.2 show the spread of both measured and predicted BAR
values for all four disease groups (HC, MCI-s, MCI-c, AD).
As shown in ﬁgures 7.1 and 7.2, while the mean predicted BARs for each group are
similar to the corresponding means for measured BARs, each clinical group occupies a much
tighter cluster of values, even allowing for a few outliers (marked as a +). This results in
reduced overlap between the clinical groups, which is especially noticeable between the MCI-s
and MCI-c groups. To test this, we classify the MCI-s and MCI-c subjects by ﬁnding a threshold
in predicted BAR that best balances sensitivity and speciﬁcity. A nested leave-one-out scheme
is used to avoid introducing optimistic bias. The resulting accuracy is 74.6%, which is similar
to the best previously reported results. The balanced accuracy and area under the ROC curve7.3. Results for BSI experiment 121
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Figure 7.1: Measured BAR across groups
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Figure 7.2: Predicted BAR across groups
(AUC) are shown in table 7.4. This also shows results for single modalities, demonstrating the
beneﬁt of combining sources of data with multikernel learning.
To illustrate the advantage of our method of atrophy prediction, we also compare it to
performing direct binary classiﬁcation on the conversion status again using GPs. This can be
done by training on the MCI subjects only in an LOOCV loop, by training on all subjects, again
with an LOOCV loop and grouping HC subjects with MCI-s and MCI-c subjects with AD, and
ﬁnally by training on the HC and AD subjects, and testing on the MCI subjects. The results are
given in table 7.5.
Table 7.4: Accuracy of discrimination be-
tween MCI-s and MCI-c with predicted
brain atrophy rate
Modalities Accuracy (%) AUC
MRI 59.7 0.595
PET 73.1 0.777
CSF 52.2 0.545
MRI, PET 67.2 0.743
MRI, CSF 58.2 0.602
PET, CSF 65.7 0.726
MRI, PET, CSF 74.6 0.725
Table 7.5: Accuracy of discrimination be-
tween MCI-s and MCI-c with training on
binary diagnostic class labels
Training Accuracy (%) AUC
MCI (CV) 40.3 0.401
HC, MCI, AD (CV) 52.2 0.569
HC, AD 55.2 0.6617.4. Results for MMSE experiment 122
7.4 Results for MMSE experiment
Results comparing predicted MMSE to binary classiﬁcation for both FDG-PET and MRI data
in the PET group are given below in table 7.6.
Data Method acc(%) sens(%) spec(%) bal acc(%) AUC p
MRI pMMSE N/a N/a N/a 67.4 0.735 0.737
MRI classiﬁcation 58.7 34.1 86.4 66.3 0.714
FDG-PET pMMSE N/a N/a N/a 72.7 0.786 0.814
FDG-PET classiﬁcation 71.5 55.0 90.1 71.5 0.788
Table 7.6: Accuracies for predicting conversion to AD in MCI subjects in the MMSE experi-
ment. Method = classiﬁcation paradigm (predicted MMSE or binary classiﬁcation), acc, sens,
spec = accuracy, sensitivity, speciﬁcity of thresholding probabilistic binary classiﬁcation re-
sults at 0.5, bal acc = accuracy at best balance of sensitivity and speciﬁcity, p = signiﬁcance of
difference in balanced accuracy between different methods for the same data.
As can be seen, the predicted MMSE method outperforms binary classiﬁcation using both
types of data, although we are unable to show that the small advantage is statistically signiﬁcant.
To explore the limits of classiﬁcation accuracy using MRI data only, we also report the results
for the larger MRI group in table 7.7.
Method acc(%) sens(%) 0.5 spec bal acc(%) AUC p-value
pMMSE N/a N/a N/a 68.9 0.761 0.712
classiﬁcation 65.4 48.4 85.0 68.6 0.743
Table 7.7: Accuracies for predicting conversion to AD in MCI subjects in the MMSE experi-
ment. Method = classiﬁcation paradigm (predicted MMSE or binary classiﬁcation), acc, sens,
spec= accuracy, sensitivity, speciﬁcity of thresholding probabilistic binary classiﬁcation results
at 0.5, bal acc = accuracy at best balance of sensitivity and speciﬁcity, p-value = signiﬁcance of
difference in balanced accuracy between different methods.
7.4.1 Effect of MRI ﬁeld strength on results
As previously stated, the subjects’ structural MRI scans were performed on a mixture of 1.5T
and 3T scanners. To see if this variable has an effect on classiﬁcation accuracy, we break down
the results for the predicted MMSE method by magnetic ﬁeld strength, as shown in table 7.8.
The results are produced by taking the previously presented predicted MMSE scores and split-
ting them into two groups based on the relevant ﬁeld strength, and then doing the LOO thresh-7.5. Discussion 123
olding procedure independently on each group of scores. The results are therefore produced
with a training set consisting of all subjects regardless of ﬁeld strength.
Group Data bal acc - all(%) bal acc - 1.5T(%) balanced acc - 3T (%)
PET FDG-PET 72.7 64.9 82.0
PET MRI 67.4 65.7 80.3
MRI MRI 68.9 65.2 75.2
Table7.8: BreakdownofaccuracyofpredictedMMSEinMCIconversionbyMRIﬁeldstrength
7.4.2 Accuracy of MMSE predictions
The primary purpose of this study was to examine the utility of predicted MMSE scores in fore-
casting conversion from MCI to AD. The accurate prediction of MMSE scores in individuals
was considered secondary and, in fact, completely accurate prediction of MMSE scores would
be undesirable for reasons that are explained in the discussion section. Nevertheless, we do
assess the ability of our regression model to predict MMSE scores, for the same three groups
and types of data as for the prediction of conversion to AD. Results are calculated and presented
for all subjects in each group regardless of diagnostic status, rather than for MCI-s and MCI-c
subjects only, as was done previously. We report the correlation coefﬁcient r and root mean
square error (RMSE) in table 7.9, and present the results as scatter plots in 7.3.
Group Data r RMSE
PET FDG-PET 0.605 1.97
PET MRI 0.596 1.99
MRI MRI 0.574 2.1
Table 7.9: accuracy of predicted MMSE compared to ground truth in, for MRI data in the MRI
group, and for PET and MRI data in the PET group.
7.5 Discussion
The results for the BSI experiment show a clear advantage for our method of training on a
well-characterised proxy for MCI conversion, rather than the diagnostic status itself. Training
on BAR enables us to reach accuracies of up to 74.6%, whereas training on diagnostic labels
struggles to perform better than chance. It therefore appears that the use of BAR bypasses the
problems caused by binary diagnostic labels. This makes better use of data as subjects can be
used for training regardless of diagnostic label, and as parameters are learned automatically7.5. Discussion 124
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there is no need to set subjects aside for tuning. We also show an advantage for multimodal
regression. Although direct comparisons between methods are difﬁcult [Young et al., 2013c],
the resulting accuracy in forecasting MCI conversion is competitive with the best yet achieved.
Despite this we were motivated to perform the BSI experiments, different in detail but in-
spired by the same idea, for two reasons. Firstly, the BSI experiment was with a relatively small
number of subjects, especially considering MRI, FDG-PET and CSF data were necessary to get
the best results (although FDG-PET alone does almost as well). In particular, the binary classi-
ﬁcation done for the purposes of comparison gave surprisingly poor results when compared to
a previous experiment using very similar data. We hypothesised that this was due to the small
training set and wanted to determine whether continuous proxy methods would maintain such
a large advantage over binary classiﬁcation with a much larger number of subjects.
The second reason was to see whether a more convenient proxy for conversion than BSI
could be used. Although the BSI gave good results, it has the limitation of requiring a follow-
up image, which makes an alternative where baseline data only is needed attractive (although it
is worth emphasising that, while 12 month follow-up scans are also required to calculate BSI
values for training data, they are not needed for testing data). This also allows us to increase the
training set size even further, as MMSE scores at baseline were available for almost all subjects.
The utility of BSI as a proxy was spoilt by the fact it was often not listed even for subjects where
a follow-up image from the right time was available, and that where it was available, slightly
different BSI methods were used on different subjects, meaning the measured BSI values used
for training lacked consistency.
The use of MMSE as a target for regression raises the question of why it is necessary
at all to do imaging and learning - might measured MMSE itself be able to distinguish MCI-
s and MCI-c subjects at baseline? Unfortunately, as for measured BSI, this is not the case.
Calculating the balanced accuracy of measured MMSE for discriminating MCI-s and MCI-c
subjects in the PET group gives a ﬁgure of just 61.5%, compared to the 67.4% and 72.7%
for predicted MMSE depending on which type of image data was used. The reason for this
is obvious in the diagrams of ﬁgures. These show the box plots of measured MMSE scores
and both sets of predicted MMSE scores for the subjects in the PET group, broken down by
diagnostic group. The ’MCI-other’ group contains all baseline MCI subjects that could not
be deﬁnitely labelled as MCI-s or MCI-c as they lacked sufﬁcient follow-up information or
reverted to normal cognition.
The effect of learning to predict MMSE score is very similar to that of learning to predict
BAR as shown in ﬁgure 7.1 and ﬁgure 7.2. As can be seen from ﬁgure 7.6, there is a7.5. Discussion 126
Figure 7.6: Measured and predicted MMSE across clinical groups in the PET group. (a) is
measured MMSE, (b) is predicted MMSE from MRI data, (c) is predicted MMSE from FDG-
PET data
great deal of overlap between the MCI-s and MCI-c groups in measured MMSE score, which
is reﬂected in its poor classiﬁcation accuracy. This is the reason why accurately predicting
the measured MMSE is undesirable for us in this work. The effect of using predicted rather
than measured MMSE is to move all diagnostic groups towards the mean MMSE, but also to
tighten the distribution within each diagnostic group. As can be seen, this reduces the overlap
between the MCI-s and MCI-c groups, enabling them to be distinguished with greater accuracy.
Furthermore, this overlap is smaller in the predictions based on FDG-PET data than those based
on MRI data (ﬁgure 7.6), reﬂecting the greater predictive accuracy of FDG-PET data we have
already seen. Interestingly, the reverse effect is seen in discrimination between healthy and
AD subjects. There is very little overlap between these groups in measured MMSE (largely
because MMSE score is one factor used to make the diagnosis) and the movement towards the
mean produced by using predicted MMSE scores actually increases the overlap between the
two groups.
So, if it does not work by accurately predicting actual cognitive test scores, how does
predicted MMSE predict conversion so well? The actual MMSE scores can be seen as coming
from a latent variable - some underlying, true disease severity - plus a large level of noise due to
individual variability. Fitting a regression model to the MMSE scores may act to partly remove
this noise, producing a measure that much more closely reﬂects the subjects’ actual level of
cognitive decline. Very similar arguments apply to predicted BAR.
It is therefore unsurprising that either measure would correlate strongly with conversion
to AD in MCI subjects. This is still, however, a rather oblique approach compared to binary
classiﬁcation. It does hold some advantages over binary classiﬁcation as well. The modelling
of a continuous measure respects the notion of all subjects being on a spectrum of cognitive7.6. Conclusion 127
decline. Labels based on diagnosis do not do this - for example, two subjects may be correctly
diagnosed as having AD, but with one case much more severe than the other. Diagnostic labels
may also be quite unreliable [Beach et al., 2012]. Finally binary classiﬁcation methods can use
either AD and healthy subjects for training, or MCI subjects. But in either case, only about
half the subjects can be used for training. Moving to a regression approach means all subjects
except a few with missing target variables can be used for training, although this can also apply
to some methods using discrete groups such as ordinal regression [Doyle et al., 2013].
We also notice that there is a very large difference in accuracy in predicting conversion
between those subjects whose MRI was obtained from a 1.5T scanner and those from a 3T
scanner. It is unsurprising that this has some effect, but the magnitude of the resulting difference
is surprising: almost 15 percentage points when using MRI data, and more than 17 percentage
points when FDG-PET is used. This is most likely due to poorer registration in subjects scanned
at the lower ﬁeld strength. As using PET data introduces a further registration for each subject
to the pipeline, between the native PET and native MRI, this could explain why the effect is
even stronger in PET data. Although the effects of variation due to different scanners at ADNI
centres on classiﬁcation accuracy has been examined [Abdulkadir et al., 2011], little attention
has been paid to this particular variable, probably because signiﬁcant numbers of 3T scans have
only entered the database in large numbers recently.
7.6 Conclusion
This chapter has shown that, while traditional classiﬁcation techniques reliant on discrete la-
belled groups can obtain high accuracy for predicting conversion to AD, even higher accuracies
can be obtained from a simple regression approach using only one type of image data and a
well-chosen continuous proxy. In this way, we can predict conversion to AD within three years
in MCI subjects with up to 82% accuracy using PET data, or 80% accuracy using MRI data.
These accuracies are, we believe, among the highest yet reported for this well-studied and very
clinically important problem (although fair comparison between results is difﬁcult). It is impor-
tant to note that these results were only obtained for test subjects scanned at 3T, irrespective of
whether MRI or FDG-PET data was used. Future plans include studying of the effect of scanner
ﬁeld more rigorously, as it appears to have such strong effects. Additionally the work presented
here could be extended, by looking at using target variables other than MMSE, such as rate
of change of cognitive scores, and to incorporate multiple targets in a multi-task regression to
further improve results.128
Chapter 8
Anatomical regional kernels
8.1 Introduction
This chapter introduces a new way to deﬁne features derived from brain images that can im-
prove classiﬁcation accuracy. For Alzheimer’s disease (AD), grey matter (GM) density maps
obtained from structural MRI images are typically used as data in the classiﬁcation. However
the actual features derived from the image can take two forms: at the the level of the MRI voxel
[Kl¨ oppel et al., 2008], or as summaries of all GM voxels within different anatomical regions.
The regions can be deﬁned by an atlas [Zhang et al., 2011] or can themselves be generated from
voxel level data [Fan et al., 2007]. There is a trade-off between these methods. Regional level
features reduce the data dimensionality and can introduce prior information relevant to the clas-
siﬁcation problem, but also eliminate ﬁne detail that may be informative about disease state.
Voxel level data can introduce noise by including uninformative brain regions and results in
a very high dimensional problem. The different feature extraction methods are compared and
discussed in depth in [Cuingnet et al., 2010].
The proposed method combines the strengths of these two approaches. It uses both voxel
level features and atlas derived regions, and automatically gives less weight to voxels within
less relevant regions. This is done using multiple kernel learning (MKL) as introduced in a
previous chapter ( 6.1). This is usually applied to combine data derived from different imaging
modalities [Young et al., 2013c, Zhang et al., 2011] or kernel functions [Hinrichs et al., 2011].
Conversely, in the approach presented here each kernel represents the voxel level data within
a different anatomical region to produce anatomical regional kernels (ARKs). This takes a
similar approach to [Chu et al., 2010], and [Liu et al., 2013] used a related nested region ap-
proach. Although the work was developed from our previous use of MKL, and is presented
as a speciﬁc case of MKL, it is related to other families of methods. Speciﬁcally, it can be
seen as a way to incorporate explicit spatial regularisation into the classiﬁer. A number of8.2. Image and biomarker data 129
other methods have been developed to do this speciﬁcally for three dimensional medical im-
age data. Spatial smoothness and sparsity can be enforced with a joint `1 and total variation
penalty [Gramfort et al., 2013]. Alternative a smoothness penalty is derived from the image
voxel neighbourhood structure, which can be built into a kernel function for use with an SVM
or other kernel method [Cuingnet et al., 2013] or used directly as a term in the objective func-
tion [Sabuncu and Leemput, 2012].
Our method and [Sabuncu and Leemput, 2012] can also both be interpreted as a variant
of automatic relevance determination (ARD) [Neal, 1996, Rasmussen and Williams, 2006], a
Bayesian method of automatic feature selection. Our method, however, operates at the regional
level in the kernel space, rather than at the voxel level in the input space. This is enabled by
the existence of a brain atlas in a custom groupwise template. Sections 8.3.4 and 8.4.1 explain
how this was achieved, and how MKL is performed within a GP framework.
The method is applied to a large population of AD, MCI and control subjects from the
ADNI study. In terms of classiﬁcation accuracy, for classiﬁcation of AD and control subjects
our method outperforms a single kernel with voxel level features by a large margin, and a single
kernel with regional features by a smaller amount. It also outperforms both voxel level and
regional level features for prediction of conversion in MCI subjects.
We also introduce two new methods to assess the quality of a classiﬁer that exploits the
probabilistic predictions made by GPs. Finally, we show that the optimal kernel weights in the
MKL formulation are informative about which regions are affected by AD.
8.2 Image and biomarker data
All data were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI)
database1. The MRI images were T1 weighted structural scans from a mixture of 1.5T and 3T
scanners. All were subjected to quality control and automatically corrected for spatial distortion
caused by gradient nonlinearity and B1 ﬁeld inhomogeneity and downloaded from the ADNI
database. Subjects were classiﬁed as healthy control (HC), AD or mild cognitive impairment
by neuropsychological and clinical testing at the time of the baseline scan, and only HC and
AD subjects were used. For the classiﬁcation experiments, a further quality control step was
taken which removed 16 subjects with registration errors, leaving a ﬁnal total of 627 AD and
control subjects plus 346 MCI-s and MCI-c subjects. Their demographics are given in table 1.
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Table 8.1: Subject groups and demographics
Disease status n 1.5T F Mean age (sd)
HC 376 162 192 74.8 (5.8)
MCI-s 163 109 56 72.5 (7.7)
MCI-c 183 120 78 72.8 (7.3)
AD 251 140 114 75.3 (7.8)
Table 8.2: Demographics of subjects for ARK experiments. n is total number of subjects in
the group, 1.5T is the number of subjects in the group whose MRI scan was at 1.5T, F is the
number of females in the group. sd is the standard deviation of ages in the group
8.3 Image processing
8.3.1 Groupwise registration
As the method deﬁnes features at the voxel level, it was necessary to transfer images into a
common space. This was done using the same procedure described in section 7.2.3: all native
space images were rigidly and then afﬁnely registered to a randomly chosen image, coalescing
the registered images to update the template after each round of registrations. This was then
followed by ten rounds of nonrigid registration to produce a ﬁnal template in the groupwise
space. All registrations were performed using the NiftyReg package [Modat et al., 2010].
8.3.2 Image segmentation
All images were segmented into GM, WM, CSF, and non-brain tissues components using the
new segment module of SPM12 with the cleanup option set to maximum. A brain mask gen-
erated from the original structural image was then applied to the GM segmentations to further
exclude any non-brain material.
8.3.3 Image parcellation
The native space images were also anatomically parcellated into 83 regions. This was done with
a novel label fusion algorithm [Cardoso et al., 2012] in a multi-atlas label propagation scheme.
A library of 30 atlases manually labelled with 83 anatomical regions was used as a basis for the
parcellation [Gousias et al., 2008].
8.3.4 Atlas construction
Unlike in other approaches using anatomical regions, features were deﬁned at the level of the
voxel rather than regions, requiring that all images share a common space. As kernels were
constructed from the voxels within anatomical regions common across subjects, the parcella-
tion deﬁning the region was also required to be in the common space. However, our initial8.4. Gaussian process classiﬁcation 131
Figure 8.1: Pipeline for constructing atlas in groupwise space
parcellations were in the native spaces of each subject. To combine these initial parcellations in
the groupwise space, the following procedure was used. First, all the parcellations were warped
into the groupwise space, using the parameters from the native space of each image to the ﬁnal
groupwise template. Care was taken to preserve the integer labels in the parcellations during
resampling. Finally to combine the individual parcellations, a consensus atlas was produced by
majority voting among the set of N parcellations X to assign a single label l to each voxel vi
of the groupwise space 
:
vi;i 2 
 = argmax
l
N X
j=1
8
> <
> :
1; if Xi;j = l
0; otherwise
(8.1)
The pipeline to construct the atlas is summarised graphically in 8.1.
8.4 Gaussian process classiﬁcation
Gaussian processes (GPs) provide a Bayesian, kernelised framework for solving both
regression and classiﬁcation problems. We refer the reader to previous chapters or
[Rasmussen and Williams, 2006] for a more detailed treatment. Brieﬂy, however, a GP (es-
sentially a multivariate Gaussian) forms the prior on the value of a latent function f. For binary
classiﬁcation, the value of the latent function is linked to class membership probability by a
sigmoidal function. The GP is parameterised by a mean function m(x) and a covariance kernel
function k(x;x0).
p(f(x);f(x0))  N(m;K) ,where m =
2
4m(x)
m(x0)
3
5, K =
2
4k(x;x) k(x;x0)
k(x0;x) kx0;x0)
3
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8.4.1 Gaussian processes as multimodal kernel methods
As equation 8.2 implies, GP classiﬁcation belongs to the family of kernel methods. Hence
a positive sum of valid kernels is a valid kernel, and a valid kernel multiplied by a positive
scalar is also a valid kernel. The covariance between the ith and jth subject, Kij, is a kernel
function k of the feature vectors for the ith and jth subject xi and xj and hyperparameters .
For ARKs, the ﬁnal kernel Kij is the weighted sum of 83 linear subkernels, each of which is the
dot product between the voxels within a particular anatomical region of the ith and jth image.
These regions are deﬁned using masks for each label derived from the groupwise atlas. The
covariance hyperparameters are the weights of the subkernels  and bias term , so the ﬁnal
kernel value Kij is given by
Kij = k(xi;xj) =  +
83 X
r=1
r(xi;r  xj;r) (8.3)
where r indexes regions 1 to 83 and  is a bias term. There are thus 84 covariance hyper-
parameters: cov = (1;2;:::;83;). All the above calculations are carried out within the
GPML toolkit 2, which was modiﬁed to take precomputed kernel matrices.
8.5 Results
To generate classiﬁcation results for the HC and AD subjects, we perform a leave-one-out cross
validation (LOOCV) across the entire set of 627 subjects. For the purposes of comparison to
existing methods, we also deploy two more conventional methods related to those introduced:
using voxel level data for the whole brain, and generating a feature per region, by dividing the
total volume of GM by the total intracranial volume to create a normalised amount of GM. Both
of these methods are then used with a single kernel linear GP formulation. These are referred
to as ’voxels’ and ’regions’ respectively.
The experimental framework for classifying the MCI subjects as MCI-s or MCI-c is a little
different. As we perform transfer learning, by training a classiﬁer on AD and control subjects
and then applying it to the MCI-s and MCI-c ones, no cross validation is necessary as the
training and test sets are already disjoint.
8.5.1 Binary accuracy
We compare the three methods by thresholding predicted probabilities at 0.5 and comparing to
ground truth labels for HC or AD status. The resulting sensitivity, speciﬁcity and accuracy are
shown in table 2. We also show the area under the ROC curve (AUC), and a p-value for differ-
ence in accuracy with McNemar’s test. The ARK formulation displays a greater accuracy and
2http://www.gaussianprocess.org/gpml/code/matlab/doc/8.5. Results 133
Method sens (%) spec (%) acc (%) p vs ARK for acc AUC IS (bits)
ARK 80.9 92.6 87.9 - 0.937 0.528
voxels 73.7 93.9 85.8 0.166 0.914 0.395
regions 80.1 91.0 86.6 0.409 0.9275 0.486
Table 8.3: Accuracy of classiﬁcation between control and AD subjects with ARK, voxels and
regions methods. IS = information score. (section 8.5.2)
Method sens(%) spec(%) bal acc(%) p vs ARK for bal acc AUC IS (bits)
ARK 67.8 70.6 68.5 - 0.741 -0.069
voxels 57.9 75.5 66.7 0.374 0.740 0.105
regions 68.9 63.8 66.7 0.555 0.732 -0.071
Table 8.4: Accuracy of classiﬁcation between MCI-s and MCI-c subjects with ARK, voxels and
regions methods. IS = information score. (section 8.5.2)
AUC than both competing methods. While the advantage over the voxels method is substantial,
we do not have enough subjects, and thus statistical power, to show that it or the smaller advan-
tage over regions is statistically signiﬁcant. We can, however, exploit the probabilistic nature
of GP classiﬁcation predictions to show the superior performance of ARKs with other forms of
validation.
For classifying MCI-c versus MCI-s, we show the same information, plus balanced accu-
racy.
8.5.2 Information scoring
The outputs of GP classiﬁcation are probabilities of a test subject belonging to a particular class
(AD, in our case). We can therefore calculate the test log predictive probability (log2 p(y0 j
(~ x0; ~ X;)) and average this across all test subjects. We then subtract this from the mean log
probabilities of a baseline method which does not use the data, but instead simply estimates
the class membership probabilities from the prevalences in the training subjects. This tells us
how much information, in bits, the classiﬁer was able to extract from the data about the identity
of the test subjects [Rasmussen and Williams, 2006]. For perfectly accurate classiﬁcation with
100% conﬁdence this would be equal to one. Results are also shown in table 8.3 for the HC vs
AD classiﬁcation and table 8.4 for classiﬁcation of MCI subjects.
As table 8.4 shows, the information scores (IS) can be negative even in cases where accu-
racy appears high. This is because the score is heavily affected by the more extreme predictions8.5. Results 134
(that is, probabilities close to one or zero) meaning the score can be negative even if most pre-
dictions are correct, if the minority of incorrect ones tend to be extreme. We show a way to
visualise the spread of individual predictions in the next section.
8.5.3 Individual predictions
We can also visualise the effects of different methods on individuals for the whole set. Figures
8.2 and 8.3 show the difference in predicted p(AD) for all subjects between ARKs and both
competing methods. Results are colour-coded so AD subjects are shown in red and NC ones
in blue, and sorted by the value of the p(AD) for the competing method. Hence blue (NC)
subjects will be represented by a line extending left from the baseline, and red (AD) subjects
by a line extending right, if ARKs improve the baseline classiﬁcation. The plots also show how
most subjects are correctly classiﬁed: the AD subjects mostly occupied the right hand side of
the plots (p(AD) > 0:5) and the NC ones the left side of the plots. We can also summarise
the differences between individual predictions by again using the information score, using the
voxels or regions as a baseline rather than training label prevalences. This gives an advantage
for ARK of 0.045 bits over voxels and 0.133 bits over regions.
Figure 8.2: Differences between individual pre-
dictionsofADversuscontrolstatusbytheARK
and voxel methods
Figure 8.3: Differences between individual pre-
dictionsofADversuscontrolstatusbytheARK
and regions methods
The same visualisation can be done for the effects of ARK features on the voxels and
regions methods for classifying MCI-s vs MCI-c, as is shown in ﬁgures 8.4 and 8.5
These plots reveal why the IS can be so misleading. The ARK formulation has a ten-
dency to make predictions more conﬁdent as it allows the classiﬁer greater ﬂexibility to ﬁt the
training data than either the voxels or regions method, due to having a much larger number of
hyperparameters. This results in improved classiﬁcation overall; however a number of subjects
with predictions that are fairly moderate (close to 0:5) are made into very conﬁdent, incorrect8.6. Discussion 135
Figure 8.4: Differences between individual pre-
dictions of MCI conversion by the ARK and
voxel methods
Figure 8.5: Differences between individual pre-
dictions of MCI conversion by the ARK and re-
gions methods
predictions. These are not numerous enough to prevent the accuracy of predictions improving
in a binary sense, but do nevertheless affect the IS disproportionately.
8.5.4 Effects of scanner ﬁeld strength
As we showed in a previous chapter (section 7.4.1), the ﬁeld strength used to acquire the sub-
jects’ structural MRI scans has a strong effect on the accuracy of predictions based on the
resulting MRI data, or even on PET data for the same subjects if a structural MRI is necessary
to process it. Here we split the MCI-s and MCI-c subjects by the ﬁeld strength at which they
were scanned. For both groups (1.5T and 3T) we present the speciﬁcity, sensitivity and accu-
racy by thresholding at 0:5. We also calculate a balanced accuracy in the usual LOO fashion
separately for each group. The results are shown in table 8.5. As can be seen, the subjects
scanned at 3T have a slightly higher accuracy. More surprisingly perhaps, the balanced accura-
cies for both groups when calculated separately are both better than the balanced accuracy for
the pooled group. This is likely because the distributions of predicted probabilities are different
for the different ﬁeld strengths, which results in suboptimal selection of a threshold when the
predictions for subjects with the two ﬁeld strengths are pooled. It should be emphasised that
these results were generated by training on all subjects; the splitting by ﬁeld strength was done
after all predictions were computed.
8.6 Discussion
ARKs enable improved classiﬁcation by combining the strengths of low level (voxel) and high
level (regional) features. This results in a classiﬁer that has more ﬂexibility than either voxels or
regions do alone. As a result, ARK classiﬁcation is able to ﬁt the training data better than either;8.6. Discussion 136
Field strength sens(%) spec(%) acc(%) bal acc(%) AUC
All 67.8 70.6 69.1 68.5 0.741
1.5T 70.0 66.1 68.1 68.6 0.710
3T 63.5 79.6 70.1 72.7 0.788
Table 8.5: Results for ARK classiﬁcation of MCI-s and MCI-c, broken down by MRI scan ﬁeld
strength
Figure 8.6: Spectrum of regional weights in AD/HC classiﬁcation. The weights are sparse, with
the vast majority of the total weight shared among just a small minority of the regions.
however, the introduction of prior anatomical information means that the hyperparameters are
maintained at biologically plausible values which prevents the extra ﬂexibility resulting in too
much overﬁtting.
8.6.1 Interpretation of hyperparameters
The optimised weights  tell us about the importance of the corresponding regions in the clas-
siﬁcation, and hence in AD. For each of the 627 sets of , we normalise  so they represent a
fraction of the total weight, then average each normalised weight across all folds. The spectrum
of weights is shown in ﬁgure 8.6.
This shows that the weights are fairly sparse, with only 14 regions having weights of more
than 1% of the total.
These are shown in ﬁgure 8.7. They include temporal lobe regions frequently implicated
in AD in studies such as [Braak and Braak, 1995], as well as the GM tissue adjacent to the
temporal horn of the left lateral ventricle, which will be very sensitive to expansion of the horn.
However, other structures much more widely distributed across the brain are also shown to be8.7. Conclusion 137
Figure 8.7: Maps of regions with more than 1% of total weight
importantintheclassiﬁcation. Forexample, thelargestweightvalueisgiventotherightnucleus
accumbens, and the left nucleus accumbens and right caudate are also given large weights.
This may reﬂect atrophy due to AD in deep as well as cortical grey matter, as is suggested in
[de Jong et al., 2008, Madsen et al., 2010]. One possible alternative explanation is that there
may be a number of patients who have dementia due to a cause other than AD, which causes
atrophy in a different set of brain regions. It is also possible that the unexpected results may be
caused by registration and/or segmentation errors, meaning a small number of highly weighted
voxels are assigned to the wrong anatomical region and therefore give it a larger weighting than
it would otherwise have.
8.7 Conclusion
Our results show that ARKs successfully combine voxel level data with prior anatomical knowl-
edge, andmayofferanaccuracyimprovementcomparedtovoxelleveldataalone. Theapproach
also suggests an improvement over features based on predeﬁned regions, although for classi-
ﬁcation of healthy controls and AD patients this is a smaller advantage than for voxel data.
We are also able to visualise both the improvements ARKs bring to individual subjects, and
the ﬁnal weights on the kernels. This may be able to reveal new regions that were previously
thought not to be involved in AD. It is interesting to note that the resulting pattern of weights is
sparse. This arises naturally from the way the problem is formulated with automatic relevance
determination.
Themethodisquitegeneral, andcouldbeappliedbothtootherimagingmodalities, suchas
PET data, or to other features derived from MRI. All that is required is that low level features,
such as voxels, are grouped into regions and can all be transferred into a common space to
provide correspondence. This could be, for example, vertexwise cortical thickness data and a
labelled cortical atlas.
The chief disadvantage of ARKs is speed of classiﬁer training, due to the high dimension-8.7. Conclusion 138
ality of the data and the large number of hyperparameters; however this is largely compensated
for by the use of modiﬁed software that uses precomputed (sub)kernel matrices.139
Chapter 9
Conclusions
9.1 Overall conclusions
The work presented in this thesis has signiﬁcantly advanced the state-of-the art for the problem
of predicting progression to AD in MCI subjects. Using the largest cohort of MCI-s and MCI-c
subjects available to us, the MRI group in chapters 7 and 8, we have obtained the following
balanced accuracies, given in table 9.1.
We report the accuracy for MRI data only here as it is the most widely used imaging
modality in dementia, and also the least invasive. However we ﬁnd that by combining MRI
ARK data with ApoE genotype (with can be obtained noninvasively, in comparison with FDG-
PET and CSF) we can increase the balanced accuracy still further to 71.7% overall.
It is clear, however, that FDG-PET data does offer superior accuracy to MRI. In every
experiment where the same method was applied to the same set of subjects with both PET and
MRI, PET always outperforms MRI alone. The best balanced accuracy we obtained with the
largest possible subset of MCI subjects – again, the PET group from the MMSE experiments
in chapter 7 – gave a balanced accuracy of 75%. Among the PET subjects whose MRI was
Method Field strength Bal acc(%) AUC
ARK 1.5T 68.6 0.710
ARK 3T 72.6 0.788
ARK all 68.5 0.741
MMSE 1.5T 65.2 0.734
MMSE 3T 0.752 0.811
MMSE all 68.9 0.761
Table 9.1: Best overall classiﬁcation with MRI data only. Balanced accuracies for 1.5T or 3T
subjects obtained from leave-one-out loop over those subjects only; training was on all subjects.9.1. Overall conclusions 140
from a 3T scanner this accuracy rises to 83%, which is the highest yet reported for predicting
conversion within three years. However, for the PET subjects whose MRI scan was at 1.5T
the accuracy is much lower, suggesting that the scanner ﬁeld strength affects the processing
of PET data even more than it does the MRI itself. This is possibly because processing PET
data requires an additional registration step compared to MRI data. This suggests that it may be
desirableforthedecisionaboutwhichmethodshouldbeusedtopredictconversiontoADinany
particular MCI subject to depend on the image quality of the subject’s structural MRI. Scanning
at 3T if at all possible is desirable, as it will enable prediction of conversion to AD within three
years with 75% accuracy if only the MRI is available, and 83% accuracy if FDG-PET is also
available.
Inthesmallgroupsofsubjectsdescribedinchapter 6andfortheBSIexperimentinchapter
7, multimodal prediction using both MRI and FDG-PET was found to give slightly better results
than FDG-PET alone. However, when the FDG-PET image processing pipeline was improved,
enablingustousevoxellevelratherthanregionlevelPETfeatures, theadvantageofmultimodal
classiﬁcation all but disappeared, as shown in table 9.2. The highest accuracy of just over
83% is obtained from PET data only for subjects scanned at 3T, which is not improved by
adding MRI data. For subjects scanned at 1.5T, however, adding MRI data does give a very
modest improvement. This suggests that multimodal classiﬁcation may strengthen data that are
suboptimal, butifanysinglemodalityisverystronglypredictiveinitsownrightthencombining
with other data does not offer any statistically signiﬁcant improvement. Interestingly, we also
found that the best results for subjects scanned at 1.5T or for all subjects together were obtained
by training on all subjects, whereas for subjects scanned at 3T the best accuracy came from
training only on 3T subjects despite the resulting smaller size of the training set. This is the
way the results in table 9.2 were obtained for the 1.5T subjects and all subjects, and for the 3T
subjects respectively.
The experiment with continuous proxies, as described in chapter 7, offered slightly higher
classiﬁcation accuracies than the conventional approach involving binary labels if only MRI
data is available. Again, however, the advantage appears to be smaller when the number of
subjects is larger (unsurprisingly, as the continuous proxy approach makes more efﬁcient use
of the data) so in the limit there may be little to choose between the two approaches. It is,
however, clear that in the case of binary labels the transfer learning approach of training on AD
and healthy subjects, and then applying the resulting classiﬁer to a population of MCI-s and
MCI-c subjects, is more effective than training directly on the MCI subjects.9.2. Future research 141
Modality/modalities Field strength Bal acc(%) AUC
PET 1.5T 68.38 0.757
PET 3T 83.08 0.867
PET all 74.13 0.796
PET+MRI 1.5T 69.12 0.750
PET+MRI 3T 83.08 0.882
PET+MRI all 73.13 0.794
Table 9.2: Best overall classiﬁcation with voxel-level PET data only and voxel level PET and
MRI data combined with MKL.
9.2 Future research
There are a number of different avenues in which the work presented in this thesis could be
extended. As mentioned in the literature review in chapter 4, three primary choices affect
the accuracy of diagnosis and prognosis in studies such as the ones introduced here. The ﬁrst
and most important is what is referred to in [Sabuncu and Konukoglu, 2014] as the biological
footprint of the condition, which is the magnitude of differences between healthy subjects and
patients. However, this is ﬁxed for any speciﬁc condition, which means that to improve the
prediction of development of AD in MCI patients, efforts must instead be focused on the two
other factors affecting accuracy: the choice of classiﬁer or machine learning algorithm, and the
choice of data.
Simply utilising more sophisticated or complex classiﬁcation algorithms does not appear
to lead to greater accuracy. This is shown experimentally in [Sabuncu and Konukoglu, 2014],
which found that choice of classiﬁer algorithm had a far smaller effect on accuracy than choice
of data or biological footprint size. The same observation can be made for the speciﬁc problem
of separating MCI-s and MCI-c subjects with ADNI data, as accuracies (using 1.5T struc-
tural MRI data) appear to have plateaued at around 75% despite a number of researchers
employing newer and more sophisticated types of classiﬁers such as deep learning methods
[Suk and Shen, 2013]. However, it is possible to improve results by using existing algorithms
in innovative ways to produce novel classiﬁcation paradigms. This can be done to to make
better use of existing subjects’ data. With binary classiﬁcation, the training data is normally
made up of one particular group - either MCI-s and MCI-c subjects, or in the transfer learning
setting control and AD subjects. Either way, a large number of potential training subjects are
left unused. However, the unused subjects do contain relevant information and ﬁnding a way to
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uous proxies is one way to do this, and this waste of data was in fact one of the motivations for
introducing them. The continuous proxy approach could itself be improved, by ﬁnding better
regression techniques and more relevant proxies. It should also be possible to improve results
by using multiple proxies (such as MMSE, ADAS-COG and BSI) with multi-task learning or
canonical correlation analysis (CCA) [Hotelling, 1936]. This could potentially even be used to
relate multivariate patterns of atrophy to baseline GM maps. However, this is not the only way
to make use of all the data. Ordinal regression retains discrete labels but be able to use all data
regardless of group for training. Initial results for this [Doyle et al., 2014] were unexceptional,
however it remains a conceptually attractive approach. Alternatively, semi-supervised learn-
ing [Chapelle et al., 2010] may prove useful and has already been applied to AD classiﬁcation
using other techniques [Filipovych and Davatzikos, 2011].
Similarly, we could also make better use of existing data by exploiting multiple timepoints.
While longitudinal features have been widely used on ADNI data, MCI-c subjects are generally
treated as homogeneous when in fact the time of conversion may vary wildly in terms of when
(within the cutoff period) they actually do convert to AD. Survival analysis methods, such as
Cox regression [Cox and Oakes, 1984], are perhaps the best way to model such data, and can
also be used with GP priors [Barrett and Coolen, 2013, Vanhatalo et al., 2013].
Almost all of these methods would likely be improved by using a sparse method for
learning. Sparsity is particularly attractive for AD or MCI classiﬁcation as it is well known
that the pattern of atrophy in AD is well deﬁned and generally restricted to speciﬁc ar-
eas of the brain [Braak and Braak, 1995]. Therefore enforcing a sparse set of weights for
either voxel or region level data should result in a more accurate model as the distribu-
tion of weights is likely to be more biologically plausible and hence more directly reﬂec-
tive of the underlying disease processes. Furthermore, promotion of sparsity will help to
reduce overﬁtting which is of particular concern in neuroimaging due to the small num-
ber of subjects and frequently very high dimensionality of the data. A sparse approach
was used in one of the highest performing methods for predicting MCI conversion with-
out use of PET data [Ye et al., 2012]. Off-the-shelf sparse methods such as the elastic net
[Zou and Hastie, 2005] can be applied to neuroimaging data. Alternatively, special methods
combining sparsity and spatial smoothness for neuroimaging data have been successfully devel-
oped [Gramfort et al., 2013, Cuingnet et al., 2013, Sabuncu and Leemput, 2012]. All of these
can be used for direct binary classiﬁcation or continuous proxy regression, and could also be
adapted for more specialised applications such as time-to-event models as in [Sabuncu, 2013].
An intermediate point between using different learning algorithms and different types9.2. Future research 143
of image data would be to ﬁnd superior features from existing data. In particular, we did
not explore the use of cortical thickness measurements in this thesis. Also, scalar momen-
tum features derived from diffeomorphic registrations have been used as features for classi-
ﬁcation and regression with some success [Marquand et al., 2013, Singh et al., 2014]. Both
of these have the advantage that they could be used with the ARK framework to further im-
prove results. Other types of feature are based on extracting statistical information from voxel
level data. Hippocampal grading has been shown to yield good results [Coup´ e et al., 2012],
which suggests that features based on MRI texture feature may also be predictive. The long-
standing grey level cooccurence matrix (GLCM) approach to texture has been applied to
AD classiﬁcation [Freeborough and Fox, 1998] with promising results. However the more
recent, fully three dimensional and rotation invariant texture features such as local binary
patterns [Fehr and Burkhardt, 2008, Banerjee et al., 2013] and statistical geometric features
[Chen et al., 1995] may perform better. Finally, it is possible to formulate a kernel in a manner
that means the elements of the kernel matrix are not similarities between vectors, but between
clouds of points which can have varying cardinalities [Rahimi and Recht, 2007]. This method
has already been used successfully with fractional anisotropy (FA) data derived from DTI brain
images [Ansari et al., 2014]. It has the advantage of retaining spatial information and thus could
potentially be more discriminating as well as not requiring nonlinear registration. An obvious
application for this would be to voxel level structural MRI data in intensity normalised, afﬁnely
aligned brains or brain ROIs. All these have the advantage of requiring structural MRI data. As
mentioned previously, despite the greater accuracy provided by FDG-PET data it is still desir-
able to improve results based on MRI data alone, due to the lower cost and invasiveness and
greater availability of MRI.
The biggest increases in accuracy are likely to come from entirely different types of data,
especially if these are informed by greater understanding of the AD process and its causes.
It is possible that future biomarkers will be used that are not informed by image data at all,
such as those based on lipid levels in blood which have attracted widespread publicity recently
[Mapstone et al., 2014]. This method, however, recruited at only two centres, rather than the
far greater number used in ADNI, and furthermore it predicted the onset of dementia in healthy
subjects rather than predicting conversion to AD in an MCI population. While this difference
may appear to be minimal, it is possible that the blood test is actually performing an easier
classiﬁcation due to a greater biological difference between the two groups. Additionally a
test for healthy subjects implies screening, which brings its own problems and has different
requirements to predicting conversion in the MCI population.9.2. Future research 144
Biomarkers extracted from newer imaging modalities have recently been shown to hold a
great deal of promise. This thesis has only employed structural MRI and FDG-PET, to examine
brain anatomy and metabolism. However AD is a disease which affects the brain in a variety of
ways. In particular, it is known to alter the white matter connectivity between regions, mean-
ing simple measures extracted from DTI such as FA correlate strongly with cognitive measure
[Nir et al., 2013], and have been shown to give very good separation between MCI-s and MCI-c
subjects in inital small scale studies [van Bruggen et al., 2012]. Similarly, AD also affects brain
function, which is detectable in fMRI. This has also shown promise in classifying AD patients
and controls on a small scale [Li et al., 2013]. More recently, arterial spin labelling (ASL), a
method of using MRI to measure cerebral blood ﬂow, has emerged as a potential biomarker for
AD [Wang et al., 2013]. The reason for the low numbers of subjects in all studies involving
these advanced MRI modalities is that they have only recently been added to the ADNI pro-
tocol. As the relevant data becomes available in larger quantities in the ADNI database, they
should enable a great variety of new methods for predicting conversion from MCI to AD to be
developed.145
Appendix A
Running times and computational complexity
A.1 Experiment and results
In order to give estimates of the likely running times of a typical classiﬁcation, this section
contains the results of a small scale experiment. The experiment was performed on a set
of 100 randomly chosen structural MRI scans of subjects from the ADNI dataset, consisting
of 50 healthy subjects and 50 with probable AD. The time taken to train a classiﬁer from
these data was noted as training time is much greater than the time to make a prediction on
an unseen subject. We present results for GP classiﬁcation using the original GPML toolkit
(http://www.gaussianprocess.org/gpml/code/matlab/doc/), for our modi-
ﬁed version of GPML using a precomputed kernel, and for comparison an SVM, also both
with and without a precomputed kernel using LIBSVM (http://www.csie.ntu.edu.
tw/˜cjlin/libsvm). For the GP classiﬁcation, training here refers to optimisation of the
hyperparameters. 200 iterations of the optimiser were used for the GP experiments, the same
number as in all previous experiments. SVM training used default parameters. The experi-
ments were performed in Matlab running on a Linux PC with 3.8GB of RAM and two 2.4GHz
processors. Results are shown below in table A.1.
A ﬁnal experiment was performed, using the same task of training a classiﬁer on the struc-
tural MRI scans of 50 AD and 50 control subjects. Here, however, the data was in the form of
Classiﬁer Precomputed kernel Running time
SVM no 7.9 seconds
SVM yes 0.005 seconds
GP no 17 minutes, 22 seconds
GP yes 16.8 seconds
Table A.1: Running times for training a model on 50 AD and 50 control subjectsA.2. Discussion 146
83 multiple regional kernels, as described in chapter 8. This implies setting a much larger num-
ber of hyperparameters as one is introduced for each kernel. Correspondingly training time was
greater than for the single precomputed kernel GP form, but still reasonable at four minutes, 24
seconds.
A.2 Discussion
The results here are for an experiment using a much smaller number of training subjects than
would be used in practice (and is smaller than most of the training sets used in other experi-
ments in this thesis). Estimates of running times in a more realistic setting may be made by
extrapolating from these results. GPs do have the disadvantage of scaling relatively poorly. As
the algorithm is dominated by a matrix inversion their computational complexity is O(n3). For
large scale classiﬁcation, this can, however, be improved on, by the fully independent train-
ing conditional (FITC) approximation [Naish-Guzman and Holden, 2007]. This is included
in the GPML software, however it was not used for any of the experiments in this thesis.
The scaling behaviour of SVMs is slightly better. Although the computational complexity is
data dependent and more diffcult to characterise, it is generally between O(n2) and O(n3)
[Chang and Lin, 2011]. GP classiﬁcation does have an advantage for the multikernel formu-
lation, due to its ability to learn a large number of hyparameters from training data only.
The method of [Zhang et al., 2011] could not perform the equivalent; grid search and cross-
validation is tractable to set a handful of parameters but not for 83.
The runtimes in table A.1 should be interpreted with caution. Although we would ex-
pect GP classiﬁcation to be slower than an SVM generally due to the greater computational
complexity, this is likely exaggerated in the results. This is because GPML is written entirely
in native Matlab, whereas LIBSVM is a highly optimised C++ library that can be called from
other environments such as Matlab or Python. Unfortunately to my knowledge there are no
fast C++ implementations of GP classiﬁcation with the ﬂexbility of GPML. However, there is
considerable scope for making GP classiﬁcation faster by developing one.
Itisquiteclear, however, thatprecomputingakernelmatrixishighlyadvantageousforboth
classiﬁers. This is because, in applications to medical image data, the dimensionality of the data
is very high so generating the kernel is a slow operation; furthermore in GPML the kernel is
regenerated for each iteration. This is actually necessary as the elements of the kernel matrix
depends on the hyperparameters, so the kernel matrix must be updated as the hyperparameters
are being optimised. However, for some kernel functions (including linear ones), the kernel
matrixisafunctionofaconstantmatrixofthesamesizeandthehyperparameters. ThisconstantA.2. Discussion 147
matrix can be calculated directly from the data and it is this that is used in our modiﬁed version
of GPML. Although, as previously stated, generating a precomputed kernel matrix is itself a
slow operation, this is not a major problem in practice as it need only be done once. New data
can then be added incrementally. If the original data are retained alongside a kernel matrix, then
the new training and/or testing data can be incorporated into the matrix by computing the new
matrix elements only and inserting them rather than computing the entire matrix from scratch.148
Appendix B
Lists of subjects in experiments
B.1 Subjects in experiment in chapter 5
The subjects used in the AD and normal control classiﬁcation experiment described in chapter
5 are listed in table B.1.
Table B.1: List of subjects used in the control/AD classiﬁcation
experiment in chapter 5. ID = ADNI roster ID number, Status =
disease status of subject.
ID Status ID Status ID Status ID Status ID Status ID Status
16 NC 272 NC 672 NC 3 AD 400 AD 803 AD
22 NC 295 NC 717 NC 76 AD 426 AD 850 AD
43 NC 312 NC 726 NC 84 AD 431 AD 891 AD
47 NC 327 NC 731 NC 93 AD 457 AD 1082 AD
55 NC 352 NC 751 NC 94 AD 470 AD 1090 AD
56 NC 433 NC 768 NC 129 AD 517 AD 1137 AD
59 NC 454 NC 779 NC 139 AD 535 AD 1144 AD
89 NC 467 NC 843 NC 147 AD 543 AD 1170 AD
95 NC 488 NC 886 NC 149 AD 547 AD 1171 AD
96 NC 498 NC 923 NC 194 AD 577 AD 1209 AD
97 NC 516 NC 926 NC 213 AD 606 AD 1221 AD
123 NC 519 NC 972 NC 221 AD 619 AD 1262 AD
159 NC 520 NC 981 NC 266 AD 690 AD 1285 AD
172 NC 525 NC 984 NC 286 AD 720 AD 1290 AD
177 NC 533 NC 1002 NC 300 AD 733 AD 1337 ADB.2. Subjects in experiment in chapter 6 149
186 NC 534 NC 1016 NC 310 AD 739 AD 1341 AD
210 NC 555 NC 1035 NC 321 AD 753 AD 1371 AD
232 NC 559 NC 1063 NC 341 AD 754 AD 1373 AD
259 NC 602 NC 1200 NC 366 AD 784 AD 1379 AD
260 NC 648 NC 1250 NC 372 AD 790 AD 1402 AD
B.2 Subjects in experiment in chapter 6
The subjects used in the experiments described in chapter 6 are listed in table B.2. This lists
all the subjects in the PET group. For each subject, it is listed whether it was also present in the
PET-CSF group.
Table B.2: List of subjects used in the PET group of the MKL
experiment in chapter 6. ID = ADNI roster ID number, Status =
disease status of subject, CSF = subject has CSF data so is used in
PET-CSF group.
ID Status CSF ID Status CSF ID Status CSF ID Status CSF
5 NC Yes 1202 NC No 200 MCI-s No 1315 MCI-s Yes
14 NC Yes 3 AD Yes 225 MCI-s No 1318 MCI-s No
16 NC Yes 10 AD Yes 227 MCI-s No 1322 MCI-s No
21 NC No 53 AD No 282 MCI-s No 1346 MCI-s No
23 NC Yes 147 AD Yes 292 MCI-s Yes 1351 MCI-s Yes
43 NC Yes 149 AD Yes 314 MCI-s Yes 1378 MCI-s No
48 NC No 167 AD No 354 MCI-s No 1384 MCI-s No
55 NC Yes 183 AD No 361 MCI-s Yes 1406 MCI-s No
67 NC No 216 AD No 378 MCI-s Yes 1407 MCI-s No
74 NC No 221 AD Yes 389 MCI-s No 1408 MCI-s No
95 NC Yes 266 AD Yes 408 MCI-s No 1414 MCI-s Yes
120 NC Yes 286 AD Yes 410 MCI-s Yes 1417 MCI-s No
123 NC Yes 316 AD Yes 414 MCI-s No 1418 MCI-s No
130 NC No 321 AD Yes 424 MCI-s Yes 1419 MCI-s Yes
171 NC No 341 AD Yes 446 MCI-s Yes 1425 MCI-s No
173 NC Yes 343 AD No 461 MCI-s No 1426 MCI-s NoB.2. Subjects in experiment in chapter 6 150
223 NC Yes 370 AD No 464 MCI-s No 57 MCI-c Yes
230 NC No 374 AD No 481 MCI-s Yes 101 MCI-c Yes
259 NC Yes 400 AD Yes 485 MCI-s No 128 MCI-c No
262 NC No 431 AD Yes 531 MCI-s Yes 141 MCI-c No
272 NC Yes 474 AD Yes 544 MCI-s Yes 155 MCI-c No
283 NC No 497 AD No 546 MCI-s No 204 MCI-c Yes
301 NC No 543 AD Yes 549 MCI-s No 214 MCI-c No
311 NC No 547 AD Yes 598 MCI-s Yes 222 MCI-c Yes
312 NC Yes 554 AD No 608 MCI-s Yes 231 MCI-c Yes
359 NC No 565 AD Yes 621 MCI-s Yes 240 MCI-c Yes
386 NC Yes 577 AD Yes 626 MCI-s Yes 256 MCI-c Yes
416 NC No 642 AD No 634 MCI-s Yes 258 MCI-c Yes
419 NC No 682 AD No 656 MCI-s No 293 MCI-c Yes
459 NC Yes 712 AD No 669 MCI-s No 325 MCI-c No
498 NC Yes 720 AD Yes 673 MCI-s Yes 326 MCI-c Yes
500 NC No 740 AD No 679 MCI-s No 344 MCI-c Yes
502 NC No 754 AD Yes 698 MCI-s No 362 MCI-c Yes
522 NC No 760 AD No 709 MCI-s No 394 MCI-c Yes
526 NC No 786 AD No 715 MCI-s No 511 MCI-c Yes
555 NC Yes 836 AD Yes 718 MCI-s Yes 513 MCI-c No
575 NC No 850 AD Yes 746 MCI-s Yes 567 MCI-c Yes
576 NC No 889 AD No 748 MCI-s Yes 675 MCI-c No
610 NC Yes 891 AD Yes 770 MCI-s No 695 MCI-c No
618 NC Yes 979 AD No 800 MCI-s Yes 708 MCI-c No
637 NC Yes 1001 AD No 865 MCI-s No 723 MCI-c Yes
647 NC No 1041 AD Yes 909 MCI-s No 860 MCI-c No
648 NC Yes 1044 AD Yes 914 MCI-s No 861 MCI-c Yes
657 NC Yes 1056 AD No 919 MCI-s No 904 MCI-c Yes
672 NC Yes 1090 AD Yes 925 MCI-s Yes 906 MCI-c Yes
680 NC Yes 1109 AD Yes 932 MCI-s Yes 941 MCI-c Yes
686 NC Yes 1157 AD No 945 MCI-s No 978 MCI-c Yes
731 NC Yes 1164 AD No 947 MCI-s No 997 MCI-c Yes
734 NC No 1171 AD Yes 950 MCI-s Yes 1007 MCI-c No
741 NC No 1205 AD No 961 MCI-s Yes 1010 MCI-c YesB.3. Subjects in experiments in chapter 7 151
751 NC Yes 1221 AD Yes 973 MCI-s Yes 1033 MCI-c Yes
778 NC Yes 1254 AD No 976 MCI-s No 1130 MCI-c Yes
779 NC Yes 1281 AD Yes 994 MCI-s Yes 1135 MCI-c No
813 NC No 1283 AD No 1030 MCI-s Yes 1217 MCI-c Yes
818 NC Yes 1285 AD Yes 1032 MCI-s No 1240 MCI-c No
842 NC No 1307 AD No 1043 MCI-s Yes 1282 MCI-c No
843 NC Yes 1339 AD No 1073 MCI-s Yes 1311 MCI-c No
845 NC No 1341 AD Yes 1103 MCI-s No 1393 MCI-c Yes
862 NC No 1368 AD No 1106 MCI-s No 1394 MCI-c Yes
863 NC No 1371 AD Yes 1114 MCI-s No 1398 MCI-c Yes
866 NC Yes 1373 AD Yes 1118 MCI-s No 1412 MCI-c No
898 NC No 1379 AD Yes 1120 MCI-s Yes 1423 MCI-c Yes
934 NC No 1382 AD No 1165 MCI-s No 1427 MCI-c No
967 NC No 1402 AD Yes 1186 MCI-s No
972 NC Yes 33 MCI-s Yes 1215 MCI-s No
985 NC No 80 MCI-s No 1218 MCI-s No
1002 NC Yes 112 MCI-s Yes 1224 MCI-s Yes
1023 NC No 135 MCI-s Yes 1246 MCI-s No
1063 NC Yes 142 MCI-s No 1260 MCI-s Yes
1133 NC No 158 MCI-s Yes 1265 MCI-s Yes
1194 NC No 160 MCI-s No 1275 MCI-s No
1197 NC No 188 MCI-s Yes 1314 MCI-s No
B.3 Subjects in experiments in chapter 7
The subjects used in the BSI experiment described in chapter 7 are listed in table B.3.
Table B.3: List of subjects used in the BSI experiment in chapter
7. ID = ADNI roster ID number, Status = disease status of subject.
ID Status ID Status ID Status ID Status ID Status ID Status
5 NC 866 NC 850 AD 424 MCI-s 1265 MCI-s 997 MCI-c
16 NC 972 NC 891 AD 446 MCI-s 1315 MCI-s 1010 MCI-c
23 NC 1002 NC 1041 AD 481 MCI-s 1351 MCI-s 1033 MCI-cB.3. Subjects in experiments in chapter 7 152
43 NC 1063 NC 1044 AD 531 MCI-s 1419 MCI-s 1130 MCI-c
55 NC 3 AD 1090 AD 544 MCI-s 57 MCI-c 1217 MCI-c
120 NC 10 AD 1109 AD 598 MCI-s 101 MCI-c 1393 MCI-c
173 NC 147 AD 1171 AD 608 MCI-s 204 MCI-c 1394 MCI-c
272 NC 149 AD 1221 AD 621 MCI-s 222 MCI-c 1398 MCI-c
312 NC 221 AD 1281 AD 626 MCI-s 231 MCI-c 1423 MCI-c
386 NC 266 AD 1341 AD 673 MCI-s 256 MCI-c
459 NC 286 AD 1371 AD 718 MCI-s 258 MCI-c
498 NC 316 AD 1373 AD 746 MCI-s 293 MCI-c
555 NC 321 AD 1379 AD 748 MCI-s 326 MCI-c
610 NC 341 AD 1402 AD 932 MCI-s 344 MCI-c
648 NC 400 AD 33 MCI-s 950 MCI-s 362 MCI-c
657 NC 431 AD 112 MCI-s 961 MCI-s 394 MCI-c
672 NC 474 AD 135 MCI-s 973 MCI-s 511 MCI-c
680 NC 543 AD 158 MCI-s 994 MCI-s 567 MCI-c
686 NC 547 AD 188 MCI-s 1030 MCI-s 723 MCI-c
731 NC 565 AD 292 MCI-s 1043 MCI-s 861 MCI-c
751 NC 577 AD 314 MCI-s 1073 MCI-s 904 MCI-c
779 NC 720 AD 361 MCI-s 1120 MCI-s 906 MCI-c
818 NC 754 AD 378 MCI-s 1224 MCI-s 941 MCI-c
843 NC 836 AD 410 MCI-s 1260 MCI-s 978 MCI-c
The subjects used in the MMSE experiment described in chapter 7 are listed in table B.4.
This table lists all subjects in the MRI group used for this experiment. For each subject, as well
as the disease group, the scanner ﬁeld strength and whether the subject had an FDG-PET scan
and was therefore also in the PET group is listed. The small number of scans done in 2.9T
scanners are grouped with the 3T scans when examining the effects of different scanner ﬁeld
strengths. The MCI-u status is for subjects which are MCI at baseline, but due to having been
only recently enrolled in ADNI cannot be assigned to MCI-s or MCI-c. In continuous proxy
experiments these subjects can be used for training as long as they have the appropriate proxy
data, but cannot be used for testing.B.3. Subjects in experiments in chapter 7 153
Table B.4: List of subjects used in the MRI group of the MMSE
experiment in chapter 7. ID = ADNI roster ID number, Status =
disease status of subject, T = ﬁeld strength of structural MRI in
Tesla, PET = subject has PET data so is used in PET group.
ID Status T PET ID Status T PET ID Status T PET
2 NC 1.5 Yes 760 AD 1.5 Yes 4414 MCI-c 3 Yes
5 NC 1.5 Yes 777 AD 1.5 Yes 4432 MCI-c 3 No
8 NC 1.5 Yes 790 AD 1.5 No 4502 MCI-c 3 Yes
14 NC 1.5 Yes 793 AD 1.5 No 4515 MCI-c 3 Yes
16 NC 1.5 Yes 796 AD 1.5 No 4530 MCI-c 3 Yes
19 NC 1.5 No 812 AD 3 No 4595 MCI-c 3 Yes
21 NC 1.5 Yes 828 AD 3 No 4661 MCI-c 3 Yes
22 NC 1.5 No 836 AD 1.5 Yes 4680 MCI-c 3 Yes
23 NC 1.5 Yes 850 AD 1.5 Yes 4689 MCI-c 3 Yes
31 NC 2.9 No 852 AD 1.5 No 4706 MCI-c 3 Yes
40 NC 1.5 No 853 AD 1.5 No 4712 MCI-c 3 Yes
56 NC 1.5 No 889 AD 1.5 Yes 4796 MCI-c 3 Yes
58 NC 2.9 No 891 AD 1.5 Yes 4857 MCI-c 3 Yes
59 NC 1.5 No 916 AD 3 No 4888 MCI-c 3 Yes
61 NC 2.9 No 929 AD 1.5 Yes 4899 MCI-c 3 Yes
67 NC 1.5 Yes 955 AD 1.5 No 4918 MCI-c 3 Yes
68 NC 1.5 No 979 AD 1.5 Yes 4928 MCI-c 3 Yes
70 NC 1.5 No 991 AD 1.5 Yes 38 MCI-u 1.5 No
72 NC 1.5 No 996 AD 2.9 No 60 MCI-u 1.5 No
74 NC 1.5 Yes 1001 AD 1.5 Yes 112 MCI-u 1.5 Yes
81 NC 1.5 No 1018 AD 1.5 No 138 MCI-u 1.5 Yes
86 NC 1.5 No 1024 AD 1.5 No 188 MCI-u 1.5 Yes
89 NC 1.5 No 1041 AD 1.5 Yes 282 MCI-u 1.5 Yes
90 NC 1.5 Yes 1044 AD 1.5 Yes 284 MCI-u 1.5 No
96 NC 1.5 Yes 1055 AD 2.9 No 377 MCI-u 1.5 Yes
97 NC 1.5 Yes 1056 AD 1.5 Yes 384 MCI-u 3 No
106 NC 1.5 No 1059 AD 1.5 Yes 393 MCI-u 3 NoB.3. Subjects in experiments in chapter 7 154
113 NC 1.5 No 1079 AD 1.5 No 397 MCI-u 3 No
120 NC 1.5 Yes 1082 AD 2.9 No 410 MCI-u 1.5 Yes
123 NC 1.5 Yes 1101 AD 3 No 414 MCI-u 1.5 Yes
125 NC 1.5 No 1102 AD 1.5 No 417 MCI-u 2.9 No
156 NC 1.5 No 1109 AD 1.5 Yes 429 MCI-u 1.5 No
166 NC 1.5 No 1137 AD 1.5 No 443 MCI-u 1.5 Yes
171 NC 1.5 Yes 1144 AD 1.5 Yes 458 MCI-u 1.5 No
172 NC 1.5 No 1152 AD 1.5 No 485 MCI-u 1.5 Yes
173 NC 1.5 Yes 1157 AD 1.5 Yes 544 MCI-u 1.5 Yes
177 NC 1.5 No 1161 AD 1.5 Yes 551 MCI-u 1.5 Yes
184 NC 1.5 No 1164 AD 1.5 Yes 566 MCI-u 1.5 Yes
186 NC 1.5 No 1170 AD 2.9 No 579 MCI-u 1.5 No
223 NC 1.5 Yes 1171 AD 1.5 Yes 669 MCI-u 1.5 Yes
229 NC 1.5 No 1185 AD 3 No 702 MCI-u 1.5 No
230 NC 1.5 Yes 1192 AD 1.5 No 721 MCI-u 1.5 Yes
232 NC 1.5 Yes 1205 AD 1.5 Yes 739 MCI-u 1.5 No
245 NC 1.5 Yes 1221 AD 1.5 Yes 748 MCI-u 1.5 Yes
257 NC 1.5 No 1253 AD 3 No 783 MCI-u 1.5 Yes
259 NC 1.5 Yes 1254 AD 1.5 Yes 821 MCI-u 1.5 No
260 NC 3 No 1257 AD 1.5 Yes 832 MCI-u 1.5 No
262 NC 1.5 Yes 1262 AD 3 No 890 MCI-u 1.5 No
272 NC 1.5 Yes 1263 AD 1.5 Yes 924 MCI-u 1.5 Yes
283 NC 1.5 Yes 1281 AD 1.5 Yes 928 MCI-u 3 No
295 NC 1.5 No 1285 AD 1.5 Yes 957 MCI-u 1.5 Yes
298 NC 1.5 No 1289 AD 3 No 958 MCI-u 1.5 Yes
301 NC 1.5 Yes 1290 AD 1.5 Yes 1028 MCI-u 1.5 Yes
303 NC 2.9 No 1296 AD 1.5 No 1038 MCI-u 1.5 Yes
312 NC 1.5 Yes 1307 AD 1.5 Yes 1051 MCI-u 1.5 No
319 NC 1.5 Yes 1308 AD 1.5 No 1074 MCI-u 1.5 Yes
327 NC 1.5 Yes 1337 AD 1.5 No 1092 MCI-u 1.5 Yes
337 NC 1.5 No 1354 AD 1.5 Yes 1103 MCI-u 1.5 Yes
352 NC 1.5 Yes 1368 AD 1.5 Yes 1104 MCI-u 3 No
359 NC 1.5 Yes 1373 AD 1.5 Yes 1204 MCI-u 1.5 Yes
360 NC 1.5 Yes 1377 AD 1.5 No 1215 MCI-u 1.5 YesB.3. Subjects in experiments in chapter 7 155
363 NC 1.5 Yes 1382 AD 1.5 Yes 1231 MCI-u 1.5 No
382 NC 2.9 No 1385 AD 2.9 No 1245 MCI-u 1.5 Yes
386 NC 1.5 Yes 1397 AD 1.5 Yes 1275 MCI-u 1.5 Yes
403 NC 2.9 No 1435 AD 1.5 No 1277 MCI-u 2.9 No
405 NC 3 No 4024 AD 3 Yes 1279 MCI-u 2.9 No
413 NC 1.5 No 4039 AD 3 Yes 1293 MCI-u 3 No
416 NC 1.5 Yes 4136 AD 3 Yes 1294 MCI-u 1.5 Yes
419 NC 1.5 Yes 4152 AD 3 Yes 1309 MCI-u 2.9 No
436 NC 1.5 No 4153 AD 3 Yes 1343 MCI-u 1.5 Yes
454 NC 1.5 Yes 4172 AD 3 Yes 1366 MCI-u 1.5 No
459 NC 1.5 Yes 4195 AD 3 Yes 1400 MCI-u 1.5 Yes
467 NC 1.5 Yes 4201 AD 3 Yes 1408 MCI-u 1.5 Yes
484 NC 1.5 Yes 4209 AD 3 Yes 1411 MCI-u 1.5 Yes
488 NC 2.9 No 4211 AD 3 Yes 1420 MCI-u 1.5 Yes
489 NC 1.5 Yes 4223 AD 3 Yes 1426 MCI-u 1.5 Yes
493 NC 2.9 No 4252 AD 3 Yes 2007 MCI-u 3 Yes
498 NC 1.5 Yes 4258 AD 3 Yes 2010 MCI-u 3 Yes
500 NC 1.5 Yes 4280 AD 3 Yes 2018 MCI-u 3 Yes
502 NC 1.5 Yes 4282 AD 3 Yes 2022 MCI-u 3 Yes
506 NC 1.5 Yes 4307 AD 3 Yes 2027 MCI-u 3 Yes
516 NC 1.5 No 4353 AD 3 Yes 2036 MCI-u 3 Yes
519 NC 1.5 No 4373 AD 3 Yes 2037 MCI-u 3 Yes
522 NC 1.5 Yes 4494 AD 3 Yes 2042 MCI-u 3 Yes
526 NC 1.5 Yes 4500 AD 3 Yes 2043 MCI-u 3 Yes
534 NC 1.5 Yes 4526 AD 3 Yes 2045 MCI-u 3 Yes
538 NC 1.5 No 4546 AD 3 Yes 2055 MCI-u 3 Yes
545 NC 1.5 No 4549 AD 3 Yes 2058 MCI-u 3 Yes
548 NC 1.5 No 4589 AD 3 Yes 2060 MCI-u 3 Yes
555 NC 1.5 Yes 4591 AD 3 Yes 2061 MCI-u 3 Yes
558 NC 1.5 No 4641 AD 3 Yes 2063 MCI-u 3 Yes
559 NC 1.5 No 4657 AD 3 Yes 2068 MCI-u 3 Yes
575 NC 1.5 Yes 4660 AD 3 Yes 2072 MCI-u 3 Yes
576 NC 1.5 Yes 4672 AD 3 Yes 2073 MCI-u 3 Yes
578 NC 1.5 No 4686 AD 3 Yes 2074 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 156
601 NC 1.5 No 4692 AD 3 Yes 2077 MCI-u 3 No
602 NC 3 No 4696 AD 3 Yes 2079 MCI-u 3 Yes
605 NC 3 No 4707 AD 3 Yes 2083 MCI-u 3 Yes
610 NC 1.5 Yes 4728 AD 3 Yes 2087 MCI-u 3 Yes
618 NC 1.5 Yes 4730 AD 3 Yes 2093 MCI-u 3 Yes
622 NC 3 No 4733 AD 3 Yes 2099 MCI-u 3 Yes
640 NC 2.9 No 4755 AD 3 Yes 2100 MCI-u 3 Yes
643 NC 1.5 No 4756 AD 3 Yes 2106 MCI-u 3 Yes
647 NC 1.5 Yes 4770 AD 3 Yes 2109 MCI-u 3 Yes
657 NC 1.5 Yes 4774 AD 3 Yes 2116 MCI-u 3 Yes
672 NC 1.5 Yes 4802 AD 3 Yes 2119 MCI-u 3 Yes
677 NC 3 No 4827 AD 3 Yes 2121 MCI-u 3 Yes
680 NC 1.5 Yes 4845 AD 3 Yes 2123 MCI-u 3 Yes
681 NC 1.5 No 4853 AD 3 Yes 2125 MCI-u 3 Yes
684 NC 1.5 No 4863 AD 3 Yes 2133 MCI-u 3 Yes
685 NC 1.5 No 4867 AD 3 Yes 2138 MCI-u 3 Yes
686 NC 1.5 Yes 4892 AD 3 Yes 2142 MCI-u 3 Yes
692 NC 1.5 No 4894 AD 3 Yes 2146 MCI-u 3 Yes
717 NC 1.5 No 4905 AD 3 Yes 2148 MCI-u 3 Yes
726 NC 1.5 No 4906 AD 3 Yes 2150 MCI-u 3 Yes
731 NC 1.5 Yes 4910 AD 3 Yes 2151 MCI-u 3 Yes
734 NC 1.5 Yes 4938 AD 3 No 2153 MCI-u 3 Yes
741 NC 1.5 Yes 4940 AD 3 Yes 2155 MCI-u 3 Yes
751 NC 1.5 Yes 4949 AD 3 Yes 2164 MCI-u 3 Yes
761 NC 1.5 No 4954 AD 3 Yes 2168 MCI-u 3 Yes
767 NC 1.5 No 4962 AD 3 Yes 2171 MCI-u 3 Yes
768 NC 1.5 Yes 4971 AD 3 Yes 2180 MCI-u 3 Yes
779 NC 1.5 Yes 5012 AD 3 Yes 2182 MCI-u 3 Yes
810 NC 1.5 No 5015 AD 3 Yes 2183 MCI-u 3 Yes
813 NC 1.5 Yes 5018 AD 3 Yes 2184 MCI-u 3 Yes
818 NC 1.5 Yes 5019 AD 3 Yes 2185 MCI-u 3 Yes
842 NC 1.5 Yes 5028 AD 3 Yes 2187 MCI-u 3 Yes
843 NC 1.5 Yes 4 MCI-s 1.5 No 2190 MCI-u 3 Yes
862 NC 1.5 Yes 51 MCI-s 1.5 Yes 2191 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 157
863 NC 1.5 Yes 107 MCI-s 1.5 No 2193 MCI-u 3 Yes
866 NC 1.5 Yes 116 MCI-s 1.5 No 2194 MCI-u 3 Yes
876 NC 1.5 No 150 MCI-s 1.5 Yes 2195 MCI-u 3 Yes
883 NC 1.5 Yes 160 MCI-s 1.5 Yes 2196 MCI-u 3 Yes
886 NC 1.5 No 176 MCI-s 1.5 No 2200 MCI-u 3 Yes
896 NC 1.5 No 178 MCI-s 1.5 Yes 2205 MCI-u 3 Yes
898 NC 1.5 Yes 200 MCI-s 1.5 Yes 2208 MCI-u 3 Yes
899 NC 1.5 No 225 MCI-s 1.5 Yes 2210 MCI-u 3 Yes
920 NC 2.9 No 273 MCI-s 1.5 No 2213 MCI-u 3 Yes
923 NC 1.5 No 276 MCI-s 1.5 No 2219 MCI-u 3 Yes
926 NC 3 No 285 MCI-s 1.5 Yes 2220 MCI-u 3 Yes
931 NC 1.5 No 291 MCI-s 1.5 Yes 2225 MCI-u 3 Yes
934 NC 1.5 Yes 292 MCI-s 1.5 Yes 2233 MCI-u 3 Yes
951 NC 1.5 No 307 MCI-s 2.9 No 2234 MCI-u 3 Yes
963 NC 3 No 324 MCI-s 3 No 2238 MCI-u 3 Yes
967 NC 1.5 Yes 351 MCI-s 1.5 No 2239 MCI-u 3 Yes
969 NC 1.5 No 361 MCI-s 1.5 Yes 2240 MCI-u 3 Yes
972 NC 1.5 Yes 376 MCI-s 2.9 No 2245 MCI-u 3 Yes
1002 NC 1.5 Yes 378 MCI-s 1.5 Yes 2247 MCI-u 3 Yes
1013 NC 1.5 Yes 389 MCI-s 1.5 Yes 2248 MCI-u 3 Yes
1014 NC 1.5 No 407 MCI-s 1.5 Yes 2264 MCI-u 3 Yes
1016 NC 2.9 No 408 MCI-s 1.5 Yes 2274 MCI-u 3 Yes
1023 NC 1.5 Yes 445 MCI-s 1.5 No 2284 MCI-u 3 Yes
1063 NC 1.5 Yes 448 MCI-s 3 No 2301 MCI-u 3 Yes
1086 NC 2.9 No 449 MCI-s 1.5 No 2304 MCI-u 3 Yes
1094 NC 1.5 No 464 MCI-s 1.5 Yes 2307 MCI-u 3 Yes
1098 NC 2.9 No 469 MCI-s 2.9 No 2315 MCI-u 3 Yes
1123 NC 3 No 481 MCI-s 1.5 Yes 2316 MCI-u 3 Yes
1169 NC 3 No 501 MCI-s 2.9 No 2324 MCI-u 3 Yes
1190 NC 3 No 505 MCI-s 1.5 No 2332 MCI-u 3 Yes
1194 NC 1.5 Yes 546 MCI-s 1.5 Yes 2333 MCI-u 3 Yes
1195 NC 1.5 Yes 552 MCI-s 1.5 Yes 2336 MCI-u 3 Yes
1197 NC 1.5 Yes 557 MCI-s 1.5 No 2347 MCI-u 3 Yes
1202 NC 1.5 Yes 590 MCI-s 1.5 Yes 2357 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 158
1203 NC 1.5 Yes 607 MCI-s 3 No 2360 MCI-u 3 Yes
1206 NC 3 No 608 MCI-s 1.5 Yes 2363 MCI-u 3 Yes
1222 NC 3 No 613 MCI-s 3 No 2367 MCI-u 3 Yes
1232 NC 2.9 No 621 MCI-s 1.5 Yes 2373 MCI-u 3 Yes
1242 NC 2.9 No 626 MCI-s 1.5 Yes 2374 MCI-u 3 Yes
1249 NC 2.9 No 641 MCI-s 1.5 Yes 2378 MCI-u 3 Yes
1250 NC 3 No 644 MCI-s 1.5 No 2379 MCI-u 3 Yes
1251 NC 3 No 656 MCI-s 1.5 Yes 2380 MCI-u 3 Yes
1256 NC 3 No 671 MCI-s 1.5 No 2381 MCI-u 3 Yes
1261 NC 1.5 No 673 MCI-s 1.5 Yes 2389 MCI-u 3 Yes
1267 NC 3 No 679 MCI-s 1.5 Yes 2392 MCI-u 3 No
1276 NC 2.9 No 698 MCI-s 1.5 Yes 2394 MCI-u 3 Yes
1280 NC 1.5 No 709 MCI-s 1.5 Yes 2395 MCI-u 3 Yes
1288 NC 3 No 715 MCI-s 1.5 Yes 2405 MCI-u 3 Yes
1301 NC 3 No 746 MCI-s 1.5 Yes 2407 MCI-u 3 Yes
2201 NC 3 Yes 771 MCI-s 2.9 No 4007 MCI-u 3 Yes
4010 NC 3 Yes 782 MCI-s 1.5 No 4029 MCI-u 3 Yes
4018 NC 3 Yes 792 MCI-s 2.9 No 4030 MCI-u 3 Yes
4020 NC 3 Yes 851 MCI-s 1.5 No 4034 MCI-u 3 Yes
4021 NC 3 Yes 867 MCI-s 1.5 No 4036 MCI-u 3 Yes
4026 NC 3 Yes 871 MCI-s 1.5 No 4051 MCI-u 3 Yes
4028 NC 3 Yes 908 MCI-s 1.5 No 4053 MCI-u 3 Yes
4032 NC 3 Yes 912 MCI-s 2.9 No 4054 MCI-u 3 Yes
4037 NC 3 Yes 919 MCI-s 1.5 Yes 4058 MCI-u 3 Yes
4041 NC 3 Yes 950 MCI-s 1.5 Yes 4059 MCI-u 3 Yes
4043 NC 3 Yes 989 MCI-s 1.5 No 4061 MCI-u 3 Yes
4050 NC 3 Yes 994 MCI-s 1.5 Yes 4063 MCI-u 3 Yes
4060 NC 3 Yes 1030 MCI-s 1.5 Yes 4072 MCI-u 3 Yes
4066 NC 3 Yes 1031 MCI-s 2.9 No 4073 MCI-u 3 Yes
4075 NC 3 Yes 1032 MCI-s 1.5 Yes 4077 MCI-u 3 Yes
4076 NC 3 Yes 1034 MCI-s 1.5 Yes 4079 MCI-u 3 Yes
4080 NC 3 Yes 1040 MCI-s 1.5 No 4115 MCI-u 3 Yes
4081 NC 3 Yes 1046 MCI-s 3 No 4122 MCI-u 3 Yes
4082 NC 3 Yes 1052 MCI-s 1.5 No 4127 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 159
4084 NC 3 Yes 1072 MCI-s 3 No 4128 MCI-u 3 Yes
4090 NC 3 Yes 1078 MCI-s 1.5 Yes 4133 MCI-u 3 Yes
4092 NC 3 Yes 1088 MCI-s 2.9 No 4143 MCI-u 3 Yes
4093 NC 3 Yes 1097 MCI-s 1.5 No 4146 MCI-u 3 Yes
4100 NC 3 Yes 1106 MCI-s 1.5 Yes 4149 MCI-u 3 Yes
4104 NC 3 Yes 1118 MCI-s 1.5 Yes 4157 MCI-u 3 Yes
4119 NC 3 Yes 1122 MCI-s 1.5 Yes 4159 MCI-u 3 Yes
4120 NC 3 Yes 1131 MCI-s 3 No 4160 MCI-u 3 Yes
4121 NC 3 Yes 1140 MCI-s 1.5 No 4162 MCI-u 3 Yes
4125 NC 3 Yes 1149 MCI-s 3 No 4168 MCI-u 3 Yes
4139 NC 3 Yes 1182 MCI-s 1.5 No 4169 MCI-u 3 Yes
4148 NC 3 Yes 1186 MCI-s 1.5 Yes 4170 MCI-u 3 Yes
4150 NC 3 Yes 1187 MCI-s 1.5 No 4171 MCI-u 3 Yes
4151 NC 3 Yes 1199 MCI-s 1.5 Yes 4175 MCI-u 3 Yes
4155 NC 3 Yes 1210 MCI-s 1.5 Yes 4184 MCI-u 3 Yes
4158 NC 3 Yes 1227 MCI-s 1.5 No 4187 MCI-u 3 Yes
4164 NC 3 Yes 1246 MCI-s 1.5 Yes 4188 MCI-u 3 Yes
4173 NC 3 Yes 1255 MCI-s 1.5 No 4194 MCI-u 3 Yes
4174 NC 3 Yes 1260 MCI-s 1.5 Yes 4197 MCI-u 3 Yes
4177 NC 3 Yes 1269 MCI-s 1.5 No 4199 MCI-u 3 Yes
4179 NC 3 Yes 1284 MCI-s 1.5 No 4205 MCI-u 3 Yes
4198 NC 3 Yes 1300 MCI-s 1.5 No 4206 MCI-u 3 Yes
4200 NC 3 Yes 1314 MCI-s 1.5 Yes 4210 MCI-u 3 Yes
4208 NC 3 Yes 1338 MCI-s 3 No 4212 MCI-u 3 Yes
4213 NC 3 Yes 1346 MCI-s 1.5 Yes 4214 MCI-u 3 Yes
4218 NC 3 Yes 1357 MCI-s 1.5 Yes 4216 MCI-u 3 Yes
4222 NC 3 Yes 1378 MCI-s 1.5 Yes 4219 MCI-u 3 Yes
4225 NC 3 Yes 1406 MCI-s 1.5 Yes 4220 MCI-u 3 Yes
4255 NC 3 Yes 1414 MCI-s 1.5 Yes 4226 MCI-u 3 Yes
4257 NC 3 No 1418 MCI-s 1.5 Yes 4229 MCI-u 3 Yes
4262 NC 3 Yes 1419 MCI-s 1.5 Yes 4232 MCI-u 3 Yes
4266 NC 3 Yes 1421 MCI-s 1.5 Yes 4235 MCI-u 3 Yes
4269 NC 3 Yes 2002 MCI-s 3 Yes 4237 MCI-u 3 Yes
4270 NC 3 Yes 2003 MCI-s 3 Yes 4241 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 160
4275 NC 3 Yes 2011 MCI-s 3 Yes 4250 MCI-u 3 Yes
4276 NC 3 Yes 2031 MCI-s 3 Yes 4251 MCI-u 3 Yes
4277 NC 3 Yes 2057 MCI-s 3 Yes 4256 MCI-u 3 Yes
4278 NC 3 Yes 2070 MCI-s 3 Yes 4259 MCI-u 3 Yes
4279 NC 3 Yes 2199 MCI-s 3 Yes 4263 MCI-u 3 Yes
4288 NC 3 Yes 2237 MCI-s 3 Yes 4268 MCI-u 3 Yes
4291 NC 3 Yes 2278 MCI-s 3 Yes 4271 MCI-u 3 Yes
4292 NC 3 Yes 4067 MCI-s 3 Yes 4281 MCI-u 3 Yes
4308 NC 3 Yes 4134 MCI-s 3 Yes 4285 MCI-u 3 Yes
4313 NC 3 Yes 4186 MCI-s 3 Yes 4287 MCI-u 3 Yes
4320 NC 3 Yes 4217 MCI-s 3 Yes 4293 MCI-u 3 Yes
4335 NC 3 Yes 4260 MCI-s 3 Yes 4297 MCI-u 3 Yes
4337 NC 3 Yes 4274 MCI-s 3 Yes 4300 MCI-u 3 Yes
4339 NC 3 Yes 4332 MCI-s 3 Yes 4301 MCI-u 3 Yes
4340 NC 3 Yes 4403 MCI-s 3 Yes 4302 MCI-u 3 Yes
4343 NC 3 Yes 4408 MCI-s 3 Yes 4303 MCI-u 3 Yes
4345 NC 3 Yes 4431 MCI-s 3 Yes 4309 MCI-u 3 Yes
4348 NC 3 Yes 4517 MCI-s 3 Yes 4310 MCI-u 3 Yes
4349 NC 3 Yes 4524 MCI-s 3 Yes 4311 MCI-u 3 Yes
4350 NC 3 Yes 4556 MCI-s 3 Yes 4312 MCI-u 3 Yes
4352 NC 3 Yes 4594 MCI-s 3 Yes 4324 MCI-u 3 Yes
4357 NC 3 Yes 4601 MCI-s 3 Yes 4328 MCI-u 3 Yes
4367 NC 3 Yes 4798 MCI-s 3 No 4331 MCI-u 3 Yes
4369 NC 3 Yes 4871 MCI-s 3 Yes 4346 MCI-u 3 Yes
4371 NC 3 Yes 4883 MCI-s 3 Yes 4351 MCI-u 3 Yes
4372 NC 3 Yes 4907 MCI-s 3 Yes 4354 MCI-u 3 Yes
4382 NC 3 Yes 4944 MCI-s 3 No 4356 MCI-u 3 Yes
4384 NC 3 Yes 4945 MCI-s 3 No 4359 MCI-u 3 Yes
4385 NC 3 Yes 5004 MCI-s 3 No 4360 MCI-u 3 Yes
4386 NC 3 Yes 42 MCI-c 1.5 No 4363 MCI-u 3 Yes
4387 NC 3 Yes 45 MCI-c 1.5 No 4377 MCI-u 3 Yes
4388 NC 3 Yes 54 MCI-c 1.5 Yes 4381 MCI-u 3 Yes
4389 NC 3 Yes 77 MCI-c 1.5 No 4383 MCI-u 3 Yes
4391 NC 3 Yes 98 MCI-c 1.5 No 4390 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 161
4393 NC 3 Yes 101 MCI-c 1.5 Yes 4392 MCI-u 3 Yes
4396 NC 3 Yes 108 MCI-c 1.5 No 4394 MCI-u 3 Yes
4399 NC 3 Yes 111 MCI-c 1.5 No 4395 MCI-u 3 Yes
4400 NC 3 Yes 126 MCI-c 1.5 No 4404 MCI-u 3 Yes
4401 NC 3 Yes 128 MCI-c 1.5 Yes 4405 MCI-u 3 Yes
4410 NC 3 Yes 141 MCI-c 1.5 Yes 4406 MCI-u 3 Yes
4421 NC 3 Yes 161 MCI-c 1.5 Yes 4415 MCI-u 3 Yes
4422 NC 3 Yes 179 MCI-c 1.5 No 4417 MCI-u 3 Yes
4424 NC 3 Yes 182 MCI-c 1.5 No 4419 MCI-u 3 Yes
4427 NC 3 Yes 195 MCI-c 1.5 No 4420 MCI-u 3 Yes
4428 NC 3 Yes 204 MCI-c 1.5 Yes 4423 MCI-u 3 Yes
4429 NC 3 Yes 227 MCI-c 1.5 Yes 4426 MCI-u 3 Yes
4441 NC 3 Yes 231 MCI-c 1.5 Yes 4430 MCI-u 3 Yes
4442 NC 3 Yes 240 MCI-c 1.5 Yes 4434 MCI-u 3 Yes
4446 NC 3 Yes 243 MCI-c 1.5 No 4438 MCI-u 3 Yes
4448 NC 3 Yes 249 MCI-c 1.5 No 4443 MCI-u 3 Yes
4449 NC 3 Yes 256 MCI-c 1.5 Yes 4444 MCI-u 3 Yes
4453 NC 3 Yes 258 MCI-c 1.5 Yes 4447 MCI-u 3 Yes
4464 NC 3 Yes 269 MCI-c 1.5 No 4455 MCI-u 3 Yes
4466 NC 3 Yes 289 MCI-c 1.5 Yes 4456 MCI-u 3 Yes
4469 NC 3 Yes 294 MCI-c 1.5 Yes 4462 MCI-u 3 Yes
4474 NC 3 Yes 314 MCI-c 1.5 Yes 4463 MCI-u 3 Yes
4482 NC 3 Yes 325 MCI-c 1.5 Yes 4465 MCI-u 3 Yes
4483 NC 3 Yes 331 MCI-c 2.9 No 4467 MCI-u 3 Yes
4485 NC 3 Yes 336 MCI-c 1.5 No 4468 MCI-u 3 Yes
4488 NC 3 Yes 344 MCI-c 1.5 Yes 4473 MCI-u 3 Yes
4491 NC 3 Yes 362 MCI-c 1.5 Yes 4475 MCI-u 3 Yes
4496 NC 3 Yes 388 MCI-c 2.9 No 4476 MCI-u 3 Yes
4499 NC 3 Yes 434 MCI-c 1.5 No 4480 MCI-u 3 Yes
4503 NC 3 Yes 461 MCI-c 1.5 Yes 4489 MCI-u 3 Yes
4505 NC 3 Yes 507 MCI-c 1.5 No 4498 MCI-u 3 Yes
4516 NC 3 Yes 511 MCI-c 1.5 Yes 4510 MCI-u 3 Yes
4545 NC 3 Yes 513 MCI-c 1.5 Yes 4514 MCI-u 3 Yes
4552 NC 3 Yes 518 MCI-c 1.5 No 4521 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 162
4555 NC 3 Yes 539 MCI-c 1.5 No 4531 MCI-u 3 Yes
4558 NC 3 Yes 549 MCI-c 1.5 Yes 4536 MCI-u 3 Yes
4559 NC 3 Yes 567 MCI-c 1.5 Yes 4538 MCI-u 3 Yes
4560 NC 3 Yes 568 MCI-c 3 No 4539 MCI-u 3 Yes
4566 NC 3 Yes 604 MCI-c 2.9 No 4547 MCI-u 3 Yes
4576 NC 3 Yes 611 MCI-c 1.5 No 4548 MCI-u 3 Yes
4577 NC 3 Yes 625 MCI-c 3 No 4553 MCI-u 3 Yes
4578 NC 3 Yes 631 MCI-c 1.5 No 4557 MCI-u 3 Yes
4579 NC 3 Yes 638 MCI-c 2.9 No 4562 MCI-u 3 Yes
4580 NC 3 Yes 649 MCI-c 2.9 No 4565 MCI-u 3 Yes
4585 NC 3 Yes 675 MCI-c 1.5 Yes 4571 MCI-u 3 Yes
4587 NC 3 Yes 695 MCI-c 1.5 Yes 4582 MCI-u 3 Yes
4604 NC 3 Yes 708 MCI-c 1.5 Yes 4584 MCI-u 3 Yes
4607 NC 3 Yes 723 MCI-c 1.5 Yes 4590 MCI-u 3 Yes
4609 NC 3 Yes 725 MCI-c 2.9 No 4596 MCI-u 3 Yes
4612 NC 3 Yes 727 MCI-c 2.9 No 4597 MCI-u 3 Yes
4620 NC 3 Yes 729 MCI-c 1.5 No 4605 MCI-u 3 Yes
4632 NC 3 Yes 750 MCI-c 1.5 No 4611 MCI-u 3 Yes
4637 NC 3 Yes 769 MCI-c 3 No 4613 MCI-u 3 Yes
4638 NC 3 Yes 834 MCI-c 1.5 No 4614 MCI-u 3 Yes
4643 NC 3 Yes 835 MCI-c 2.9 No 4621 MCI-u 3 Yes
4644 NC 3 Yes 839 MCI-c 1.5 No 4623 MCI-u 3 Yes
4645 NC 3 Yes 856 MCI-c 1.5 No 4624 MCI-u 3 Yes
4649 NC 3 Yes 860 MCI-c 1.5 Yes 4626 MCI-u 3 Yes
4652 NC 3 Yes 865 MCI-c 1.5 Yes 4636 MCI-u 3 Yes
4739 NC 3 Yes 869 MCI-c 1.5 No 4646 MCI-u 3 Yes
4762 NC 3 Yes 873 MCI-c 1.5 No 4654 MCI-u 3 Yes
4795 NC 3 Yes 874 MCI-c 1.5 No 4659 MCI-u 3 Yes
4832 NC 3 Yes 887 MCI-c 1.5 No 4668 MCI-u 3 Yes
4835 NC 3 Yes 906 MCI-c 1.5 Yes 4674 MCI-u 3 Yes
4843 NC 3 Yes 909 MCI-c 1.5 Yes 4675 MCI-u 3 Yes
4855 NC 3 Yes 913 MCI-c 2.9 No 4678 MCI-u 3 Yes
4872 NC 3 Yes 915 MCI-c 1.5 No 4679 MCI-u 3 Yes
4878 NC 3 Yes 922 MCI-c 2.9 No 4711 MCI-u 3 YesB.3. Subjects in experiments in chapter 7 163
4900 NC 3 Yes 941 MCI-c 1.5 Yes 4713 MCI-u 3 Yes
4921 NC 3 Yes 947 MCI-c 1.5 Yes 4715 MCI-u 3 Yes
4951 NC 3 Yes 952 MCI-c 1.5 No 4722 MCI-u 3 Yes
4952 NC 3 Yes 954 MCI-c 1.5 No 4723 MCI-u 3 Yes
5040 NC 3 Yes 973 MCI-c 1.5 Yes 4736 MCI-u 3 Yes
3 AD 1.5 Yes 976 MCI-c 1.5 Yes 4742 MCI-u 3 Yes
7 AD 1.5 No 982 MCI-c 1.5 No 4743 MCI-u 3 Yes
10 AD 1.5 Yes 987 MCI-c 1.5 Yes 4746 MCI-u 3 Yes
29 AD 1.5 No 1004 MCI-c 1.5 No 4750 MCI-u 3 Yes
53 AD 1.5 Yes 1007 MCI-c 1.5 Yes 4757 MCI-u 3 Yes
76 AD 1.5 No 1010 MCI-c 1.5 Yes 4764 MCI-u 3 Yes
83 AD 1.5 No 1015 MCI-c 1.5 No 4765 MCI-u 3 Yes
84 AD 1.5 No 1043 MCI-c 1.5 Yes 4769 MCI-u 3 Yes
88 AD 1.5 No 1054 MCI-c 1.5 No 4777 MCI-u 3 Yes
91 AD 1.5 No 1057 MCI-c 1.5 Yes 4780 MCI-u 3 Yes
93 AD 1.5 No 1070 MCI-c 1.5 No 4782 MCI-u 3 Yes
94 AD 1.5 No 1077 MCI-c 1.5 Yes 4791 MCI-u 3 Yes
110 AD 1.5 No 1117 MCI-c 3 No 4799 MCI-u 3 Yes
129 AD 1.5 No 1121 MCI-c 3 No 4803 MCI-u 3 Yes
139 AD 2.9 No 1126 MCI-c 3 No 4804 MCI-u 3 Yes
162 AD 1.5 No 1130 MCI-c 1.5 Yes 4805 MCI-u 3 Yes
183 AD 1.5 Yes 1135 MCI-c 1.5 Yes 4806 MCI-u 3 Yes
194 AD 1.5 No 1138 MCI-c 3 No 4813 MCI-u 3 Yes
213 AD 1.5 Yes 1148 MCI-c 2.9 No 4814 MCI-u 3 Yes
221 AD 1.5 Yes 1217 MCI-c 1.5 Yes 4815 MCI-u 3 Yes
228 AD 1.5 Yes 1240 MCI-c 1.5 Yes 4816 MCI-u 3 Yes
266 AD 1.5 Yes 1243 MCI-c 1.5 Yes 4817 MCI-u 3 Yes
299 AD 1.5 No 1244 MCI-c 1.5 No 4823 MCI-u 3 Yes
300 AD 1.5 No 1247 MCI-c 3 No 4825 MCI-u 3 Yes
310 AD 1.5 No 1265 MCI-c 1.5 Yes 4838 MCI-u 3 No
321 AD 1.5 Yes 1271 MCI-c 1.5 No 4842 MCI-u 3 Yes
332 AD 2.9 No 1282 MCI-c 1.5 Yes 4849 MCI-u 3 Yes
341 AD 1.5 Yes 1299 MCI-c 1.5 Yes 4852 MCI-u 3 Yes
343 AD 1.5 Yes 1311 MCI-c 1.5 Yes 4869 MCI-u 3 YesB.4. Subjects in experiment in chapter 8 164
366 AD 1.5 No 1315 MCI-c 1.5 Yes 4873 MCI-u 3 Yes
370 AD 1.5 Yes 1331 MCI-c 3 No 4876 MCI-u 3 Yes
374 AD 1.5 Yes 1351 MCI-c 1.5 Yes 4885 MCI-u 3 Yes
392 AD 2.9 No 1363 MCI-c 1.5 No 4889 MCI-u 3 Yes
404 AD 2.9 No 1389 MCI-c 3 No 4891 MCI-u 3 Yes
426 AD 1.5 No 1394 MCI-c 1.5 Yes 4893 MCI-u 3 Yes
431 AD 1.5 Yes 1398 MCI-c 1.5 Yes 4898 MCI-u 3 Yes
438 AD 1.5 Yes 1407 MCI-c 1.5 Yes 4902 MCI-u 3 Yes
457 AD 3 No 1412 MCI-c 1.5 Yes 4904 MCI-u 3 Yes
470 AD 1.5 Yes 1423 MCI-c 1.5 Yes 4909 MCI-u 3 Yes
487 AD 2.9 No 1427 MCI-c 1.5 Yes 4917 MCI-u 3 Yes
492 AD 1.5 Yes 2047 MCI-c 3 Yes 4919 MCI-u 3 Yes
517 AD 1.5 No 2216 MCI-c 3 Yes 4920 MCI-u 3 No
528 AD 1.5 No 2398 MCI-c 3 Yes 4925 MCI-u 3 Yes
535 AD 1.5 Yes 4005 MCI-c 3 Yes 4926 MCI-u 3 Yes
543 AD 1.5 Yes 4035 MCI-c 3 Yes 4929 MCI-u 3 Yes
547 AD 1.5 Yes 4042 MCI-c 3 Yes 4936 MCI-u 3 Yes
554 AD 1.5 Yes 4057 MCI-c 3 Yes 4941 MCI-u 3 Yes
577 AD 1.5 Yes 4094 MCI-c 3 Yes 4955 MCI-u 3 Yes
592 AD 1.5 No 4096 MCI-c 3 Yes 4960 MCI-u 3 Yes
606 AD 3 No 4102 MCI-c 3 Yes 4974 MCI-u 3 Yes
619 AD 1.5 No 4114 MCI-c 3 Yes 4976 MCI-u 3 Yes
642 AD 1.5 Yes 4131 MCI-c 3 Yes 4985 MCI-u 3 Yes
653 AD 1.5 Yes 4167 MCI-c 3 Yes 4989 MCI-u 3 Yes
733 AD 2.9 No 4189 MCI-c 3 Yes 5014 MCI-u 3 Yes
740 AD 1.5 Yes 4203 MCI-c 3 Yes
753 AD 2.9 No 4240 MCI-c 3 Yes
754 AD 1.5 Yes 4366 MCI-c 3 Yes
759 AD 1.5 No 4402 MCI-c 3 Yes
B.4 Subjects in experiment in chapter 8
The subjects used in the experiments described in chapter 8 are listed in table B.5. For each
subject, as well as the disease group, the scanner ﬁeld strength is listed. The small numberB.4. Subjects in experiment in chapter 8 165
of scans done in 2.9T scanners are grouped with the 3T scans when examining the effects of
different scanner ﬁeld strengths.
Table B.5: List of subjects used in the ARK experiments in chapter
8. ID = ADNI roster ID number, Status = disease status of subject,
T = ﬁeld strength of structural MRI in Tesla.
ID Status T ID Status T ID Status T ID Status T
2 NC 1.5 4179 NC 3 1056 AD 1.5 1187 MCI-s 1.5
5 NC 1.5 4198 NC 3 1059 AD 1.5 1199 MCI-s 1.5
8 NC 1.5 4200 NC 3 1079 AD 1.5 1210 MCI-s 1.5
14 NC 1.5 4208 NC 3 1081 AD 2.9 1227 MCI-s 1.5
16 NC 1.5 4213 NC 3 1082 AD 2.9 1246 MCI-s 1.5
19 NC 1.5 4218 NC 3 1083 AD 2.9 1255 MCI-s 1.5
21 NC 1.5 4222 NC 3 1090 AD 1.5 1260 MCI-s 1.5
22 NC 1.5 4225 NC 3 1095 AD 1.5 1268 MCI-s 1.5
23 NC 1.5 4234 NC 3 1101 AD 3 1269 MCI-s 1.5
31 NC 2.9 4254 NC 3 1102 AD 1.5 1284 MCI-s 1.5
40 NC 1.5 4255 NC 3 1109 AD 1.5 1300 MCI-s 1.5
48 NC 1.5 4257 NC 3 1137 AD 1.5 1314 MCI-s 1.5
56 NC 1.5 4262 NC 3 1144 AD 1.5 1318 MCI-s 1.5
58 NC 2.9 4266 NC 3 1152 AD 1.5 1338 MCI-s 3
59 NC 1.5 4269 NC 3 1157 AD 1.5 1340 MCI-s 3
61 NC 2.9 4270 NC 3 1161 AD 1.5 1346 MCI-s 1.5
66 NC 1.5 4275 NC 3 1164 AD 1.5 1357 MCI-s 1.5
67 NC 1.5 4276 NC 3 1170 AD 2.9 1378 MCI-s 1.5
68 NC 1.5 4277 NC 3 1171 AD 1.5 1384 MCI-s 1.5
70 NC 1.5 4278 NC 3 1184 AD 1.5 1406 MCI-s 1.5
72 NC 1.5 4279 NC 3 1185 AD 3 1414 MCI-s 1.5
74 NC 1.5 4288 NC 3 1192 AD 1.5 1417 MCI-s 1.5
81 NC 1.5 4290 NC 3 1201 AD 1.5 1418 MCI-s 1.5
86 NC 1.5 4291 NC 3 1205 AD 1.5 1419 MCI-s 1.5
89 NC 1.5 4292 NC 3 1209 AD 3 1421 MCI-s 1.5
90 NC 1.5 4308 NC 3 1221 AD 1.5 2002 MCI-s 3B.4. Subjects in experiment in chapter 8 166
96 NC 1.5 4313 NC 3 1248 AD 1.5 2003 MCI-s 3
97 NC 1.5 4320 NC 3 1253 AD 3 2011 MCI-s 3
106 NC 1.5 4335 NC 3 1254 AD 1.5 2031 MCI-s 3
113 NC 1.5 4337 NC 3 1257 AD 1.5 2057 MCI-s 3
118 NC 1.5 4339 NC 3 1262 AD 3 2070 MCI-s 3
120 NC 1.5 4340 NC 3 1263 AD 1.5 2199 MCI-s 3
123 NC 1.5 4343 NC 3 1281 AD 1.5 2237 MCI-s 3
125 NC 1.5 4345 NC 3 1283 AD 1.5 2278 MCI-s 3
130 NC 1.5 4348 NC 3 1285 AD 1.5 4067 MCI-s 3
156 NC 1.5 4349 NC 3 1289 AD 3 4134 MCI-s 3
166 NC 1.5 4350 NC 3 1290 AD 1.5 4186 MCI-s 3
171 NC 1.5 4352 NC 3 1296 AD 1.5 4217 MCI-s 3
172 NC 1.5 4357 NC 3 1304 AD 3 4260 MCI-s 3
173 NC 1.5 4367 NC 3 1307 AD 1.5 4274 MCI-s 3
177 NC 1.5 4369 NC 3 1308 AD 1.5 4332 MCI-s 3
184 NC 1.5 4371 NC 3 1334 AD 1.5 4403 MCI-s 3
186 NC 1.5 4372 NC 3 1337 AD 1.5 4408 MCI-s 3
196 NC 1.5 4376 NC 3 1339 AD 1.5 4431 MCI-s 3
223 NC 1.5 4382 NC 3 1341 AD 1.5 4517 MCI-s 3
229 NC 1.5 4384 NC 3 1354 AD 1.5 4524 MCI-s 3
230 NC 1.5 4385 NC 3 1368 AD 1.5 4556 MCI-s 3
232 NC 1.5 4386 NC 3 1371 AD 1.5 4594 MCI-s 3
245 NC 1.5 4387 NC 3 1373 AD 1.5 4601 MCI-s 3
257 NC 1.5 4388 NC 3 1377 AD 1.5 4694 MCI-s 3
259 NC 1.5 4389 NC 3 1379 AD 1.5 4745 MCI-s 3
260 NC 3 4391 NC 3 1382 AD 1.5 4798 MCI-s 3
262 NC 1.5 4393 NC 3 1385 AD 2.9 4871 MCI-s 3
272 NC 1.5 4396 NC 3 1391 AD 1.5 4883 MCI-s 3
283 NC 1.5 4399 NC 3 1397 AD 1.5 4907 MCI-s 3
295 NC 1.5 4400 NC 3 1402 AD 1.5 4944 MCI-s 3
298 NC 1.5 4401 NC 3 1409 AD 1.5 4945 MCI-s 3
301 NC 1.5 4410 NC 3 1430 AD 1.5 5004 MCI-s 3
303 NC 2.9 4421 NC 3 1435 AD 1.5 30 MCI-c 2.9
311 NC 1.5 4422 NC 3 4009 AD 3 41 MCI-c 1.5B.4. Subjects in experiment in chapter 8 167
312 NC 1.5 4424 NC 3 4024 AD 3 42 MCI-c 1.5
319 NC 1.5 4427 NC 3 4039 AD 3 45 MCI-c 1.5
327 NC 1.5 4428 NC 3 4136 AD 3 50 MCI-c 1.5
337 NC 1.5 4429 NC 3 4152 AD 3 54 MCI-c 1.5
352 NC 1.5 4433 NC 3 4153 AD 3 77 MCI-c 1.5
359 NC 1.5 4441 NC 3 4172 AD 3 98 MCI-c 1.5
360 NC 1.5 4442 NC 3 4192 AD 3 101 MCI-c 1.5
363 NC 1.5 4446 NC 3 4195 AD 3 108 MCI-c 1.5
382 NC 2.9 4448 NC 3 4201 AD 3 111 MCI-c 1.5
386 NC 1.5 4449 NC 3 4209 AD 3 126 MCI-c 1.5
403 NC 2.9 4453 NC 3 4211 AD 3 128 MCI-c 1.5
405 NC 3 4464 NC 3 4215 AD 3 141 MCI-c 1.5
413 NC 1.5 4466 NC 3 4223 AD 3 161 MCI-c 1.5
416 NC 1.5 4469 NC 3 4252 AD 3 179 MCI-c 1.5
419 NC 1.5 4474 NC 3 4258 AD 3 182 MCI-c 1.5
436 NC 1.5 4482 NC 3 4280 AD 3 195 MCI-c 1.5
441 NC 3 4483 NC 3 4282 AD 3 204 MCI-c 1.5
454 NC 1.5 4485 NC 3 4307 AD 3 217 MCI-c 1.5
459 NC 1.5 4488 NC 3 4338 AD 3 222 MCI-c 1.5
467 NC 1.5 4491 NC 3 4353 AD 3 227 MCI-c 1.5
484 NC 1.5 4496 NC 3 4373 AD 3 231 MCI-c 1.5
488 NC 2.9 4499 NC 3 4379 AD 3 240 MCI-c 1.5
489 NC 1.5 4503 NC 3 4477 AD 3 241 MCI-c 1.5
493 NC 2.9 4505 NC 3 4494 AD 3 243 MCI-c 1.5
498 NC 1.5 4508 NC 3 4500 AD 3 249 MCI-c 1.5
500 NC 1.5 4512 NC 3 4526 AD 3 256 MCI-c 1.5
502 NC 1.5 4516 NC 3 4546 AD 3 258 MCI-c 1.5
506 NC 1.5 4545 NC 3 4549 AD 3 269 MCI-c 1.5
516 NC 1.5 4552 NC 3 4583 AD 3 289 MCI-c 1.5
519 NC 1.5 4555 NC 3 4589 AD 3 293 MCI-c 1.5
520 NC 1.5 4558 NC 3 4591 AD 3 294 MCI-c 1.5
522 NC 1.5 4559 NC 3 4615 AD 3 314 MCI-c 1.5
526 NC 1.5 4560 NC 3 4641 AD 3 325 MCI-c 1.5
533 NC 1.5 4566 NC 3 4657 AD 3 326 MCI-c 1.5B.4. Subjects in experiment in chapter 8 168
534 NC 1.5 4576 NC 3 4660 AD 3 331 MCI-c 2.9
538 NC 1.5 4577 NC 3 4672 AD 3 336 MCI-c 1.5
545 NC 1.5 4578 NC 3 4686 AD 3 344 MCI-c 1.5
548 NC 1.5 4579 NC 3 4692 AD 3 362 MCI-c 1.5
553 NC 3 4580 NC 3 4696 AD 3 388 MCI-c 2.9
555 NC 1.5 4585 NC 3 4707 AD 3 390 MCI-c 1.5
558 NC 1.5 4586 NC 3 4728 AD 3 394 MCI-c 1.5
559 NC 1.5 4587 NC 3 4730 AD 3 423 MCI-c 1.5
575 NC 1.5 4599 NC 3 4732 AD 3 434 MCI-c 1.5
576 NC 1.5 4604 NC 3 4733 AD 3 461 MCI-c 1.5
578 NC 1.5 4607 NC 3 4755 AD 3 507 MCI-c 1.5
601 NC 1.5 4609 NC 3 4756 AD 3 511 MCI-c 1.5
602 NC 3 4612 NC 3 4770 AD 3 513 MCI-c 1.5
605 NC 3 4616 NC 3 4774 AD 3 518 MCI-c 1.5
610 NC 1.5 4620 NC 3 4783 AD 3 539 MCI-c 1.5
618 NC 1.5 4632 NC 3 4801 AD 3 549 MCI-c 1.5
622 NC 3 4637 NC 3 4802 AD 3 563 MCI-c 1.5
640 NC 2.9 4638 NC 3 4820 AD 3 567 MCI-c 1.5
643 NC 1.5 4643 NC 3 4827 AD 3 568 MCI-c 3
647 NC 1.5 4644 NC 3 4845 AD 3 572 MCI-c 3
648 NC 1.5 4645 NC 3 4853 AD 3 604 MCI-c 2.9
657 NC 1.5 4649 NC 3 4863 AD 3 611 MCI-c 1.5
672 NC 1.5 4652 NC 3 4867 AD 3 625 MCI-c 3
677 NC 3 4688 NC 3 4887 AD 3 631 MCI-c 1.5
680 NC 1.5 4739 NC 3 4892 AD 3 638 MCI-c 2.9
681 NC 1.5 4762 NC 3 4894 AD 3 649 MCI-c 2.9
684 NC 1.5 4795 NC 3 4905 AD 3 658 MCI-c 1.5
685 NC 1.5 4832 NC 3 4906 AD 3 667 MCI-c 1.5
686 NC 1.5 4835 NC 3 4910 AD 3 675 MCI-c 1.5
692 NC 1.5 4843 NC 3 4911 AD 3 695 MCI-c 1.5
711 NC 1.5 4855 NC 3 4924 AD 3 697 MCI-c 1.5
717 NC 1.5 4872 NC 3 4938 AD 3 708 MCI-c 1.5
726 NC 1.5 4878 NC 3 4940 AD 3 723 MCI-c 1.5
731 NC 1.5 4900 NC 3 4949 AD 3 725 MCI-c 2.9B.4. Subjects in experiment in chapter 8 169
734 NC 1.5 4921 NC 3 4954 AD 3 727 MCI-c 2.9
741 NC 1.5 4951 NC 3 4962 AD 3 729 MCI-c 1.5
751 NC 1.5 4952 NC 3 4971 AD 3 750 MCI-c 1.5
761 NC 1.5 5040 NC 3 4992 AD 3 752 MCI-c 2.9
767 NC 1.5 3 AD 1.5 5012 AD 3 769 MCI-c 3
768 NC 1.5 7 AD 1.5 5013 AD 3 834 MCI-c 1.5
778 NC 1.5 10 AD 1.5 5015 AD 3 835 MCI-c 2.9
779 NC 1.5 29 AD 1.5 5017 AD 3 839 MCI-c 1.5
810 NC 1.5 53 AD 1.5 5018 AD 3 856 MCI-c 1.5
813 NC 1.5 76 AD 1.5 5019 AD 3 860 MCI-c 1.5
818 NC 1.5 78 AD 2.9 5028 AD 3 861 MCI-c 1.5
824 NC 1.5 83 AD 1.5 4 MCI-s 1.5 865 MCI-c 1.5
842 NC 1.5 84 AD 1.5 33 MCI-s 1.5 869 MCI-c 1.5
843 NC 1.5 88 AD 1.5 51 MCI-s 1.5 873 MCI-c 1.5
862 NC 1.5 91 AD 1.5 102 MCI-s 1.5 874 MCI-c 1.5
863 NC 1.5 93 AD 1.5 107 MCI-s 1.5 878 MCI-c 1.5
866 NC 1.5 94 AD 1.5 116 MCI-s 1.5 887 MCI-c 1.5
876 NC 1.5 110 AD 1.5 135 MCI-s 1.5 906 MCI-c 1.5
883 NC 1.5 129 AD 1.5 150 MCI-s 1.5 909 MCI-c 1.5
886 NC 1.5 139 AD 2.9 158 MCI-s 1.5 913 MCI-c 2.9
896 NC 1.5 149 AD 1.5 160 MCI-s 1.5 915 MCI-c 1.5
898 NC 1.5 162 AD 1.5 169 MCI-s 1.5 922 MCI-c 2.9
899 NC 1.5 167 AD 1.5 176 MCI-s 1.5 941 MCI-c 1.5
907 NC 1.5 183 AD 1.5 178 MCI-s 1.5 947 MCI-c 1.5
920 NC 2.9 194 AD 1.5 200 MCI-s 1.5 952 MCI-c 1.5
923 NC 1.5 213 AD 1.5 225 MCI-s 1.5 954 MCI-c 1.5
926 NC 3 216 AD 1.5 273 MCI-s 1.5 973 MCI-c 1.5
931 NC 1.5 219 AD 1.5 276 MCI-s 1.5 976 MCI-c 1.5
934 NC 1.5 221 AD 1.5 285 MCI-s 1.5 982 MCI-c 1.5
951 NC 1.5 228 AD 1.5 288 MCI-s 1.5 987 MCI-c 1.5
963 NC 3 266 AD 1.5 290 MCI-s 3 997 MCI-c 1.5
967 NC 1.5 299 AD 1.5 291 MCI-s 1.5 1004 MCI-c 1.5
969 NC 1.5 300 AD 1.5 292 MCI-s 1.5 1007 MCI-c 1.5
972 NC 1.5 310 AD 1.5 307 MCI-s 2.9 1010 MCI-c 1.5B.4. Subjects in experiment in chapter 8 170
981 NC 1.5 316 AD 1.5 324 MCI-s 3 1015 MCI-c 1.5
984 NC 1.5 321 AD 1.5 339 MCI-s 1.5 1043 MCI-c 1.5
985 NC 1.5 328 AD 1.5 351 MCI-s 1.5 1054 MCI-c 1.5
1002 NC 1.5 332 AD 2.9 361 MCI-s 1.5 1057 MCI-c 1.5
1013 NC 1.5 341 AD 1.5 376 MCI-s 2.9 1066 MCI-c 3
1014 NC 1.5 343 AD 1.5 378 MCI-s 1.5 1070 MCI-c 1.5
1016 NC 2.9 356 AD 1.5 389 MCI-s 1.5 1073 MCI-c 1.5
1021 NC 1.5 366 AD 1.5 407 MCI-s 1.5 1077 MCI-c 1.5
1023 NC 1.5 370 AD 1.5 408 MCI-s 1.5 1117 MCI-c 3
1035 NC 2.9 372 AD 1.5 424 MCI-s 1.5 1121 MCI-c 3
1063 NC 1.5 374 AD 1.5 445 MCI-s 1.5 1126 MCI-c 3
1086 NC 2.9 392 AD 2.9 448 MCI-s 3 1130 MCI-c 1.5
1094 NC 1.5 404 AD 2.9 449 MCI-s 1.5 1135 MCI-c 1.5
1098 NC 2.9 426 AD 1.5 464 MCI-s 1.5 1138 MCI-c 3
1099 NC 1.5 431 AD 1.5 469 MCI-s 2.9 1148 MCI-c 2.9
1123 NC 3 438 AD 1.5 481 MCI-s 1.5 1213 MCI-c 1.5
1169 NC 3 457 AD 3 501 MCI-s 2.9 1217 MCI-c 1.5
1190 NC 3 470 AD 1.5 505 MCI-s 1.5 1224 MCI-c 1.5
1194 NC 1.5 474 AD 1.5 546 MCI-s 1.5 1240 MCI-c 1.5
1195 NC 1.5 487 AD 2.9 552 MCI-s 1.5 1243 MCI-c 1.5
1197 NC 1.5 492 AD 1.5 557 MCI-s 1.5 1244 MCI-c 1.5
1200 NC 1.5 497 AD 1.5 588 MCI-s 1.5 1247 MCI-c 3
1202 NC 1.5 517 AD 1.5 590 MCI-s 1.5 1265 MCI-c 1.5
1203 NC 1.5 528 AD 1.5 607 MCI-s 3 1271 MCI-c 1.5
1206 NC 3 535 AD 1.5 608 MCI-s 1.5 1282 MCI-c 1.5
1222 NC 3 543 AD 1.5 613 MCI-s 3 1295 MCI-c 1.5
1232 NC 2.9 547 AD 1.5 621 MCI-s 1.5 1299 MCI-c 1.5
1242 NC 2.9 554 AD 1.5 626 MCI-s 1.5 1311 MCI-c 1.5
1249 NC 2.9 565 AD 1.5 641 MCI-s 1.5 1315 MCI-c 1.5
1250 NC 3 577 AD 1.5 644 MCI-s 1.5 1331 MCI-c 3
1251 NC 3 592 AD 1.5 656 MCI-s 1.5 1351 MCI-c 1.5
1256 NC 3 606 AD 3 671 MCI-s 1.5 1363 MCI-c 1.5
1261 NC 1.5 619 AD 1.5 673 MCI-s 1.5 1387 MCI-c 2.9
1267 NC 3 627 AD 1.5 679 MCI-s 1.5 1389 MCI-c 3B.4. Subjects in experiment in chapter 8 171
1276 NC 2.9 642 AD 1.5 698 MCI-s 1.5 1393 MCI-c 1.5
1280 NC 1.5 653 AD 1.5 709 MCI-s 1.5 1394 MCI-c 1.5
1288 NC 3 690 AD 1.5 715 MCI-s 1.5 1398 MCI-c 1.5
1301 NC 3 691 AD 3 746 MCI-s 1.5 1407 MCI-c 1.5
1306 NC 1.5 696 AD 1.5 770 MCI-s 1.5 1412 MCI-c 1.5
2201 NC 3 699 AD 1.5 771 MCI-s 2.9 1423 MCI-c 1.5
4003 NC 3 724 AD 2.9 782 MCI-s 1.5 1425 MCI-c 1.5
4010 NC 3 730 AD 1.5 792 MCI-s 2.9 1427 MCI-c 1.5
4014 NC 3 733 AD 2.9 800 MCI-s 1.5 2047 MCI-c 3
4018 NC 3 740 AD 1.5 830 MCI-s 3 2216 MCI-c 3
4020 NC 3 753 AD 2.9 851 MCI-s 1.5 2398 MCI-c 3
4021 NC 3 754 AD 1.5 867 MCI-s 1.5 4005 MCI-c 3
4026 NC 3 759 AD 1.5 871 MCI-s 1.5 4015 MCI-c 3
4028 NC 3 760 AD 1.5 908 MCI-s 1.5 4035 MCI-c 3
4032 NC 3 777 AD 1.5 912 MCI-s 2.9 4042 MCI-c 3
4037 NC 3 784 AD 1.5 914 MCI-s 1.5 4057 MCI-c 3
4041 NC 3 790 AD 1.5 919 MCI-s 1.5 4094 MCI-c 3
4043 NC 3 793 AD 1.5 921 MCI-s 1.5 4096 MCI-c 3
4050 NC 3 796 AD 1.5 925 MCI-s 1.5 4102 MCI-c 3
4060 NC 3 812 AD 3 945 MCI-s 1.5 4114 MCI-c 3
4066 NC 3 814 AD 3 950 MCI-s 1.5 4131 MCI-c 3
4075 NC 3 816 AD 1.5 961 MCI-s 1.5 4167 MCI-c 3
4076 NC 3 828 AD 3 989 MCI-s 1.5 4189 MCI-c 3
4080 NC 3 836 AD 1.5 994 MCI-s 1.5 4203 MCI-c 3
4081 NC 3 841 AD 1.5 1030 MCI-s 1.5 4240 MCI-c 3
4082 NC 3 844 AD 3 1031 MCI-s 2.9 4366 MCI-c 3
4084 NC 3 850 AD 1.5 1032 MCI-s 1.5 4402 MCI-c 3
4086 NC 3 852 AD 1.5 1034 MCI-s 1.5 4414 MCI-c 3
4090 NC 3 853 AD 1.5 1040 MCI-s 1.5 4432 MCI-c 3
4092 NC 3 884 AD 1.5 1045 MCI-s 1.5 4502 MCI-c 3
4093 NC 3 889 AD 1.5 1046 MCI-s 3 4515 MCI-c 3
4100 NC 3 891 AD 1.5 1052 MCI-s 1.5 4530 MCI-c 3
4104 NC 3 916 AD 3 1072 MCI-s 3 4595 MCI-c 3
4119 NC 3 929 AD 1.5 1078 MCI-s 1.5 4661 MCI-c 3B.4. Subjects in experiment in chapter 8 172
4120 NC 3 938 AD 1.5 1080 MCI-s 1.5 4680 MCI-c 3
4121 NC 3 955 AD 1.5 1088 MCI-s 2.9 4689 MCI-c 3
4125 NC 3 956 AD 1.5 1097 MCI-s 1.5 4706 MCI-c 3
4139 NC 3 979 AD 1.5 1106 MCI-s 1.5 4712 MCI-c 3
4148 NC 3 991 AD 1.5 1114 MCI-s 1.5 4784 MCI-c 3
4150 NC 3 996 AD 2.9 1118 MCI-s 1.5 4796 MCI-c 3
4151 NC 3 999 AD 1.5 1122 MCI-s 1.5 4857 MCI-c 3
4155 NC 3 1001 AD 1.5 1131 MCI-s 3 4888 MCI-c 3
4158 NC 3 1018 AD 1.5 1140 MCI-s 1.5 4899 MCI-c 3
4164 NC 3 1024 AD 1.5 1149 MCI-s 3 4918 MCI-c 3
4173 NC 3 1027 AD 1.5 1155 MCI-s 1.5 4928 MCI-c 3
4174 NC 3 1041 AD 1.5 1182 MCI-s 1.5
4176 NC 3 1044 AD 1.5 1183 MCI-s 1.5
4177 NC 3 1055 AD 2.9 1186 MCI-s 1.5References 173
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